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ABSTRACT
Dengue viruses (DV) are re-emerging mosquito-borne pathogens for which four distinct
lineages , grouped based on serology and referred to as serotypes 1-4 (D I V - D4 V), have
been described. Epidemiological data imply that re-infection with a "heterologous
serotype , i. , one other than that to which the individual was originally exposed
enhances the risk for development of severe disease , dengue hemorrhagic fever (DHF).
The hallmark of DHF is a transient capilary leakage syndrome of rapid onset, temporally
associated with the resolution of fever and viremia. In its most grave form, the vascular
permeability phenomenon in DHF may progress to dengue shock syndrome (DSS), which
is often fatal in the absence of appropriate medical care.
. Despite the fulminant natue of vascular leakage during DHF/DSS , this
phenomenon does not appear to be due to direct cytopathic effects ofDV. Rather
inappropriate reactivation and/or regulation of dengue-specific memory are the prevailing
theorized (immunopathological) etiologies. Traditional vaccine development techniques
have proven insuffcient for DV
, .
since any vaccine must offer complete protection
against all four serotyes to avoid enhanced pathology on natural viral challenge.
Understanding the underlying mechanisms that contribute to dengue disease, particularly
the development of dengue-specific memory, is therefore of critical importance.
Dengue immunopathology and the specific aspects of immunological memory
that determine disease severity are heatedly debated. Previous research in our lab has
suggested that T cell responses contribute to the severity of dengue ilness. Clinical data
indicate enhanced immune activation in more grave cases of DV infection, and serotype
cross-reactive T cells from multiple individuals are present after both primary and
secondary dengue infections. However, little is known about the conditions under which
T cells are primed and dengue-specific memory is generated.
Dendritic cells (DCs) are bone' marrow-derived cells that playa central role in
directing activity within the immune system. DCs shape quantitative and qualitative
aspects of adaptive- immunity, and therefore the intrinsic characteristics of host memory
to a pathogen. DCs are essential in generating primary immune responses, due to their
particular effectiveness in stimulating naIve T cells. DCs also play important roles in the
reaCtivation of memory to an infectious agent, and as reservoirs for the dissemination of
invading microorganisms. Exposure to pathogens or their products initiates a series of
phenotyic and functional changes in DCs , termed maturation. DC maturation involves a
coordinated response of immunomodulatory surface molecule elaboration and cytokine
production, culminating in antigen presentation to, and co-stimulation of, T cells specific
for the invading agent. The DC response is ostensibly tailored to facilitate effective
eliniination by regulating effective downstream interactions of the DC with T cells.
A number of viruses have evolved to infect DCs and alter their functional
behavior, facilitating their own survival within the host, and the herd. DV readily infects
DCs both in primary cell cultues and in vivo. However, reports on the effects of DV
infection on DC maturation vary both with regard to some of the cytokines produced, and
the phenotyes of infected versus bystander cells. Although DCs appear to be activated
following DV exposure , responses on the single-cell level appear to depend on the
infection state of the cell , hypothetically driven by intracellular virus-mediated effects.
Therefore , downstream responses to these divergent populations- , actively infected
Vll
cells versus uninfected bystander cells-are likely to be the consequence of at least two
modes of DC behavior. Because DCs playa pivotal role in adaptive immune
development, and because the resulting memory response appears to be critical in
affecting disease pathology after heterologous DV re- infection, I sought to explore the
phenom na of DC maturation in response to dengue exposure, and to begin to answer the
question of how active infection alters the fuctional capabilities of bCs. Notably,
primary dengue infection is generally well-controlled with minimal pathology.
Therefore\ this thesis addresses the hypothesis that DV infection ofDCs results in cellular
activation and stimulation of antiviral immunity, despite virus-mediated alteration of DC
maturation.
In order to address this hypothesis , I examined both DV infection-dependent and-
independent effects on DC functional responses including surface molecule regulation
secretory activity, and CD4 T cell allostimulatory priming. DCs derived from human
peripheral blood monocytes were readily infected with multiple strains of DV. DV
infection of DCs derived from separate donors was dose-dependent, with substantial
variability in DC susceptibility to infection. Exposure to live DV activated surface
molecule expression in DCs, similar to the effects of defined maturation stimuli
including a combination ofTNF-a and IFN-a , or LPS. In addition, UV- inactivated DV
induced expression of cell surface molecules, albeit to a lesser extent than did live virus
demonstrating inherenf stimulatory properties of DV particles. Using intracellular
staining for DV envelope (E) protein, I detected increased surface molecule expression
on both infected DCs and uninfected bystander DCs from the same culture, as compared
to mock-infected DCs. These data indicate that activation was not prevented in cells
Vll
undergoing active viral replication. However, the degree of surface molecule induction
depended on the infection state of the cell. Infected DCs had enhanced PD-L2 and MHC
n expression relative to uninfected bystander cells, while PD- , CD80 , CD86 , and
MHC I expression were suppressed with active infection. Therefore, intracellular DV
replication altered the process of cell surface molecule regulation within these cells.
DV infection of DCs also resulted in the secretion of a broad array of cytokines
and chernokines. These included the antiviral cytokine IFN-a, inflammatory cytokines
TNF-a, IL- , and IL- , and inflammatory chemokines IPlO , MCP- , MIP- , and
RANTES. DV infection did not induce DC production of the IL- 12 p70 heterodimer, and
secretion of the immunosuppressive cytokine IL- IO was low in most experiments.
Similar to the results seen with surface molecule induction, UV inactivation ofDV
reduced, but did not eliminate, cytokine and chemokine responses. At the single-cell
level, TNF-a and IPIO production profiles of infected DCs and uninfected bystander DCs
were distinct. DV infection in DCs reduced production ofIPlO , but stimulated TNF-a
as compared to. uninfected bystander cells in the same culture. Blocking experiments
demonstrated that IFN-a/ produced by DCsin response to infection actively inhibited
viral protein expression and drove IPIO, but not TNF-a , production.
DV infection of DCs did not consistently suppress DC stimulation of allogeneic
CD4 T cell proliferation. In cases where infection enhanced DC stimulatory function, T
cell proliferation was less pronounced than that induced by DCs activated with
exogenous TNF-a plus IFN-a. Increasing multiplicity of infection (MOI) ofDCs with
DV resulted in increasing DC infection rates , but a statistically significant trend at the
highest MOIs for decreased T cell alloproliferation, suggesting that direct infection of
DCs reduces their CD4 T cell priming function. MOI-dependent reduction in DC
stimulatory function depended on replication-competent virus. Increased MOIs during
DV infection ofDCs did not cause an elevation in detectable IL- I 0 in supernatants
derived from T-DC co-cultures. In addition, increased DV MOI ofDCs was not
associated with increased levels of either IL- 13 or IFN-y in supernatants from T - DC co-
culture , suggesting that actively infected DC do not skew CD4 T cells towards a specific
T h phenotype. These data demonstrate that DV infection induces functional maturation
ofDCs that is modified by the presence of virus through both IFN-dependent and
independent mechanisms. However, the allostimulatory phenotye of DCs was not
universally enhanced, nor was it skewed towards antiviral (Th l)-type responses.
These data suggest a model whereby dengue infection during primary illness
results in controlled immune stimulation through activation of bystander DCs, and the
generation of mixed T h-type responses.' Direct DV infection of DCs appears to attenuate
activation of, and potentially clearance by, antiviral mechanisms. During secondary
infection, reduced IPlO production and enhanced TNF-a secretion by infected cells
coupled with MHC I downregulation and enhanced PD-L2 expression, would subvert
both T h I CD4 T cell recruitment and result in CD8 T cell suppression and death.
Furthermore, DV -specific effects on DCs would allow for continued viral replication in
the absence of effective clearance. These DV-mediated effects would modify T cell
memory responses to infected DC , and potentially facilitate the expansion of pathologic
T cell subsets. Contributing to this pathological cascade, antibody-dependent
enhancement of infection in monocytic cells and macrophages would shift antigen
presentation and cytokine production paradigms , increasing the risk ofDHF.
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CHAPTER I
INTRODUCTION
. AN OVERVIEW OF VACCINATION AND EMERGING VIRAL DISEASE
The past two centuries have seen remarkable changes in Western medicine; perhaps most
notably in the way we combat infectious disease. Just before the turn of the 18 century,
Edward Jenner s scientific approach to vaccination against smallpox provided a
documented means to combat variola major without the use of variolation-inoculation
with the less virulent form ofsllallpox variola minor (Jenner, 1798). Word of the
success of vaccination swept Europe, and the procedure became increasingly customary,
rapidly gaining in public acceptance. By the close of the 1800s, advances in public and
personathygiene , combined with the work of the pillars of the scientific community
(particularly Ehrlich, Pasteur, Koch, and von Behring), heralded great advances in the
ability of humankind to combat infectious agents. However, with the notable exceptions
of the viruses rabies and smallpox , vaccines were essentially restricted to controlling
bacterial disease (reviewed by Hilleman, 1998).
A few short decades later the HINI influenza pandemic of 1918- l920 left in its
wake an estimated death toll of 50 milion human lives. The panic and devastation that
influenza caused in both civilian and military populations arguably ended the First World
War and eventually led to a massive overhaul of medical institutions in the U.S (Barr,
2004). Federal intervention in U.S. medical practice included wholesale restructuring
(and often elimination) of the vast majority of medical schools, and instigated widespread
rethinking of medical education, including far more rigorous selection and training of
candidate physicians (Barr, 2004). The resulting changes facilitated the rise of modern
medical science in the United States-specifically, medical practice based on scientific
principles , as espoused in Europe (Barr, 2004).
After the end of World War I, viral vaccine technological development
accelerated. Sterile culture methods allowed Theiler to generate a remarkably safe and
effective vaccine against yellow fever virus (YFV), marking yet another pivotal move in
medicine s chess match against viral disease. By the late 1950s, inactivated vaccines
included those for Japanese encephalitis , influenza, poliomyelitis, and adenoviruses. In
particular, Enders s work with poliomyelitis paved the way for the generation of live
. attenuated vaccines , which would soon include those for measles (MV), mumps , and
rubella in the late 1960s (Hileman, 1998). By the close of the 20 century, an improved
understanding of genetics accompanied by the generation of recombinant viral proteins in
cultured vectors (in this case, yeast) provided the means to mass-produce a vaccine
against the hepatitis B virus (HBV) in 1984 (McAleer et aI. , 1984).
Arguably, the halcyon moment of these advances was to come as a return to the
starting point. More than two hundred years in the making, and perhaps the single
greatest accomplishment in medical history, was the elimination from natual circulation
of humankind' s deadliest and most feared foe, smallpox (variola major and minor). The
last documented natural infection with smallpox occurred in Somalia, on the 26th of
October in I 977. Shortly thereafter (in 1980), culminating an aggressive decades- long
vaccination strategy on a global scale, the World Health Organization (WHO) officially
declared this ancient scourge-which may have been responsible for the deaths of
Egyptian pharaohs and the fall of the Aztec empire in Mexico-eradicated (WHO , 1980).
However, despite many great successes , the flow of new vaccines against viral disease
was drying up as the 20 century neared its close.
It wasn t long before the general sense of urgency was joined with the funding
needed to rekindle vaccination studies. On June 5 , 1981 , principal author Michael
Gottlieb and collaborators at UCLA and Cedars-Mt. Sinai reported five cases of a
tyically rare opportnistic infection with the parasite Pneumocystis carin ii in otherwise
healthy young men (Gottliebet aI. , 1981). Today, the virus responsible is known as
human immunodeficiency virs (HIV), the causative agent of acquired
immunodeficiencysyndiome, AIDS. HIV and its associated constellation of
opportnistic and neoplastic diseases became a source of intense public and media focus
and arguably helped drive the burgeoning research and healthcare establishment in the
late 20 century.
Lost in the furor over HIV' sdevastating global impact is the fact that this virus is
. clearly not alone as an emerging infectious disease with major implications for public
health. Also in 1981 , another epidemic was occurrng in Cuba. In the most severe cases
patients experienced abnormal bleeding, hepatomegaly, and a fulminant capilary leakage
syndrome resulting in circulatory failure, shock and sometimes death (Guzman et al.
1990). The causative agent was dengue virus (DV), a small RNA virus closely related to
the virus that causes yellow fever. This and previous dengue epidemics , particularly in
Southeast Asia, represen ed a cautionary message to the world: a viral threat, largely
ignored, was in the midst of a dramatic resurgence. Unlike yellow fever, dengue had not
been so amenable to vaccine development, despite more than five decades of scientific
\1-
progress. Today, several vaccines are in development but none is yet commercially
available, although this may change given growing public demand.
. A HISTORY OF DENGUE ILLNESS
Putative dengue disease had been described in the Americas as early as the late 1700s. In
1780 , Philadelphia physician Benjamin Rush reported treating patients who suffered from
a dengue- like illness in his home city (Rush, 1789). Because of profound differences in
the understanding of disease etiology at that time, a definitive clinical history of the
emergence of DV is limited and largely speculative. However, it has been suggested
based on an analysis of nucleotide substitution rates in multiple dengue viruses that the
most likely timeframe for dengue viral emergence from sylvatic(i, , with monkeys
being the primate host) to sustained human transmission occurred between 280 and 380
years ago , with accelerated genetic divergence appearing in the last century (Twiddy et
aI. , 2003).
During World War II , Japanese scientists first isolated DV (Kimura, 1944), and
American scientists confirmed their findings just a few years later. Interest in dengue as
a disease had been piqued by the toll it exacted on both American and Japanese troops
during the war in the Pacific theater. By 1952, American scientists had isolated and
described another distinct dengue virus (or serotype, as this distinction is based on
serology) and were gainIng an understanding of the relation ofDV serology to disease
(Sabin, 1952). Today, it is understood that there are four dengue virus serotypes (DI 
D4V), which may circulate simultaneously within a given region, a state termed
hyperendemicity." The interrelated roles that antigenic variability and co-circulation of
multiple DV serotyes play in disease will be discussed in greater detail in coming
sections.
. In the years following World War II and up until the present day, major dengue
outbreaks have occured in tropical regions around the globe and appear to be doing so
with increasing frequency and severity. Today, the global incidence of dengue infection
is estimated at over 50 million cases per year (reviewed by Gubler
, 2002), with the WHO
reporting 200 thousand to 500 thousand cases of severe disease
, dengue hemorrhagic
fever (DHF) (WHO , 2002).
. ECOLOGY OF DENGUE VIRUSES AND THEIR VECTORS
DVs are meinbers of the genus Flavivirus in the family of vi fUses Flaviviridae. Yellow
fever virus is the prototye
, and the agent from which the nomenclature is derived (favus
designating yellow in Latin). The flavivirus genus contains over 70 viruses
, of which
several are the cause of emergent or re-emergent diseases. Phylogenetic analyses clearly
indicate that flavivirses that belong to the mosquito-borne clades represent a distinct
evolutionary lineage ITom the other vector (tick)-borne flaviviruses (Kuno et ai. , 1998;
Billoir et ai. , 2000). More than half of the flaviviruses are transmitted by mosquito
vectors, as is the case for YFV , DV, and two additional important human pathogens such
as Japanese encephalitis virus (JEV) and West Nile virus (WNV) (reviewed by
Mackenzie etal. , 2004). edes aegypti and Aedes albopictus mosquitoes are the primary
vectors for dengue transmission; the former also transmits YFV
, particularly in Africa.
In the life cycle of both viruses primates are the vertebrate host
, although unlike YFV
DV does not require a sylvatic reservoir, a characteristic that may have evolved in
concert with the feeding habits of its major vector Aedes aegypti.
Aedes aegypti is a "domesticated" species , having adapted effciently to thrive in
areas affected by human habitation, where it reproduces in standing water collected in old
tires , barrels , and similar refuse, or in stagnant pools in cleared areas. Aedes aegypti 
active throughout the day, and thus adapted to human diurnal behavior. Commonly
. found in urban environments , mosquitoes of this species are fastidious feeders , and a
single mosquito with access to multiple individuals is likely to bite often, and repeatedly,
especially when disturbed (reviewed by Gubler, 1998). This particular characteristic may
be exaggerated by a host of neurological effects that DV infection has on the mosquito
. increasing the time needed for feeding and hypothetically increasing the chance for
interruption and movement to another host (Platt et al. , 1997).
During the first half of the 20 century in the Americas , efforts to reduce yellow
fever through mosquito control, which included spraying and the elimination of
reservoirs for standing water, were effective in limiting the range of endemic dengue
(Gubler, 1998). However, relaxation of these control measures has resulted in re-
establishment of endemic dengue in many historically affected areas. International travel
has exacerbated the problem by introducing variant-and potentially more virulent-
strains into new environs (Gubler, 1998). In effect, human mobility combined with lax
vector control, reduced pUblic education , and significant genetic diversity among DVs all
appear to be contributing to the broadening range and apparent increase in severity of
dengue disease.
. THE BIOLOGY OF DENGUE VIRUSES
Flaviviruses are single-stranded RNA viruses of (+) polarity, with an approximately ll-
kb genome surrounded by capsid (C)'protein. The viral capsid is enclosed in a lipid
envelope that is derived from host.cellular membranes and contains the two other dengue
. structural proteins , membrane (M) and envelope (E). The structural proteins are encoded
at the 5' end of the dengue genome , in the order C , pre-membrane (prM), and E. TheE
protein mediates binding to the host cell membrane, at which point the virus is
internalized through receptor-mediated endocytosis. The seven non-structural proteins
follow, in sequence order, 5' to 3' : NSI , NS2A, NS2B , NS3 , NS4A, NS4B , and NS5. 5'
and 3' untranslated regions flank the coding portion of the genome , which is translated
from a single open reading frame (ORP) to yield a single polypeptide (reviewed by
Lindenbach, 200 I).
A number of molecules have been proposed as the host receptors for dengue
virus , including heat shock proteins (Reyes-Del Valle et ai. , 2005), CD14-associated
molecules (Chen et aI. , 1999) and glycosaminoglycans such asheparan sulfate (Chen et
, 1997), which may be involved in concentrating the virus at the host cell surface.
Several groups have also demonstrated that the C-type lectin, dendritic cell (DC)-specific
intracellular adhesion molecule-3 (ICAM-3)-grabbing non- integrin (DC-SIGN), mediates
infection of dendritic cells , which naturally express DC-SIGN at high levels prior to
activation (TassaneetritHep et aI. , 2003; Lozach et aI. , 2005; Kwan et aI. , 2005).
Immortalized cell lines that are normally ineffciently infected by DV become highly
susceptible to infection following ectopic expression of DC-SIGN or its homologue
liverllymph node-specific ICAM- grabbing non-integrin (L-SIGN). L-SIGN is
expressed on specialized endothelial cells in the liver and lymph nodes , suggesting that
high-level dengue infection may target multiple tissues in vivo. An antibody that cross-
reacts with both DC-SIGN and L-SIGN blocks infection in either ectopic expression
system; this suggests that infection requires binding to a shared epitope on the two
molecules (Tassaneetrithep et aI. , 2003). Surprisingly, in two reports the internalization
sequence of DC-SIGN was dispensable for dengue infectivity, suggesting that additional
. molecules are involved in virs internalization (Lozach et aI. , 2005; Tassaneetrthep et aI.
2003). The broader context of these findings wil be discussed later in this Introduction
(see "Dengue virus infection of dendritic cells "
Studies with the flavivirus tick-borne encephalitis (TBE) virus show that the E
protein undergoes a conformational change upon endosomal acidification, which induces
an irreversible change ITom a packed dimeric structure to a more open trimeric structue
(reviewed by Mukhopadhyay et ai. , 2005) and reveals the active site for membrane fusion
(Allison et aI. , 2001). The nucleocapsid is released into the cytoplasm where dissociation
of the viraLRNA permits' the initiation of translation. Translation occurs at the surface of
the endoplasmic reticulum (ER), with cleavage of the polypeptide mediated by host
signalases and the viral serine protease. The capsid protein mediates translocation of prM
into the lumen of the ER, which in turn mediates similar translocation of the E protein.
Following multiple cleavage events , the prM and E proteins form stable heterodimers in
the ER lumen, while C remains associated with the ER at the cytoplasmic surface. The
RNA genome is then packaged and the immature virion moves through the trans-Golgi
system, undergoing pH - pendent structural rearrangement. This change appears to
allow for the cleavage of a peptide fragment from prM by host furin, which facilitates
switching from a spiked particle surface composed ofprM-E heterodimers to a smooth
particle surface comprised of E homodimers , with the mature M protein essentially
obscured. At this point, the virus is infectious, and is exocytosed from the cell
(Mukhopadhyay et aI. , 2005).
During the process of infection, the multiple dengue non-structural proteins serve
a variety of both indispensable and accessory functions, many of which researchers are
discovering and defining. NS 1 has been implicated in cell signaling through a
glycerophosphatidylinositol (GPI)-linked membrane-bound form which, when expressed
in BeLa cells , induced protein phosphorylation following NS I-specific antibody
treatment (Jacobs et aI. , 2000). NSI-driven signaling also occurs through interaction
with signal transducer and activator of transcription (ST A T)-3~; resulting in the
production of the inflammatory cytokines tumor necrosis factor (TNF)-a and interleukin
(IL)-6 following transfection into murine DCs (Chua et aI. , 2005). NS2B is a cofactor
required for proper function ofNS3 , which has multiple functions including serine
protease activity, nucleoside triphosphatase and helicase functions required for viral RNA
synthesis, and 5 triphosphatase activity involved in RNA capping (reviewed by Clyde et
aI. , 2006). NS5 serves as the viral RNA-dependent RNA polymerase and has
methyltransferase fuction (Clyde et aI. , 2006). NS5 has also been reported to activate
gene transcription resulting in the secretion of the chemokine IL-8 (Medin et aI. , 2005).
IL-8 has been demonstrated to interfere with antiviral IFN-a function by inhibiting 2'
oligoadenylate synthetase (OAS) activity (Khabar et aI. , 1997).
It has been dem6nstrated that the non-structual proteins NS2A, NS4A, and NS4B
directly suppress the effects of interferon (IFN)-mediated signaling. Expression of these
proteins from plasmids transfected into chick embryonal fibroblast (CEF) and human
lung epithelial carcinoma A549 cell lines facilitated the replication ofIFN-sensitive
Newcastle disease virus (NDV) (Munoz-Jordan et aI. , 2003). In the same study (using
293T cells), NS2A, NS4A , and NS4B inhibited activity from an IFN-stimulated response
element (ISRE)-54 reporter construct in response to IFN-~ stimulation, but not Sendai
virus infection. This indicates thatthe noted effect was secondary to inhibition ofIFN-~
signaling, as opposed to effects on interferon regulatory factor (IRF)-3; IRF-3 is critical
in initiating IFN responses to viral infection by itself eliciting IFN-~ production (Sato et
aI. , 2000; Fitzgerald et ai. , 2003).
The effects of the aforementioned dengue NS proteins were synergistic , but NS4B
by itself was sufficient to inhibit ST AT- l phosphorylation and nuclear localization in
response to either exogenousIFN-~ or IFN-y (Munoz-Jordan et aI. , 2003). Additional
studies implicated amino acids 77- 125 as the NS4B inhibitory active site, with a separate
region responsible for ERlocalization required for IFN-inhibitory function (Munoz-
Jordan et aI. , 2005). As previously noted, dengue genome replication occurs at the ER
surface, suggesting a potential role for NS4B in shielding the viral RNA from
intiacellular sensory mechanisms during replication. IFN inhibition appears to be of
critical importance for dengue survival and replication in the host since IFN-a is readily
detected in the plasma of children with dengue infection (Kurane et aI. , 1993), and a
murine model of primary dengue infection demonstrated a requirement for the
combination ofIFN-a and -y to clear the virus (Johnson and Roehrig, 1999).
CLINICAL PRESENTATION OF DENGUE INFECTION
Dengue illness is manifested in a spectrum of symptoms and disease severity. Many
dengue infections are mild, either asymptomatic or presenting as an undifferentiated
febrile ilness. Undifferentiated dengue fever (DF) is particularly common in infants and
very young children, who may also exhibit a maculopapular rash. Such cases represent
most infections in endemic regions , with two separate studies in Thailand reporting from
50% (Endy et aI. , 2002) to 90% (Burke et aI. , 1988) of infections as being sub-clinical.
In older children and adults dengue disease may manifest with more severe symptoms , or
classical" dengue fever. The classical presentation is characterized by high, sometimes
biphasic fever, accompanied by constitutional symptoms that include retro-orbital pain
and headache, and the severe muscle pain (myalgia) for which dengue garnered the
moniker "break-bone fever" (Rigau-Perez, 1998). Anorexia, vomiting, and abdominal
pain or tenderness are not uncommon. There may also be signs of mild coagulation
dysfunction, with mucosal injection, micro hemorrhages and petechiae, and occasionally
occult GI bleeding, although the latter is rare. Patients suffering from DF tyically
. display leucopenia and may also present with thrombocytopenia. Recovery from DF is
generally complete with few lasting sequelae although fatigue and depression may persist
for weeks to months after the resolution of fever (WHO , 1997).
The most severe cases of dengue infection are termed dengue hemorrhagic fever
(DHF). DHF tends to be seen most often in young children and infants, but is not limited
to this age range (WHO , 1997). Beyond high fever (:?39 C) and constitutional
symptoms , the hallmarks of DHF are increased vascular permeability, hemorrhagic
phenomena, and hepatOlhegaly. The clinical case definition ofDHF as described by the
World Health Organization includes the presence of all of the following: high fever
bleeding tendency (including but not limited to a positive tourniquet test, petechiae and
signs of micro hemorrhage, mucosal bleeding, hematemesis and/or melena), severe
thrombocytopenia ( 100 000hnm ), and evidence of plasma leakage, including elevated
hematocrit or signs of pleural effusion (WHO , 1997).
The clinical severity of DHF is graded according to WHO guidelines, with grade
I being defined by the minimal criteria, where the only evidence of hemorrhage is a
positive tourniquet test or brising tendency. Grade 2 includes the additional criterion of
spontaneous bleeding. DHF grades 3 and 4 are cases where dengue shock syndrome
(DSS) is present. DSS is diagnosed when the patient presents with signs of circulatory
failure due to functional hypovolemia. Such signs range from a weak, rapid pulse and
cold, clammy skin accompanied by restlessness (grade 3) to profound shock, with
undetectable pulse and blood pressure (grade 4). DSS is a critical condition, often being
fatal if untreated, as poor organ perfusion leads to multi organ system failure. However
the plasma leakage syndrome, which i 'S roughly concurrent with defervescence , is rapid
and transient. Appropriate medical care, particularly fluid resuscitation and monitoring
for occult bleeding, results in full recovery from DHF (Dung et aI. , 1999).
. IMMUNOPATHOLOGY OF SEVERE DENGUE ILLNESS
The etiology of enhanced vascular permeability that is s en during some cases of dengue
infection is il-defined, although there has been considerable research done in identifying
risk factors for the development ofDHF/DSS. The most prominent of these is
heterologous secondary linfection, that is , infection with a dengue serotype other than the
one to which the individual was first exposed (Nisalak et aI. , 2003; Guzman et ai. , 1990;
Burke et aI. , 1988). It is generally believed that heterologous re-infection activates
inappropriate humoral and cellular immune responses, resulting in disease through failed
immune regulation and inappropriate cytokine cascades , as opposed to direct viral
cytopathic 'effects. The dysregulation of secondary immune responses appears to involve
multiple immune system components of diverse nature, with contributions from factors
intrinsic to both host and virus. The following sections wil discuss these issues , and
introduce the roles that host and viral factors play in target cell infection.
As previously noted, the majority of DHF cases are associated with heterologous
derigue re-infection. In some instances DHF has been noted in infants experiencing
primary infections. It has been hypothesized that reduction in the levels of passively
transferred maternal antibody results in infants becoming susceptible specifically when
antibody levels become sub-neutralizing and may in fact enhance infection (Kliks et aI.
1988). A study from Bangkok, Thailand reported that the serotyes most commonly
isolated during primary infection in infants (D2V and D3V) were the same serotypes
most commonly seen in secondary infection in older children, suggesting common
pathologic mechanisms (Nisalak et aI. , 2003). Cross-reactive sub-neutralizing antibodies
are responsible for the in vitro phenomenon of antibody-dependent enhancement (ADE),
where antibody-coated virus enters phagocytic cells, especially monocytes and
macrophages , via Fcgamma receptors (FcyR). FcyR on the cell surface recognize the
constant fragment (Fc) of virus-coating IgG antibody, and mediate uptake of infectious
immune complexes (reviewed by Tirado and Y oon, 2003).
ADE has been &monstrated in vitro for several viruses , including DV and HIV
(Littaua et aI. , 1990; Morens and Halstead, 1990; Jolly and Weiss, 2000). This process
not only increases cellular infection, it can also induce distinct signaling patterns in
infected cells when cOnipared to naked virus , including IL- l 0 production and suppression
of antiviral responses (Mahalingam and Lidbur, 2002). Further evidence for the role of
an in vivo ADE-type phenomenon in severe dengue disease is supported by the
observation of a protective effect on the risk of developing DHF for a histidine to
arginine mutation at position 133 in the: FcyRIIA allele (Loke et aI. , 2001). The arginine
mutation was shQWn to be responsible for reducing uptake of IgG I but not IgG2b when
compared with the common histidine variant (Clark et ai. , 1991).
Mathematical modeling suggests that evolutionary pressure on dengue viruses
confers a selective advantage on strains that develop the capacity for ADE, thus
increasing their virulence (Cummings et aI. , 2005). However, that model also predicted
that as multiple serotypes developed greater ADE capability, the system would became
destabilized and chaotic. There would be large oscillations in the overall incidence of
infection, risking viral extinction through exhaustion of secondary infection-susceptible
hosts. Despite the aforementioned findings, there is some dispute regarding the role that
pre-existing cross-reactive antibodies play in determining the severity of dengue ilness.
Studies performed on clinical samples to correlate levels of enhancing-antibody with an
outcome of increased disease severity have not proven definitive , with both supporting
(Kliks et aI. , 1989) and refuting (Laoprasopwattana et aI. , 2005) evidence in the literatue.
An in vivo ADE-type phenomenon is not the only theory to espouse a link
between humoral immune responses and severe dengue disease. During acute dengue
disease, the viral NS I prbtein has been measured in plasma at high levels in a soluble
form that may also be involved in dengue pathogenesis (Young et aI. , 2000; Libraty et aI.
2002). In one study, polyclonal antibodies generated against dengue NSI in mice
recognized epitopes on human targets , particularly clotting factors, platelets , and
endothelial cells (Falconar, 1997). Monoclonal antibodies developed in the same study
reacted with multiple human proteins , including ICAM- , fibrinogen, factors VII and IX
and prothrombin. Work performed by a separate group found that binding of antibody
specific for NS 1 to endothelial cells induced caspase-dependent death; this effect was
enhanced in the presence of complement (Lin et aI. , 2003). Anti-NS 1 antibodies may
also induce endothelial cell nitric oxide (NO) production, resulting in apoptosis (Lin et
aI. , 2002) and potentially blood vessel dilatation. Thus, dengue NSI appears to
contribute both to vascular leakage and platelet and coagulation factor consumption
risking disseminated intravascular coagulation (DIe), hemorrhage, and shock.
Humoral immunity represents only one of the two arms of adaptive immune
responses. It is also theorized that cell-mediated immunity contributes to the
immunopathological mechanisms in DHF (Rothman and Ennis , 1999). Early studies
found evidence of increased T cell activation during dengue disease, and suggested that
these effects were exacerbated in cases with greater pathology (Kurane et aI. , 1991;
Green et ai. , 1999a). Subsequent work has identified the presence of serotye cross-
reactive T cells following both primary (Green et aI. , 1997; Kurane et aI. , 1998; Bashyam
et aI. , 2006) and secondary infections (Mathew et ai. , 1998; Mongkolsapaya et aI. , 2003).
MHC Class I HLA polymorphisms have. also been correlated with disease risk as well
further suggesting that certain T cell responses may be either protective or pathogenic
and may have a strong h6st genetic factor (Loke et aI. , 2001).
Work specifically addressing the role of CD8 T cells in secondary dengue
infection reported expansion ofCD8 T cells with higher affinity for epitopes from
heterologous serotypes , rather than the subsequent infecting serotye, an effect termed
original antigenic sin" (Mongkolsapaya et aI. , 2003). That same study also reported that
the CD8 T cells responding during acute secondary infection were apoptotic. Separate
studies on whole peripheral blood mononuclear cells (PBMC) obtained from individuals
following experimental dengue vaccination found that CD8 T cells were responsive to
peptide epitopes from the homologous strain as well as variant peptides derived from
heterologous strains (Bashyam et aI. , 2006). In that study, there were also clear
differences between vaccinated donors regarding quantitative and qualitative aspects of
the dengue-specific CD8 T cell memory pool. Cytokine production profies varied both
between donors for a given epitope and within a given donor for variant epitopes
revealing donor- and epitope-dependent variation in function of dengue-specific CD8 T
cells following reactivation,
Beyond CD8 T cell responses , CD4 T cells have also been examined in regards to
the pathogenesis of dengue infection. In a prospective study of dengue ilness in Thai
schoolchildren, dengue antigen stimulation of pre-secondary ilness PBMC demonstrated
poor responses against the secondary infecting serotye (D3V). However, there was a
broad serotye-cross-reactive IFN-y secretory response , particularly in non-hospitalized
subjects , while TNF-a secretory responses were found only in subjects who were
hospitalized during secondary infection (Mangada et aI. , 2002). Further studies using
intracellular cytokine staining ofPBMC from dengue-vaccinated individuals found a
trend for elevated TNF- /IFN-l CD4 T cell ratios following heterologous antigen
stimulation, again suggesting a role for TNF -a in pathologic immune reactivation
(Mangada and Rothman, 2005).
These results demonstrate that functionally diverse T cell repertoires are present
. following infection withDV, and that specific T cell subsets as well as some functions of
the cells comprising these subsets may be associated with immunopathology or
immunoprotection. When reviewing these studies, interesting questions emerge regarding
the priming history of the cells being studied. Elucidation of the potential range of
functional activities (including secretion ofIL- , IL- , or granulocyte macrophage
colony stimulating factor (GM-CSF), which all affect APC function and/or T cell
function) in these cells may reveal additional insight into the mechanisms of severe
disease. The qualitative and quantitative aspects of T cell priming induced by APCs that
have been exposed to or infected with DV is thus an important avenue of investigation.
One consistent theme of the multiple hypotheses regarding DHF pathogenesis is
the influence of soluble mediator cascades. A number of studies with clinical samples
have identified cytokines and chemokines associated with increased risk of severe
disease. Several studies have demonstrated that elevated plasma levels of IL- I 0 , which
has immunosuppressive properties, are independently correlated with risk of severe
disease or thrombocytopenia (Perez et aI. , 2004; Green et aI. , 1999b; Libraty et aI. , 2002).
Elevated levels of plasma IL- I 0 also correlate with poor disease outcome in Ebola virus
infection of humans , which results in a fulminant hemorrhagic fever associated with high
mortality (Baize et aI. , 2002; Villinger et aI. , 1999). These findings suggest that induction
of immunosuppression m'ay enhance virulence for some RNA viruses , although it may
alternatively be postulated that elevated IL- I 0 production associated with severe disease
is a function of enhanced counter-regulatory mechanisms induced following uncontrolled
initial activation. Interestingly, IFN-y concentrations in plasma do not correlate with
disease severity in dengue infection-in agreement with findings that suggest a protective
role for this cy okine in dengue ilness (Mangada et aI. , 2002). Because of the
antagonistic role that IL- I 0 plays in. IFN -y signaling, these findings suggest that elevated
, IL-JOmay exert pathogenic effects by blocking protective IFN-y. activity early in ilness
when antiviral activity may be important in suppressing viral load and immune
activation.
Another cytokine associated with severe dengue disease is TNF-a. Seru levels
ofTNF-a were found to be elevated'in the sera of patients with dengue , as compared to
controls, and this effect correlated with hemorrhagic manifestations (Azeredo et ai.
2001). In a study of children and adults with DHF, the highest serum TNF-a levels were
found in patients with DHF grades III and IV (Hober et ai. , 1993). One study
investigating the role ofTNF-a in Thai children with dengue found that 80-kilodalton
soluble TNF-a receptor (sTNFR80) concentrations in plasma were higher in patients with
DHF than with DF or other febrile illnesses and correlated with the pleural effusion
index, ameasure of capilary leakage. That same study also detected TNF-a in plasma
more frequently in cases ofDHF than DF (Green et aI. , 1 999a). TNF-a is thought to
regulate changes in vascular endothelium , and acute sera from DF patients has been
demonstrated to induce microvascular endothelial cell activation that was inhibited by
addition of TNF -a blocking antibodies; the same sera induced apoptosis in these cells as
well (Cardier et aI. , 2005).
The chemokines IL-8 and RANTES (Regulated on Activation, Normal T cell
Expressed and Secreted) have also been investigated in studies of dengue disease
severity. In a report from India, serum IL-8 levels were demonstrated to be highest in
patients experiencing DSS , with statistically significant differences in DHF grade IV
patients as compared to grades I and II , while IL- 8 was not detected in the sera of healthy
controls (Raghupathy et aI. , 1998). A separate study from Indonesia reported similar
results, detecting IL-8 most frequently and at the highest median levels in DHF grade IV
patients as compared to-other DHF grades, patients with DF, or healthy controls. That
study also found elevation in plasma elastase levels with severe disease, which the
authors proposed might have been due to IL-8-mediated neutrophil activation (Juffrie et
al.; 2000). Plasma levels of RANTES , on the other hand, were shown to be lower in
DHF patients later during the course of disease than were levels in patients with DF, or in
healthy controls (Perez et aI. , 2004).
Taken as a whole, these data suggest that specific cytokine responses (i. , high-
level IL.:lO , TNF-a , and IL-'8production , or weak RANTES induction) may predispose
an individual to development of pathology during dengue infection. This provides
further evidence for the importance of iilmunopathogenesis in dengue illness and
indicates that both host- and virus-associated factors that influence cytokine and
chemokine cascades may dictate disease outcome.
Epidemiological evidence is compelling for a role of virus-associated factors in
determining the severity of dengue illness. The occurrence of DHF in the Western
Hemisphere has been specifically linked to the arrival of Asian genotypes ofD2V
despite the presence of chculating American D2V genotypes (Rico-Hesse et aI. , 1997).
For example , during an outbreak of American genotye D2V in Iquitos , Peru, in a
population previously exposed to D I V, severe dengue illness in the form of DHF /DSS
was conspicuously absent (Watts et aI. , 1999). In a longitudinal study from Bangkok
Thailand, although multiple serotyes were associated with epidemic dengue, D2V was
the most frequent serotype isolated from secondary infection, yet it was the only serotype
that did not independently contribute to the presence of DHF during an epidemic (Nisalak
et aI. , 2003). The most severe epidemics (based on incidence) were associated with
dengue 3 serotypes , and D3V was the most common isolate from primary DHF (Nisalak
et aI. , 2003). Lastly, the frequency of isolating D 1 V correlated with the yearly proportion
of primary disease cases , suggesting that D 1 V strains in this region had particular
virulence in children who lacked prior dengue priming (Nisalak et ai. , 2003). Together
these studies highlight the complex role that viral characteristics play in determining
disease pathology. In vitro studies aimed at determining virulence factors examined
regions in the 5' and 3' UTRs of the dengue genome and those resulting in changes in the
non-stmctural genes, which might also be important in determining disease severity
(Mangada and Igarashi , 1997; Mangada and Igarashi; 1998).
In dengue research, it is particularly important to combine clinical and
epidemiological data with in vitro studies because of the prohibitive ethics of studying
the priming process in vivo in the natural human host. Although the murine system is
arguably ideal for studying basic immunological principles , mouse models are inherently
problematic when studying dengue infection. Major issues include the drastic gene
manipulation, non-physiologic infection routes, and/or specific virus strains required to
generate dengue disease ift susceptible murine infection models (Johnson and Roehrig,
1999; Shresta et ai. , 2006; Kurvila et aI. , 2007). Also , disease pathology in mice does
not effectively recapitulate that seen in humans. Fundamental differences in the human
and murine immune systems might also be considered prohibitive, particularly given the
species-specific adaptation of dengue to human hosts. Therefore , a great deal of effort
has been directed at investigating the effects of DV infection on the responses of human
target cells in vitro.
. CELLULAR TARGETS OF INFECTION
Several reports indicate a range of susceptible in vivo targets of dengue infection
including leukocytes , endothelial cells , and hepatocytes (Jessie et aI. , 2004; Rosen et aI.
1989; Couvelardet aI. , 1999). However, these data are far from definitive and rely on
small sample numbers, with low detection rates. Obtaining human tissue samples for
analysis is diffcult since the potential research benefit does not justify the danger to
patients inherent in biopsy of internal organs. Therefore, the use of in vitro model
systems for dengue infection has served as a surrogate for in vivo work.
Due to the ease of manipulation and maintenance, researchers have directed a .
great deal of effort towards the use of immortalized cell lines in the study of DV. The
potential involvement of the liver in vivo has lead several groups to address infection
using 'the hepatoma cell line HepG2. Dengue infection of HepG2 cells was found to
induce apoptosis through NFKB activation (Marianneau et aI. , 1997), as well as induction
of the chemokines IL- , RATES , and macrophage inflammatory protein (MIP)- l a, and
MIP- l~ (Medin et ai. , 2005), suggesting that hepatocyte infection in vivo might be
associated with pathology via direct mechanisms as well as damage through the
recruitment of cellular immune effectors.
Attempts to understand the vascular permeability phenomenon that occurs during
severe dengue infection have led some researchers to explore the role of histamine , which
is secreted by mast cells and basophils and has potent vasodilatory functions. Histamine
has been implicated in disease for both human patients (Tuchinda et aI. , 1977) and in a
murine dengue infection model (Chaturvedi et aI. , 1991). The human mast cell line
KU8l2couid be infected with DV through an ADE-mediated mechanism, releasing
inflammatory cytokinesIL- l~ and IL-6 (King et aI. , 2000). In a comparison of ADE of
infection of KU812 cells and the monocytic cell line U93 7 , KU8l2 cells alone induced
production of the chemokines RANTES , MIP- Ia and MIP- l~ by 72 hours post- infection
(King et aI. , 2002). Surprisingly, however, neither study implicated DV as a stimulus for
mast cell degranulation and histamine release, suggesting that a role for histamine may
involve more complex mechanisms than cellular infection alone. One possibility is that
in some individuals , DV may stimulate IL- 13 production by T cells during priming, with
elevation of DV-specific IgE production (and mast cell degranulation on secondary
exposure) .
As noted previously, ex vivo analyses have not provided definitive evidence for
lymphocyte infection, although one study implicated B cells specifically as being the
predominantly infected cell in PBMC (King et aI. , 1999). DV infection of both
lymphocytes and monocytic cell lines has been accomplished, with the authors reporting
the establishment of persistently infected cell lines , indicating the susceptibility of
multiple cell lineages to dengue infection, at least in vitro in immortalized cells (Kurane
et aI. , 1990). Most notab\y, monocytic cell lines were of particular interest in early 
vitro studies given the putative role of ADE in severe dengue etiology. Investigators
identified roles for FcyRI and FcyRII in mediating ADE in infection ofU937 and K562
cell lines , respectively (Littaua et aI. , 1990). IFN-y enhanced this process by increasing
FcyR expression (Kontny et aI. , 1988). Unlike much of the evidence regarding infection
of other cell lines , infection of monocytic cells has translated rather consistently into
investigations of primary cell cultue , although infection rates are generally low.
Similar to research on cell lines , early studies of dengue infection in primary cells
focused predominantly on cells of myeloid/monocytic lineage (Morens and Halstead
1990; Kliks et ai. , 1989). More recent literature reports of monocytic/macrophage cell
infection, including liver sinusoid-resident Kupffer cells, suggest that these cells are
activatedduring.infection and produce inflammatory cytokines, although infection of
Kupffer cells was not productive (Chen and Wang, 2002; Marianneau et ai. , 1999).
Infection of monocytic cells and macrophages was a prominent topic of study for some
time, although recent work has expanded to include other primary cell tyes as well. DV
infection of primary human ,umbilical vein endothelial cells (HUVEC) results in virion
production and multiple inflammatory events , including the secretion of IL-6 and IL-
and platelet adhesion (Huang etaL , 2000; Huang et aI. , 2002). Despite these findings of
primary cell activation following DV exposure , infection rates are low. This is tre even
for monocytes and macrophages , particularly in the absence of enhancing antibody. DCs
however, are a notable exception to the typically poor susceptibility to infection that is
seen with other primary cells.
As previously noted, DV binds to the C-type lectin DC-SIGN, a molecule
expressed at high levels pecifically on DCs. These findings followed the seminal
discovery that DV infects human DCs, both in vivo and in vitro (Wu et ai. , 2000). In that
study, the authors first reported the infection of blood monocyte-derived DCs following
exposure to the prototype D2V strain New Guinea C. Infected DCs failed to induce
dendritic cell- lysosome associated membrane protein (DC-LAMP) compared with
uninfected bystander cells, suggesting that dengue infection interferes with normal
processes associated with DC activation. DC infection occurred in situ in skin explants
. derived from cadavers , with dengue protein expression in 60-80% of emigrant HLA DR-
expressing cells following tissue inoculation. Although the authors also reported
Langerhans cell infection, this was proposed based on CDla expression (a marker also
expressed by monocyte-derived DCs), and the emigration of the infected cells following
superficial skin inoculation, therefore leaving this conclusion in question. The authors
also identified cells co-staining for dengue antigens and the DC marker CD I a in skin
biopsies from a dengue-vaccinated donor. By directly demonstrating efficient infection
of human skin-derived cells both during acute infection and in tissue explants and
correlating these findings ",ith an established in vitro model, this study opened an
intriguing avenue into investigating the pathogenesis of dengue infection. Definitive
evidence for an in vivo cell target highly susceptible to infection was identified, and the
particular cell type, the DC , was known to be intimately involved in the generation of
immune responses. What follows in the remainder of this introduction is the story of
DCs-their origins, functions , and role in generating adaptive immunity. The growing
body of work on DV infection of DCs , and the results of similar studies with other
viruses , will also be addressed.
. THE BIOLOGY OF DENDRITIC CELLS
DCs are a vital component of the innate immune system and are critical in the detection
of and response to microbial challenge. DCs are derived from bone marrow precursors
and include cells of both plasmacytoid and conventional lineages (reviewed by
Villadangos and Schnorrer, 2007). Conventional (i. , myeloid) DCs migrate via the
blood to final sites of residence, where their differentiation is arrested in an "immatue
or pre-activated state. Immature DCs are present in the epidermis (as Langerhans cells),
vascularized interstitial tissues of the dermis and solid organs, and mucosal surfaces such
as those of the gastrointestinal, and respiratory tracts (Banchereau and Steinman, 1998).
Immature DCs constitutively sample their surrounding environment and employ a vast
array of intracellular and cell-surface-bound receptors. Many of these receptors act as
sensory mechanisms to detect both endogenous and exogenous antigens (Villadangos and
Schnorrer, 2007). The range of antigen moieties recognized is strikingly diverse: DCs
express receptors for each of the major classes of biomolecules , including proteins
nucleic acids , sugars , and lipids. In many cases, binding of pathogen-derived products to
. specific receptors on the DC induces signal transduction cascades that culminate in
transcriptional, functional , and morphological changes to the DC. A microbial "danger
signal" (Matzinger, 1994) thus initiates a program of DC "maturation" (Banchereau and
Steinman, 1998).
Functionally, DC matuation includes a transient burst of antigen uptake followed
by a switch to enhanced antigen processing and presentation, the secretion of cytokines
and chemokines , and homing to secondary lymphoid tissues to stimulate T cell responses
(Banchereau and Steinmdn, 1998; Reis e Sousa, 2006). The maturation process evolves
as the DC encounters additional signals , i. , intracellular viral double-stranded RNA
(dsRNA) (Cella et aI. , 1999), or the binding ofCD40 ligand (CD40L) (O' Sullivan and
Thomas , 2002), which is expressed on T cells during co-stimulation. Plasticity in DC
activity ostensibly allows for priming of the most appropriate adaptive response for
pathogen clearance.
DC co-stimulatory molecule expression influences quantitative aspects of T cell
responses to DCs. A major aspect of DC maturation is the regulation of surface
molecules involved.in DC- T cell interactions. Early studies of DCs indicated that
inflammatory mediators such as TNF-a or IFN-a stimulated increased expression of
, surface molecules that are involved in initiating T cell proliferation (Sallusto and
Lanzavecchia, 1994; Luft et ai. , 1998). Some of the earliest DC-expressed molecules
studied included the B7-familyco-stimulators CD80 and CD86 , which bind both
activating and deactivating receptors on responding T cells during T cell-dendritic cell
co-regulation. The more recently discovered programmed death- lligands (PD-L), PD-
LI and PD- , are members of the same family of molecules as CD80 and CD86
(Freeman ,et al.; 2000; Latchman et aI. , 2001). However, these proteins appear to act as T
cell suppressor molecules through binding to programmed death- l (PD- I) expressed on
activated T cells (Cai et aI. , 2004; Freeman et aI. , 2000; Latchman et aI. , 2001). The
phenotyic changes DCs underwent after exposure to activating stimuli also
demonstrated the induction of CDS3 , a marker considered specific for matue DCs (Zhou
and Tedder, 1995; Zhou and Tedder, 1996). The DC surface-bound TNF-family co-
stimulator CD40 binds CD40 ligand (CD40L) expressed on activated T cells, and is
crucial for both effective IT cell "help" and memory generation and for antibody isotype
switching (reviewed by Quezada et ai. , 2004). DCs present endogenous and/or
exogenous peptides in the context of class I and II Major Histocompatibility Complex
proteins , which in turn signal to antigen-specific CD8 and CD4 T cells , respectively.
DCs are effective cross-presenters as well , i. , they are able to load peptides normally
destined for MHC II presentation into the context of MHC I (Viladangos and Schnorrer
2007). Therefore, expression of DC surface molecules serves to initiate and control T
cell responses , and differential expression of specific molecules allows DCs to finely tune
the responses of antigen-specific T cells.
DC co-stimulatory molecule expression also influences qualitative aspects of T
cell responses to DCs. In a study using the experimental allergic encephalitis model in
mice; blocking CD80 signaling reduced disease incidence, while blocking CD86
enhanced disease severity (Kuchroo et aI. , 1995). These effects were related not to the
magnitude of T cell responses , but to selective induction of a transferable, protective T h
type response when CD80 was blocked during immunization. Since the co-
administration of anti-IL-4 antibody abolished the effect, the authors concluded that
blocking CD80 enabled endogenous IL-4 production in responding T cells, facilitating
the protective Th2 response (Kuchroo et aI. , 1995). In vitro while PD-Ll suppresses both
l and T tye resporises, PD-L2 appears to selectively suppress Th l responses only
(Latchman et ai. , 2001). CD40 expression on DCs can aid in Th l skewing during
interaction with CD40L, through the stimulation of DC IL- 12 secretion and induction of
T cell IFN-y production (Cella et aI. , 1996).
IL- 12 represents the most well-defined DC-derived cytokine responsible for the
induction of Th I-type imhmne responses (reviewed by Moser and Murphy, 2000).
However , human DCs are futher able to initiate and direct additional immune responses
through the production of a wide variety of cytokines and chemokines (Banchereau and
Steinman, 1998). DCs secrete IFN-a , which in humans can direct Th l development (i.
IFN-y production) through phosphorylation of STAT4 , which does not occur in mice
(Moser and Murphy, 2000). This effect is in addition to the well-described antiviral
functions of type I IFNs, the downstream activities of which include mRNA translation
inhibition RNA degradation, RNA editing, nitric oxide (NO) production, and the
. induction of MHC molecules involved in the presentation of viral antigens to T cells
(reviewed by Samuel, 2001). DCsalso produce inflammatory cytokines such as TNF-a
IL- , and IL-6. TNF-a in paricular can affect T cell responses through kiling of
actively proliferating T cells (Zheng et aI. , 1995; reviewed by Lenardoet aI. , 1999). IL-
10 production by DCs can affect a variety of cells, including the DC itself. IL- IO inhibits
cytokine signaling including that by IFNs , regulates T cell proliferation and cytokine
release, and faciltates B cell development (Pestka et aI. , 2004). DCs also produce a vast
array ofchemokines , a function exemplified by a report examining virus infection of
human DCs Wiqueras et aI. , 2006). In that report, chemokine secretion by DCs occurred
in three temporal waves, each associated with recruitment of distinct immune effector
populations. Chemokines such as IPlO (CXCLlO), ITAC (CXCLll), and Mig (CXCL9)
are associated with the recruitmentofTh l T cells, enhancing Th l-type responses, while
others , such as MDC (macrophage-derived chemokine , CCL22) attract T h2 cells. The
range .of secreted products induced following DC activation is incredibly diverse
highlighting the central role of these cells in the stimulation and orchestration of immune
responses.
DCs are kinetic beasts. The response of a DC to stimulation, even with a purified
non- living agent, is not a snapshot-the adoption of a fixed functional phenotype-but
rather a dynamic continuum of complex signaling. Two factors that modify T cell
responses to DCs are 1) the temporal relationship to stimulus exposure and 2) the antigen
dose presented to the T cell in the context of the DC. During co-cultue with autologous
naIve CD4 T cells and toxic shock syndrome toxin (TSST), Th l priming was enhanced by
reducing the time after lipopolysaccharide (LPS)'stimulation ofDCs , increasing the
antigen (i. TSST) dose, and addition of exogenous IL- 12 (Langenkamp et ai. , 2000).
Conversely, in the same study, increasing the time post-stimulation of DCs , low antigen
dose; and IL-4 supplementation all enhanced T h2 priming. The same conditions
associated with T h2 priming also preferentially induced non-polarized CC-chemokine
receptor-7 (CCR7)-expressing "central memory" T cells which secreted the T cell growth
factor IL- , but not Th effector molecules IFN-y or IL- , at levels comparable to CCRT
effector memory" T cells (Langenkamp et aI. , 2000). Thus , DCs have intrinsic
properties for primingTh and memory phenotypes of naIve CD4 T cells , which depend
on multiple facets of DC function at any given point in time.
The strength and duration of the signal that T cells receive during priming are also
critica:l in the development ofT cell memory, particularly the T cell' s "fitness." T cells
that are weakly stimulated can proliferate in response to IL- , but they fail to adopt
characteristics that allow them to persist in a homeostatically controlled environment
where survival depends on successfully competing for space and growth factors such as
IL-7 and IL- 15 (Gett et aI. , 2003). As a result, when T cells respond to virus-infected
DCs, weak stimulation atid activation may limit their viability during homeostatic
expansion and contraction. Their relative numbers in the memory pool would thus
decline , making cell-mediated immunity upon re-exposure to the pathogen less effective.
"" .
. VIRAL INFECTION OF HUMAN DCs: A BRIEF OVERVIEW
The infection of DCs by viruses can be instrumental in viral dissemination (Wang et aI.
2007; MacDonald and Johnston, 2000). This infection process is a common phenomenon
having been demonstrated for multiple RNA and DNA viruses responsible for a broad
range of di&eases. Conventional DCs are targets for a variety of RNA viruses , including
measles virus (MV) (Grosjean et aI. , 1997), respiratory syncytial virus (RSV) (de Graaff
et aI. , 2005), HIV (Granelli-Piperno' et aI. , 1996; Canque et aI. , 1996), hantaan virus
(HTNV) (Raftery et aI. , 2002), YFV l7D (Barba-Spaeth et aI. , 2005), and influenza
viruses (InN) (Cella et aI. , 1999). The observation that many viruses infect DCs may
indicate that viruses have evolved a common "targeting" mechanism designed to subvert
. or exploit DC immune functions. Viruses can thus facilitate their own survival by
infecting DCs and altering the interface of innate and adaptive immunity in the process.
. Although literatue reports often use DC phenotypic changes to denote
matuation " this connotatio.n does not account for functional activity. Phenotypic
changes and cytokine production have been traditionally associated with enhanced DC
function during co-culture with T cells. However, these activation events often belie
broad diversity in DC APC function that is based on stimulus, time, and the products
generated by (and in response to) infectious agents (reviewed by Reis e Sousa, 2006).
With regards to infection, diverse function often includes agent-specific modulations that
reveal themselves only up0n discrimination between infected and uninfected cells or
further pertrbation of the culture system, such as the addition of T cells. An example of
this is measles virus (MV) infection of DCs , where T cell-associated signals such as
CD40L enhance viral replication and elicit IL- I 0 production that is not seen in uninfected
cells (Servet-Delprat et aI. , 2000). The following sections address the effects of viral
infection of DCs , with specific attention to virus-mediated modulation of DC functions.
. VIRUSES ASSOCIATED WITH IN VITRO SUPPRESSIVE RESPONSES
Multiple early studies in vitro using MV to infect DCs indicated that proliferative
. responses of both syngeneic , activated whole T cells and allogeneic resting CD4 T cells
to MV-infected DCs were profoundly reduced when compared to responses initiated by
uninfected DCs (Fugier-Vivier et aI. , 1997; Schnorr et aI. , 1997; Grosjean et aI. , 1997).
These findings contrasted' starkly to the observation that DCs infected with measles
matured " by increasing their surface expression levels of a wide number of
immunoregulatory proteins, including co-stimulatory molecules CD40 , CD80 , and CD86
the DC activation marker CD83 , and MHC molecules (Schnorr et ai. , 1997; Servet-
Delprat et aI. , 2000). It was also demonstrated that enhanced expression of CD80 and
CD86 was a function of the autocrine activity ofIFN-a/~ released in response to MY
infection, indicating that the DCs had preserved IFN responsiveness (Dubois et aI. , 2001).
Determining which mechanisms were involved in suppressing T cell proliferative
responses to MV-infected DCs began with the finding that CD40-CD40L interactions-
normally associated with facilitating immune responses-triggered both potent DC
down-regulation of surface molecule expression and an increase in MV replication
(Servet-Delprat et aI. , 2000; Fugier-Vivier et ai. , 1997). Massive cell death was observed
during T cell-DC co-cultue, with apoptosis of the latter cells (but not the former)
depending on Fas-mediated signals , which also facilitated virion release through DC lysis
(Servet-Delprat et aI. , 2000). Additional studies suggested that DCs were inducing death
signals themselves through expression ofTNF-related apoptosis- inducing ligand
(TRAIL), which was found to be sequestered intracellularly (Vidalain et aI. , 2000). The
effects of infection on DC function during co-culture depended on viral replication, since
UV-inactivated MY treatment ofDCs did not have the profound consequences that
infection with live virus did (Fugier-Vivier et aI. , 1997; Grosjean et aI. , 1997). Also , the
observed effects were not the result ofT cell trans-infection, since treatment of infected
DCs with paraformaldehyde fixation or UV irradiation to eliminate infectious virus did
not restore T cell proliferation, and T cell expression of measles antigen during co-culture
was rare (Grosjean et al.; 1997;Schnorr et ai. , 1997; Fugier-Vivier et aI. , 1997).
MV replication in DCs also appeared to modify intracellular cytokine induction
pathways , sinceCD40-CD40L interactions specifically facilitated IL- l 0 production in
MV- infected DCs , yet did not appear to prevent IL- 12 production (Fugier-Vivier et ai.
1997; Servet-Delprat et aI. , 2000; Dubois et aI. , 2001). IL- 12 production was also
preserved following stimulation of MV - infected DCs with LPS (Schnorr et aI. , 1997).
However, IL- IO has multiple immunosuppressive activities, as evidenced by the
accelerated apoptosis of, and suppressed surface expression of immunostimulatory
molecules by, epidermal DCs (Langerhans cells) in response to this cytokine (Ludewig et
aI. , 1995). IL- lO also opposes the signaling induced by IFN-y and IFN-a (Ito et aI.
1999).
The message of thbe findings is that MV utilizes a number of strategies to
prevent or exploit immune responses initiated by DCs after infection. These include the
induction ofT cell and DC death, the utilization ofT-DC interactions (specifically,
CD40-CD40L binding) to increase virion production and reduce co-stimulatory molecule
expression, the death of DCs to facilitate virion release, and the induction of IL- l 0 to
inhibit antiviral responses and suppress DC and T cell functions. Expression of the MV
glycoprotein itself on the surface of infected DCs may be crucial for some of these
observed effects, particularly suppression ofT cell proliferation (Dubois et aI. , 2001).
Thus , MY appears to facilitate multiple APC-opposing feedback loops, in which the
prototypical antiviral agents IFN-a and IFN-y are functionally marginalized due to DC
IL- lO production, whilst at the same time eliminating substantial MV -specific immunity
through the deletion of DCs and T cells. In vivo these T - DC interactions would be
dependent on cognate recognition, suggesting that MY is able to ablate MY -specific
adaptive immune responses induced by infected DCs. The mechanisms described here
are clearly advantageous to the virus for its survival and dissemination, increasing viral
replication while likely retarding viral clearance , and permitting sufficient time for
transfer to another susceptible host.
Respiratory syncytial viral (RSV) is similar to MV in that they are both typically
diseases of childhood, yet they differ significantly in terms of the generation of
immunity. While MV results in transient profound immunosuppression followed by
lasting immunity, RSV appears to have particularly poor inimunogenicity. In the absence
of vaccination (no effective vaccine being available), individuals are exposed to RSV
throughout life, may be repeatedly infected, and are subject to the risk of more severe
disease with age-related in\mune senescence and underlying disease (reviewed by
Schmidt et ai. , 2004). Clinically, RSV-specific antibody production is not necessarily
correlated with protection, and may even be involved in the pathogenic manifestations of
disease (Chin, 1969).
Reminiscent of findings with MV in vitro studies with primary human cells
, showed that despite elevated surface molecule expression on DCs after RSV exposure
infected DCs essentially ablated autologous naive CD4 T proliferative responses in
response to either the superantigen staphylococcus enterotoxin B (SEB), or anti-CD3
antibodies , during co-culture. T cells derived from these same co-cultures demonstrated
weak cytokine production (including IFN-y, IL- , IL- , and TNF-a) as compared to
cells co-cultured with DC infected with influenza virus, or treated with synthetic dsRNA
, (in the form of poly I:C , a toll-like receptor (TLR)-3 agonist), or IL- I~ plus TNF-a (de
Graaff et aI. , 2005). Although suppression of proliferation appeared to be due to a
soluble mediator, neither IL- l 0 nor transforming growth factor (TGF)-~ was responsible
for the reduced proliferation seen in response to RSV -infected DCs (de Graaff et aI.
2005). These data suggest that RSV infection of DC induces a functionally defective
state, in which the DC is unable to facilitate T cell priming, reminiscent of the poor
immunogenicity ofRSV in vivo.
The results highlighted above reflect earlier in vitro work with a similar system
examining T cell responses to autologous RSV-infected DCs, with cells being derived
from children at birth, age 1 , and age 4. Sorted naIve CD4 T cells in co-culture with DCs
and the superantigen toxic shock syndrome toxin (TSST) revealed deficient IFN-
production by intracellular staining in response to RSV-infected DCs, an effect that was
stable over time for a given individual. In the same report, the authors performed an
analysis on children at the age of I who were sorted based on RSV disease history, using
the same culture system. In this comparison, lower frequencies of IFN-y producing T
cells were found in co-cultures with cells derived from individuals with a history of
bronchiolitis rather than a benign disease course (Schauer et aI. , 2004). Previous work by
the same group had demonstrated that the reduced IFN-y production by T cells in this co-
culture system was dependent on replication-competent RSV infection of DCs, was
associated with selective DC CD86 induction, and could be overcome by stimulation of
the DCs with poly I:C, but not by CD40L stimulation (Bartz et aI. , 2003). Because of the
role of dsRNA in IFN-a/~ induction and activation of DCs (Cella et aI. , 1999), this
suggests that RSV may have evolved to avoid stimulating DC functions specifically
associated with type I IFN s. Indeed, a clinical isolate of RSV was associated with
ablation of typically potent IFN-a induction in plasmacytoid DCs (Schlender et aI.
2005), and RSV encodes IFN-antagonizing proteins (Spann et ai. , 2004). Taken together
these data indicate that DC functional maturation following RSV infection is defective
that at least some of the defects are associated with poor type I IFN responses, and that
these defects are influenced by viral and host genetic components.
In RSV infection, the T h type-skew induced during primary exposure may have
consequences for disease pathology during repeated challenges , as evidenced by
increased incidence in severe RSV disease noted following use of a formalin-inactivated
RSV vaccine (Chin, 1969; Fulginitti 1969). This vaccine is thought to have biased RSV-
specific responses towards a T 2-type response due to the nature of the adjuvant (alum
precipitation was used in vaccine preparation) included with the inactivated virus, and the
pulmonary eosinophilia noted following post-vaccination natural infection (Chin, 1969).
There is also evidence, derived from experiments in a murine model of RSV infection
that additional factors may predispose the host to development of pathogenic T cell
subsets. This argument is based on the observation that an oligo clonal, potently
expanded subset ofV~14 CD4 T cells specific for the RSV G protein are associated with
RSV-mediated pathology, with elimination of this subset providing protection against
severe disease upon RSV challenge (Varga et aI. , 2001). However, the role of DC in
generation of these pathogenic T cells (i. , their priming history) is not yet defined. In
the vast majority of human RSV cases , the individual recovers effectively from infection;
this may occur serially until adaptive RSV -specific responses are sufficient to make re-
exposure asymptomatic.
Viral infection of DCs associated with immune suppression is also implicated in
the development of indolent infection and chronic disease. Studies in humans and mice
suggest that, like acute immunosuppression, chronicity may be achieved through
utilization of IL- I 0 to attenuate host antiviral responses. This has been proposed to be
the case in humans for HCV (Hofer et ai. , 2005), and has been elegantly demonstrated for
the arenavirus , lymphocytic choriomeningitis virus (LCMV) clone 13 infection of mice
(Brooks et aI. , 2006). In the latter case , LCMV clone 13 is a derivative of LCMV strain
Armstrong. Although infection with the Armstrong strain is acute in nature , clone 13
establishes persistent infection in adult mice. A single amino acid change in the LCMV
glycoprotein (GP) is known to enhance binding to DCs (Oldstone, 2002). In the
experiments by Brooks et aI. , clone 13 , but not Armstrong, was associated with DC IL- I 0
production, and persistent infection induced by clone 13 infection was absent in IL- I 0
knockout mice.
Taken as a whole , these data serve to ilustrate multiple pathways by which
viruses can subvert DC function to facilitate their own survival and replication. 
particular, several of the aforementioned systems highlight the induction of IL- I 0 and
suppressionofIFN (particularly IFN-a/~) as convergent evolutionary tactics utilized by
viruses to modulate host immunity. Paradoxical T cell suppression in the context of
phenotyic activation is not uncommon, and in some cases appears to reflect DC
functions that are elicited by reverse signaling (i. , T cell signals to the DC) during
priming and co-stimulation events.
VIRAL INFECTION ASSOCIATED WITH DENDRITIC CELL ACTIVATION
AND T CELL STIMULATION
Not all cases of DC infection with viruses result in immunosuppressive outcomes. In a
study examining infection of DCs with the attenuated yellow fever virus, vaccine strain
17D, despite active replication in DCs , these cells did not express CD83 , which is
considered a prototypical marker of myeloid DC maturation. However, infected DCs
were able to stimulate YFV -specific autologous CD4 T cell and CD8 T cell responses in
a YF- immune donor, as well as responses in a flavivirus-naIve donor when an influenza
peptide was inserted into the NS2B-3 junction of the 17D virus used for DC infection
(Barba-Spaeth et aI. , 2005).
Additional studies on YFV indicated that infection of human monocyte-derived
DCs induced TNF-a, IL- , and, to a lesser extent, IL- IO production, in addition to the
chemokines IPIO and MCP- l. While IPlO and IL-6 induction were abrogated when the
virus was either UV- ina tivated or heat inactivated, TNF-a was absent only with heat
inactivation. Together, these data suggest a multi-tiered response to YFV l7D infection
in DC , with alternate pathways activated by distinct viral components or processes. The
authors reported only very modest DC CD83 induction with YFV infection, similar to the
previous report (Barba-Spaeth et aI. , 2005), and only at the highest MOI of I. However
YFY induced both CD80 and CD86, demonstrating a disconnection between the
traditional DC maturation marker, CD83 , and two of the B-7 family co-stimulatory
mo.le'cules often associated with phenotypic maturation. The same study, using murine
DCs in vitro revealed TLR- , 7 , 8 , and 9- dependent activation ofCDllc+ DCs by YFV
in the absence of DC infection. The authors also reported DC activation in vivo in l7D-
challenged mice, demonstrating YFV -specific expansion of CD8 T cells. Notably, the
data suggested a mixed Th l/Th2 response to the virus , with Thl/Tc l responses appearing
to' be inhibited through TLR2 activation (Querec et aI. , 2006).
Taken together, these two studies suggest that YFV l7D activates DCs and
facilitates their T cell priming capabilities. One could speculate further that, given the
superior effectiveness of the 17D vaccine, ideal vaccination strategies target multiple DC
signaling modalities and thus promote a balanced Th l/Th2 response in addition to
cytotoxic CD8 T cell activity.
It has also been demonstrated that Hantaan virus (HTNV), a bunyavirus that
causes hemorrhagic fever with renal syndrome, infects both blood- and culture-derived
DCs (Raftery et aI. , 2002). Infection neither induced apoptosis , nor inhibited HLA-DR-
specific antibody-induced apoptotic signaling. The authors reported production of both
TNF-a and IFN-a in response to infection; following exposure to HTNV , the DCs
increased expression of CD40 , CD80 , CD86 and HLA molecules to a level similar to that
of cells treated with TNF -a. In co-culture with whole allogeneic T cells , the response of
infected DCs again proved similar to TNF -a treated cells, as HTNV infection of DCs
improved their capacity to induce T cell proliferation (Raftery et aI. , 2002).
. These reports demonstrate that, for some viruses , infection results in a DC
phenotype associated with functional activation, including cytokine production and
importantly, . the ability, to prime T cell responses. This observation is in contrast to the
immunosuppressive effects of viruses described in the previous section, and serves to
highlight the broad diversity in DC responses induced by a range of viral pathogens.
Lastly, beyond simply regulation of DC function, viruses may utilize DCs as reservoirs
for transmission to other cell types and/or dissemination of infection.
. VIRAL DISSEMINATION AND THE PECULIAR CASE OF HIV
In the case of HI V, there is considerable evidence that DCs are not a primary target of
infection in the classical sense , in that there is little replication of the virus in the infected
cell. The "infection" process appears to occur through binding of the HIV virion to DC-
SIGN, an event that preserves the infectivity of the virus and results in transfer to , and
infection of, resting T cells (Geijtenbeek et ai. , 2000a). In particular, DC-SIGN
expression on the DC induces T cell clustering through binding of T-cell expressed
ICAM- , allowing HIV to enrich its microenvironment with available targets. In this
case , the DC acts as a "Trojan horse , internalizing and sequestering the virus and
maintaining it in a non- lysosomal low pH compartent, and presenting it to CD4 T cells
which are then infected in trans , an effect that has been observed in both in vitro and 
vivo (Kwon et ai. , 2002; C meron et aI. , 1992). Therefore , HIV is able to utilize DCs for
temporary survival in the host while accumulating target cells , a strategy that fosters
rapid replication and dissemination and eventually establishes a state of chronic disease.
To the point, these observations demonstrate that DCs need not serve as an active source
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, of virion production to facilitate viral replication. Rather, viruses may use DCs as a
temporary " safe house " enabling the virus to avoid detection whilst manipulating DC
functions to further their own ends.
. DENGUE INFECTION OF DENDRITIC CELLS
As noted previously, DCs were originally shown to be infected by DV both ex vivo and 
. vitro by Wu et al (2000). Shortly thereafter, subsequent work demonstrated that DV
induces DC phenotyic changes and cytokine production in DCs generated in vitro from
adherent blood moriocytes (Libraty et aI. , 2001; Ho et aI. , 2001). In one study, these
inCluded increases in co-stimulatory molecules CD80 , CD86 , and HLA DR, induction of
CD83 , arid secretion ofTNF-a and IFN-a, but not IL- l2 or IL-6. In the absence of
feeding cytokines , infected DCs showed slightly higher levels of apoptosis before 22
hours, but had greater survival by 46 hours (Ho et aI. , 2001). Similar results were found
in a second study, in which following infection DCs induced CD40 , CD83 , CD80 , CD86
and both MHC class I and II molecules at 48 hours (Libraty et aI. , 2001). In that study,
intracellular staining for dengue antigen revealed that infected DCs had significantly
reduced expression ofCD83 , CD80, CD86 , and MHC Class I when compared to
uninfected bystanders. Consistent with the report by Ho et al (200 I), the authors reported
that in response to infection DCs secreted TNF-a and IFN-a without a significant IL-
p70 response , and DV infection did not induce IL- lO. Libraty et ai. (2001) also noted
that IFN -y treatment at the time of infection reduced virus output, restored surface
molecule expression in infected cells , and increased IL- 12 p70 secretion, suggesting that
earlyIFN-y i duction in vivo during secondary infection might enhance DC activation
and adaptive immune stimulation.
A later in vitro study addressed the issue of virus strain on DC infection. The
investigators generated chimeric infectious clones by replacing specific regions of the SE
Asian D2V strain 16681 with sequences from another SE Asian D2V strain or an
American D2V strain. When monocyte-derived DCs were exposed to these viruses , the
infectious clone generated from 16681 and the 1668l parent virus infected DCs more
efficiently than either an infectious clone with three American genotype structure inserts
(and a SE Asian backbone) or the parent American genotype virus (Cologna and Rico-
Hesse, 2003). In that report, of the three American structures introduced, the E protein
mutation was most critical for reduced virion output.
The importance of the E protein becomes more apparent.when viewed in light of
the role that this protein serves in binding to the DC receptor, DC-SIGN, as discussed in .
the section on dengue virus biology. Strengthening the hypothesis that DC infection is
critically involved in dengue pathogenesis , a multi-site study performed in Thailand
. found that the more rare "G" polymorphism in the promoter region of DC-SIGN (denoted
DCSIGNI-336by the authors) had a significantly lower frequency in individuals
diagnosed with dengue fever, with an incidence in DF cases of 4.7%. The frequency of
individuals carring the G allele among DHF patients (22.4%) was similar to that in the
control population (19. 5%). These results suggest that the G form of the allele is
associated with protection from DF but not DHF , potentially by affecting an Spl binding
site and reducing transcriptional activity from the DC-SIGN locus (Sakuntabhai et ai.
2005). In particular, this may reduce susceptibility of DCs to infection by DV in
individuals carring the G allele. Additional evidence for host genetics affecting DC
function in dengue infection may be implied from the observation that a single nucleotide
polymorphism (SNP) in the vitamin D receptor (VDR) is associated with reduced risk of
DSS (Loke etaL , 2002). Signaling through the VDR has been shown to attenuate the
activation and function ofDCs (Griffin et aI. , 2001).
During preparation of this thesis, additional reports emerged on the effects of DV
on DCs , including suppression of T cell stimulation. The first of these indicated that
although dengue infection activated bystander cells, actively infected DCs failed to
increase surface molecule expression, with CD40 and HLA DR reduced even in
comparison to mock infected cells (Palmer et aI. , 2005). In accordance with earlier
studies (Libraty et aI. , 2001; Ho et aI. , 200 I), Palmer et aL (2005) reported TNF -a and
. IFN-a secretion with minimal detection ofIL- 12 p70. In contrast to the study by Libraty
et at (200 I), Palmer et ai. (2005) also reported IL 1 0 production by DC in response to
dengue infection, and elevated levels ofIL- I 0 when dengue-infected as opposed to
mock- infected DC were co-cultued with allogeneic T cells. Thus, the authors
hypothesized that IL- l 0 was responsible for the observation of lower T cell proliferative
responses to DCs infected at higher MOIs (Palmer et aI. , 2005).
Additional work by the same group found that CD40 ligation on DCs following
DV infection increased both the percentage of infected DCs and virion output in the
exposed cultures , similat to what had been observed for MV a number of years prior (Sun
et aI. , 2006). In that study, TNF-a and IL- 12 p70 secretion were enhanced, while IFN-a
secretion appeared to be suppressed by CD40L stimulation (Sun et aI. , 2006). Also in
that study, although DC apoptosis following dengue infection was lower than that seen
with mock infection, the addition of CD40L reduced cell death in both populations , in
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contrast to observations in the MV system. Lastly, CD40L stimulation of infected
cultures restored CD80 , CD86 , and CD83 expression on infected DCs when compared to
bystanders and erianced IFN-y production in co-culture with allogeneic CD4 T cells , but
A later study compared DC responses on the single-cell level following infection
'ii
did not reverse the decrease in Tcell proliferative responses to DCs seen with increasing
MOIs (Sun et ai. , 2006).
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with either parent (strain l6681) or attenuated (PDK53) D2V strains. Regardless of the
infvction state of the DC, both strains increased CD80, CD83 , and CD86 expression
compared to control treatment while MHC class I and II expression were elevated
. following 1668l exposure alone (Sanchez et aI. , 2006). That study also used
intracellular staining for cytokines and dengue protein, demonstrating that after PDK53
infection, TNF -a production occurred primarily in infected cells , while both infected and
bystander DCs produced TNF -a following 16681 infection; only l6681 induced IL-
which was detected in both infected and bystander DCs (Sanchez et aI. , 2006).
Therefore, active replication and virus genetics both contribute to the surface expression
and secretory phenotype of DCs following DV infection. IL- 12 p70 production and
secretion were minimal, and although the authors reported some low-level IL-
secretion, intracellular cytokine staining did not reveal IL- I 0 production and thus the
infection state of the respon'sible cells (Sanchez et aI. , 2006). This may have been a
failure in either the quality of the staining antibody or a function of low IL- l 0 production
levels , resulting in inadequate signal strength for flow cytometry (Sanchez et aI. , 2006).
. Consistent with reports ofIFN- interference by DV in cell lines , DV has also been
shown to alter IFN-dependent signaling in primary human DCs. Work by Ho et al (2005)
demonstrated that, similar to findings in multiple cell lines (Diamond et aI. , 2000), IFN-a
andIFN-
y '
could inhibit DV infection and replication in DCs , although IFN-a required
pretreatment to be effective. DV induced STATl , 2 , and 3 phosphorylation, with STAT3
showing early (3hr) activation and DNA binding, while slower kinetics (24hr) were
observed for STATl. Infected DC were resistant to exogenous IFN-a mediated
activation of STAT 1 and 3 , but responded to IFN-y (Ho et ai. , 2005), reminiscent ofIFN-
y effects on DC phenotype in work by Libraty et al (2001). The phosphorylation 
STATl , but not STAT3 , depended on endogenous IFN-a production, and active infection
reduced IFN-amediated Tyk2 phosphorylation (Ho et aI. , 2005)
As a w401e , the stlldies highlighted here demonstrating DV infection of DC begin
to elucidate some of the mechanisms by which the virus is able to modulate host immune
responses. Blockade ofIFN-a/~, elicitation ofIL- , and interference with the
expression of DC surface molecules all represent manipulations of DC function that can
have profound consequences for the development of dengue-specific immunity in vivo.
THESIS OBJECTIVES
Primary dengue infection is associated with the generation of serotype-specific protective
immune responses , with complete clearance of the virus and, in the vast majority of
cases, minimal pathology. Memory to dengue appears to playa critical role in the
etiology of the most severe manifestation of disease, DHF. Dengue infection of dendritic
cells likely plays a crucial role in determining downstream immune responses , serving as
a source of virus production, initiating immune activation, and driving T cell
differentiation and functional behavior. The presence of replicating ;virus in DCs
. resulting in production of dengue proteins and RNA, means that infected DCs are
, influenced in a manner that differentiates them from uninfected, bystander cells that are
exposed to an otherwise identical microenvironment. Therefore , the functions of these
two distinct populations are expected to differ, with consequences for the development of
dengue-specific immunity.
My hypothesis was therefore that dengue virus infection of dendritic cells
results in the activation of functions consistent with immune regulation and antiviral
immunity, with intracellular replication inhibiting activity critical to viral clearance.
The experimental work of this thesis is presented in three sections:
Chapter III: INFECTION AND PHENOTYPIC MATURATION OF DENDRITIC CELLS
FOLLOWING DENGUE VIRUS EXPOSURE
Enhanced expression of surface molecules on DCs prior to , and during, antigen
presentation has contact-dependent consequences for the nature ofT cell priming. Both
quantitative and qualitative regulation ofT cell function can be affected, determining the
effectiveness of downstream immune responses. Therefore, I sought to determine if DV
exposure was a stimulus for the increased expression of DC surface molecules involved
in T cell regulation. In addition, exposure to viral particles affects DC phenotypic change
through multiple pathways , including the direct effects of binding, internalization and
replication, and the indirect effects of subsequent soluble mediator release. Thus , I also
sought to elucidate the contributions of each aforementioned pathway to changes in DC
phenotype. These aims were addressed as follows:
ci) Generation of monocyte-derived DCs and infection with DV
Whole culture phenotypic matuation responses of DCs following DV
infection and comparison to defined stimuli and killed virus
Comparison of phenotypic matuation responses of actively infected DCs and
uninfected bystanders in the same culture
Chapter IV: INDUCTION AND REGULATION OF DENDRITIC CELL CYTOKINE
AND CHEMOKINE RESPONSES BY DENGUE VIRUS
Soluble mediators released following exposure ofDCs to virus have autocrine and
paracrine effects on DCs. These effects include induction of an infection-resistant state
changes in cell surface phenotype, and secondary release of further soluble mediators.
Soluble factors further influence DC function by modulating their interactions with
downstream cellular responses. This can include the selective recruitment of specific sets
of cellular effectors , as well as regulation of the activity of these effectors , based on the
signaling induced in responding cells by DC-released molecules. Therefore, I sought to
determine the effects of DV on DC cytokine and chemokine production, by again
addressing both direct (particle- and replication-dependent) and indirect (secondary
secretory response) effects. I addressed these issues by:
Whole culture secretory responses of DCs to infection with DV and
comparison to LPS or kiled virus
Dose-responsiveness of whole culture secretory responses of DCs to
infection with DV
Comparison ofTNF-a and IPlO response profiles in infected DCs as
compared to uninfected bystanders
Effects ofIFN-a/~ blockade on single-cell TNF-a and IPlO production
e). Differences in single-cell DC IP I 0 production profies following
infection with variant D2V strains
Chapter V: EFFECTS OF DENGUE INFECTION ON THE ABILITY OF DENDRITIC CELLS TO
PRIME ALLOGENEIC RESTING CD4 T CELLS
Arguably the most critical function of DCs following exposure to pathogens such as
viruses is the. induction ofT cell-'mediated immune responses. Proper regulation ofT
cell responses is crucial in determining both the appropriate magnitude of the response, as
well as the. direction of that response with regards to effector actions of T cells. 
properly regulated T cell response wil facilitate effective elimination of the invading
pathogen. . T cell expansion is particularly important, given the relative paucity of
pathogen-specific T cells in a naIve individual. While Th type responses characterized
by IFN-y production are considered critical for elimination of intracellular pathogens
such as viruses , I 2-type responses characterized by IL-4 and - 13 are thought to be
important in effective antibody production by B cells and elimination of extracellular
agents. IL- lO is important in the attenuation of the magnitude of T cell responses, as well
as inhibition of IFN-y function. I therefore sought to determine if DV infection of DCs
promoted proliferation and T h-skewing in responding CD4 T cells.
Comparison of resting CD4 T cell proliferative responses to DV-
infected DCs versus mock-infected or cytokine-matured DCs
Effects ofindreasing DV MOI of DC on their CD4 T cell priming
function
Effects of infectious immune-complexed virus on DC priming function
CHAPTER II
MATERIALS AND METHODS
. MONOCYTE ISOLATION AND CULTURE
We generated monocyte-derived DCs following the methods of Sallusto and
Lanzavecchia (1994) with minor modifications. Briefly, peripheral blood mononuclear
cells (PBMC) were obtained from the heparinized blood of healthy adult volunteers in a
dengue non endemic region using Ficoll-hypaque (Amersham/GE Healthcare Bio-
Sciences AB , Uppsala Sweden), under a protocol approved by the University of
Massachusetts Medical School Institutional Review Board. Monocytes were isolated
from PBMC using MACS (Miltenyi) CDl4 positive selection, according to the
manufacturer s protocol, and were separated on an LS column (Miltenyi) using a
MidiMACS magnet (Miltenyi). The CDI4- fraction was collected and used for T cell
isolation (see below). CDI4+ cells were washed and re-suspended at 1.4- 1.8xl0
cells/mL in 24-well plates, in RPMI 1640 containing penicillin/streptomycin (1 mg/mL
each), and 10% heat-inactivated fetal calf serum (FCS; Hyclone) supplemented with 800
U/mL recombinant human (rh) GM-CSF and 500 U/mL rhIL-4 (Peprotech). At day 3-
5 mL of medium was removed and replaced with fresh medium containing 1600 U/mL
rhGM-CSF and 1000 U/mL rhIL-4. On day 6- , vigorous pipetting and gentle scraping
collected DCs. These cells were CD3-, CD8- , CDI4- , CD19- , and CD56- , but were MHC
class n , MHC class I 1ow , and expressed the myeloid DC marker CDla . Cells had an
immature DC phenotype (as shown in Figue I) by low staining for CD83.
. T CELL ISOLATION
CD45RA + CD45RO. CD4 T cells were isolated by negative selection using a naIve T cell
isolation kit (StemSep;StemCell Technologies) according to the manufacturer s protocol.
Briefly, the CDI4- fraction of cells generated by positive selection ofmonocytes was
washed and re-suspended with MACS buffer at a final concentration of 5xl 0 cells per
mL. Biotinylatedanti-CD45RO was added and incubated for 30 minutes at 4 C. Anti-
lineage/anti-biotin antibodies were added and the mixture was incubated for 30 minutes
at 4 C. Cells were washed two times with 5 mL of MACS buffer and separated using a
MidiMACS magnet and LScolumn (Miltenyi). The cells were washed , counted, and
re-suspended in RPMI 1640 supplemented with penicillin/streptomycin and 10% heat-
inactivated human AB serum (Gemini BioProducts) (RPMI ABlO) at 1.0xl06 cells/mL.
Human AB serum was used in lieu of FCS at all steps during isolation and culture of T
cells due to an observed tendency of FCS to induce non-specific proliferation. T cells
isolated in the manner described were typically 90-95% CD3 , and :?95% CD4 . The
CD3+CD4+ cells were routinely :?98% CD45RA +CD45RO- (not shown). T cells were
added to wells in a 96-well plate at 50 000 T cells in 50 ilL for co-culture experiments.
. DENGUE VIRUS INFECTION OF DENDRITIC CELLS
D2V New Guinea C (NGC) is a laboratory-adapted prototype Southeast Asian D2V
strain obtained from A TCt. D2V 16681 and D3V CH53489 are prototype strains
originally obtained from the Walter Reed Army Institute of Research. D4V 814669 is a
prototype strain originally obtained from the National Institutes of Health. D2V INH and
VEN are American genotype viruses originally obtained from Dr. Rebeca Rico-Hesse
Southwest Foundation for Biomedical Research. Dengue 2 strain COl66/96 is a low-
passage clinical isolate from a Thai DF patient (Vaughn et aI. , 1997). Viruses were
. propagated in the mosquito cell line C6/36. Virus titers were determined by plaque assay
on Vero eells. Inactivated, non-replicative virus was prepared by,placing an aliquot of
virus stock 5-6 em under a germicidal lamp (2300 Jl W/cm2 UV A irradiation at 254 nm)
and incubating for 30 minutes on ice.
For infection, DC pellets in 15 mL polypropylene tubes were incubated at 37
5% C02 for 90 minutes with supernatant from C6/36 cultures (mock infection), UV-
inactivated virus , or live virus. Tubes were left loosely capped and the pellets were
disrupted using vortex mixing every 30 minutes. Following adsorption, the cells were
washed and plated in 24-well plates (1.0 mL/well) or 48-'well plates (0. 50 mL/well) at
1.0x10 cells/mL and maintained at37 , 5% C02. TNF-a at 50 ng/mL (R&D systems;
Peprotech) and IFN-a 1000 U/mL (5 ng/mL) (Peprotech), or LPS (50ng/mL, from
coli; Sigma) was added where noted. For DC infection using a range ofMOIs , virus
stock was serially diluted 5-fold in medium as needed, and DCs were infected in a fixed
volume as described above.
INFECTION OF DENDRITIC CELLS WITH IMMUNE-COMPLEXED
DENGUE 2 VIRUS
Uninfected C6/36 mosq ito cell supernatant or live D2V NGC was combined with either
control plasma or plasma from a dengue 3 immune donor at a dilution of 1 :20, which was
previously determined to enhance DV infection ofK562 cells (Laoprasopwattana et aI.
2005). The virus-plasma mixtures were incubated on ice for 30 minutes prior to addition
to DCs alan MOI=I. Following adsorption, DCs were washed and re-cultured for 24,
hours as previously described.
MULTIPLEX ANALYSIS OF CVTOKINES AND CHEMOKINES
Analysis of cell culture supernatants for cytokines and chemokines utilized BeadLyte
cytokine assay kits (Upstate) as per the manufacturer s protocol; analyses were
performed at the Baylor Institute for Immunological Research. Cytokine concentrations
were calculated using Bio-Plex Manager 3. 0 software with a 5-parameter curve-fitting
algorithm applied for standard curve calculations. Assay specifics: In Figure 7 , the lower
limit of detection threshold was 10 pg/mL for all analytes , with the exception of IL-
p40 (40 pg/mL), IFN-y (13 pg/mL), Eotaxin (69 pg/mL) and MIP- la (86 pg/mL). In
this. assay, upp r limits of detection were greater than 10 000 pg/mL with the exception of
RANTES (8750 pg/mL). Samples were diluted 2. fold for analysis. For the purposes of
graphical analysis, samples outside the limits of detection were plotted at the limit. In
this assay, IPlO levels in DV-infected DC supernatants were not quantifiable according
the analysis software. Samples from which the data in Figures 8 and 9 were derived were
diluted 7. 5- fold for analysis. Lower limits of detection were 10 pg/mL. Samples from
which the data in Figure 10 were derived were diluted 2-fold for analysis. Some data for
IPIO in Figure 10 represent extrapolated values beyond the high value in the five-point
standard curve based on the linearity of the high end of the curve. These values were not
determined to be out of range by the analysis software and represent quantifiable values
(John Connolly, Baylor Luminex Core Facility, personal communication). Lower limits
of detection were 10 pg/mL. Samples from which the data presented in Figure 18 were
derived were diluted 2-fold for analysis; lower limits of detection were 10 pg/mL.
ANTIBODIES FOR FLOW CYTOMETRIC ANALySIS
The following monoclonal antibodies to human targets were purchased from
. BD/Pharmingen: FITC anti-CD3 , FITC anti-CD45RA, FITC IgG , FITC IgG1 , PE anti-
HLA A, B , C , PE anti-CD40 , PE anti-IPlO, PE anti-CD45RO , PE apti-CD56 , PE anti-
COla, PE-anti PD- , PE anti-CD80 , PE IgG , PE IgG1 , PerCP anti-CD4 , PerCP
IgG1 , APCanti-CD3 APC anti-CD19, APC anti-CD56 , APC anti-CD83 , APC anti-
CD la, APC anti-HLA DR, APC anti-PD- , APC anti-CD86 , APC anti-TNF-a, and
APC IgG1k. Purified mouse IgG1 k was purchased from BD and used as a blocking
antibody in some experiments, Monoclonal cross-reactive anti-dengue complex
antibody (clone M8051l25 , IgG2a) was purchased from Fitzgeraldlndustries (Concord
MA) and was either custom-conjugated to FITC or labeled with Zenon Pacific Blue
(Molecular Probes/Invitrogen) reagent according to the manufacturer s protocol. In
some experiments , viral envelope staining was performed using FITC goat anti-mouse
IgG (Sigma) as a secondary antibody.
IMMUNOCYTOCHEMISTRY AND FLOW CYTOMETRIC ANALYSIS
For staining of cell surface markers, DCs were washed twice with DPBS (Gibco) 2%
FCS , 0. 5% sodium azide, (PBS-azide wash buffer, P A WB). In some experiments , DCs
were incubated for 15 minutes with 500 ng mouse IgG1k to reduce non-specific staining.
Cell-marker specific antibodies were added at 50 ng per antibody for 30 minutes at 4
Cells were washed three times and fixed using Cytofix (BD) or Cytofix/Cytoperm (BD)
according to the manufacturer s protocol. Cells were assayed for dengue E protein
expression bypermeabilization and staining for 30 minutes with anti-dengue (I I-g)
antibody. For inttacelhilarcytokine staining, ll-g ofbrefeldin A (Golgiplug, BD) per
million cells was added 6-8 hours prior to harvesting and fixation. DCs were washed 2
times with PermWash (BD), and then anti-IPlO (0. 5 I-g) and/or anti-TNF..a (0. 5 I-g), and
anti.;dengue '(I I-g) antibody were added for 30 minutes, after which the cells were
washed three times with Perm/Wash buffer and re-suspended in PAWB for analysis.
Flow cytometry was performed on F ACSCalibur, F ACSAria, or LSRII flowcytometers
(BD Immunocytometry Systems , San Jose, CA) with data collection utilizing CellQuest
3 or F ACSDiva 5.x software. Data were analyzed using FlowJo ver.6 and up
software (Treestar).
INTERFERON ALPHA/BETA BLOCKING EXPERIMENTS
DCs were harvested and washed as previously described. The cells were then incubated
with medium alone, or with medium plus IgG or anti- CD 118 (interferon-alpha receptor
subunit 2; IFNAR2) antibody (PBL laboratories) at 50 I-g/mL for 30 minutes. The
addition of virus resulted in dilution of antibody to 10 I-g/mL. Viral adsorption
washing, and DC culture were carried out as previously described, in the presence of
antibody where specified. Upon re-suspension, the appropriate antibody (IgG or anti-
IFNAR2) was added at 10 I-g/mL for the duration of culture as required.
DENDRITIC CELL-T CELL CO-CULTURE
For co-cultures examining a range ofT: DC ratios , D2V-infected, mock- infected, or
cytokine-treated DCs were harvested, washed, and re-suspended in RPMI ABlO at 10
cells/mL , then serially diluted as needed. DCs were added to T cells (5xl04 cells in 50
ItL) in 100 IJL aliquots in .quintuplicate wells for each condition to a final volume of 150
pL/well in 96-well plates. In experiments utilizing a range of MOIs , DCs were washed
and re-suspended as described above , with a final count of 5x I cells/mL, and added to
100 ItL ofT cell suspension (at 5x105 T cells/mL) in aliquots of 50 ItL (2500 DC, T: DC
ratio of20: I) in quintuplicate wells in 96-well plates. For experiments with immune-
complex treated DCs, DCs were washed and re-suspended as previously described, at
5xl04 cells/mL , then serially diluted as needed and 50 ItL of the appropriate dilution
added to 100ltL ofT cells (at 5x105 T cells/mL) in quintuplicate wells in 96-well plates
(T: DC ratio of 20: 1). T cells incubated with ug/mL phorbol myristoyl acetate (PMA)
plus 0. 1 Itg/mL ionomycin (Sigma) served as positive controls. Negative control wells
were T cells receiving medium alone.
TRITIATED THYMIDINE INCORPORATION
Following 3-4 days of co-culture, tritiated thymidine (Perkin-Elmer) was added to each
well at a concentration of 1 ItCi in 50 ItL ofRPMI ABIO , 18-20 hours before harvesting.
Cells were harvested onto glass fiber fiter mats and the incorporation of radioactive
thymidine measured using a Betaplate liquid scintillation ~-counter. PMAIionomycin
stimulated cells routinely produced counts in the range of 50 000 to greater than 100 000
cpm; negative controls were routinely less than 100 cpm (not shown).
STATISTICS
All statistical analyses utilized the nonparametric Wilcoxonsigned rank test. Forcell
. surface phenotyping, the ratio of mean fluorescence intensities (MFI) was calculated for
each comparison and compared to a hypothetical value of 1. Statistical analyses of co-
culture experiments were performed between groups on mean raw cpm values derived
from replicate (quintuplicate) wells. For all analyses , P values of 05 were considered
statistically significant.
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CHAPTER III
INFECTION AND PHENOTYPIC MATURATION OF DENDRITIC CELLS
FOLLOWING DENGUE VIRUS EXPOSURE
GENERATION OF IMMATURE MONOCYTE-DERIVED DENDRITIC CELLS AND
. THEIR SUSC)!PTIBILITY TO INFECTION WITH DENGUE VIRUS
Immature monocyte-derived DCs (iDC)are the in vitro counterparts of in vivo myeloid
DCs, including dermal interstitial DCs (Banchereau and Steinman, 1998). Early studies
demonstrated dengue virus infection of in vitro-cultured DCs (Wu et ai. , 2000; Ho et ai.
2001; Libraty et ai. , 2001). Therefore, in order to study the effects that dengue virus has
on the functional activities oftarget cells , we generated myeloid DC in culture and
infected them with the laboratOly-adapted D2V New Guinea C strain (NGC). Positive
selection of monocytes from the PBMC of anonymous whole blood donors with
MACS allowed us to isolate highly purified populations of CD l4-expressing
monocytes. Following supplementation with GM-CSF and IL- , monocyte-derived DCs
exhibited uniform forward- and side-scatter morphology, large proportions (tyically
85% or more) of CD la-expressing cells , and low expression ofCD83 (Figure fA). Cells
generated in this manner also expressed high levels of HLA DR, intermediate levels of
HLA A, B, C , and lost CDl4 expression (not shown), characterizing them as immature
myeloid DCs.
Following generation of these cells , we first sought to determine the period of
maximal viral protein production following infection with D2V. A previous report
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Figure 1 Monocyte-derived dendritic cells (DCs) are highly susceptible to
infection with dengue virus.
A) Flow cytometric analysis of immature DCs derived from CD14-positively
selected monocytes. Results are representative of at least 10 experiments. DCs
were CD14- HLA A , 8 , Cmid HLA DW (not shown). B) DCs were mock infected
(black fill) or infected for 24 (red line) or 48 (blue line) hours with live dengue 2 virus
New Guinea C strain (D2V) at a multiplicity of infection (MOl) of 2. Infection was
performed by adsorbing with virus for 90 minutes , washing, and returning the DCs to
culture. At the specified time , DCs were intracellularly stained for dengue E protein
using a FITC monoclonal anti-dengue complex antibody. The data shown are
representative of three similar experiments. C) DCs were infected with live virus (red
line) as in (8), or with virus pre-treated for 30 minutes on ice using short-wave
(254nm) UV irradiation (green line). Gating based on dengue-specific staining of
mock- infected cells is represented by the black line at the base of the figure. The
data shown are representative of more than five experiments.
indicated that D2V NGC infection ofDCs resulted in the appearance of viral protein at
12 hours and peak production between 24 and 48 hours (Wu et aI. , 2000). Therefore
after 6-8 days in ' culture , we harvested and infected DCs with D2V NGC, then returned
them to cultue for 24 or 48 hours. After the respective time period, we harvested the
DCs and fixed them, then performed intracellular staining for dengue viral E protein
using a monoclonal anti-dengue E protein antibody. Following infection with D2V NGC
we found maximal E protein production before 48 hours (Figure IB).
One of the principal functions ofDCs is antigen uptake andprocessing. To
ensure that dengue E protein staining was indicative of de novo viral protein synthesis
and was not simply unprocessed viral protein taken up via endocytosis , we compared
staining for E protein after infection with live or UV-inactivated D2V NGC. At 24 hours
only DCstreated with live D2V , and not cells exposed toUV.. irradiated virus, expressed
detectable dengue E protein (Figure 1 C). These data demonstrate that D2V readily
infects DCs , and that dengue E protein was synthesized de novo in infected cells.
DENDRITIC CELL INFECTION WITH MUL TIPLE DENGUE
VIRUS STRAINS
Since D2V New Guinea C is a laboratory-adapted virus, we sought to determine if other
dengue viruses were able to infect DCs. We included prototype strains of dengue
serotypes 2 (strain 1668l9, 3 (strain CH53489), and 4 (strain 814669) and low-passaged
dengue 2 strains isolated from patients (COI66/96, VEN , INH) at an MOI=2.
Intracellular staining at 24 hours post-infection detected the presence of DV E protein in
DCs infected with all of the virus strains tested (Figure 2). These results demonstrate
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Figure 2 Wild type dengue
viruses infect DCs.
DCs were infected for 24 hours as
102 102 previously described , using a range
of dengue viruses , then stained for
intracellular dengue E protein. Black
fill: Mock infection. Red traces: DV
infection. A) Dengue intracellular E
protein staining in DCs from a single
D2V NGC D2V THAI donor infected with laboratory-
adapted D2V New Guinea C strain
low-passage American D2V strains
INH and VEN , and the D2V proto-
22. type strain 16681. B) Dengue intra-41. cellular E protein staining in DCs
from a single donor infected with
New Guinea C , low-passage DF
patient isolate C0166/96 (D2V Thai),
D3V prototype strain CH53489 , and
D3V CH53489 D4V 814669 D4V prototype strain 814669. NGC
Thai , and 16681 strains were tested
in at least 5 independent experi-
ments; IHN and VEN strains were
tested in four donors D3V and D4V
are from a single experiment.
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. that multiple dengue viruses , including low-passage clinical isolates , are able to
efficiently infect immature DCs.
DOSE-DEPENDENT INFECTION OF DENDRITIC CELLS WITH DENGUE 2
VIRUS STRAIN NEW GUINEA C
Previous reports using other strains of dengue to infect dendritic cells have utilized
varying input levels of virus (Ho et ai. , 2001; Libraty et aI. , 2001; Palmer et ai. , 2005;
Sanchez et ai. , 2006). In order to determine dose-dependence of infection, and the
amount of virus required forieproducible, quantifiable infection in DC , we infected cells
from multiple (N=7) donors, each with the same range of virus concentrations. To do so
we performed 5- fold serial dilutions ofD2V NGCin medium and adsorbed the virus 
DCs at MOIs of 0. , 0. , I , and 5. Following adsorption, the cells were washed and
returned to culture for 24 hours , after which they were harvested, fixed, and stained for
intracellular dengue E protein (Figure 3). Non-specific staining of un infected DC with
the anti-dengue antibody was 0.75% or lower (mean:JSD of 0.45:J0. 17%).
Infection was evident in some instances even with the lowest amount of input
virus (MOI=0.04), with three of seven donors ' DCs demonstrating antigen expression of
greater than 2% (range , 2. 7. 8% r Although substantial infection (greater than 20%)
occurred in five of seven donors at an MOI=1 (range, 24-50%), dengue E protein was
essentially undetectable in donor 2 and was low (2%) in donor 1. We found consistently
high levels of dengue infection at an MOI of 5 (mean:JSD , 53. 5:J19. 1 % , range, 20%-
73%). There was substantial variability in infection rates, which was not wholly
dependent on the virus preparation used or the day of assay, since donors I to 5 were
infected using a single virus stock, and donors 1 , 2 , and 3 were infected simultaneously in
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Figure 3. Dose responsiveness of multiple donors ' DCs to
infection with D2V New Guinea C strain.
DCs from seven donors were infected with D2V NGC at varying MOls , using five-
fold serial dilutions in three Independent experiments (experiment 1 , donors 1-
experiment 2 , donors 4 and 5; experiment 3 , donors 6 and 7). Virus adsorption
washing, and DC re-culture were performed as previously described. At 24 hours
DCs were harvested and intracellularly stained for dengue E protein.
a single experiment. Together, the data indicate that infection of immature DC with
dengue' virus is dose-dependent, and suggest donor-dependent variability in the
permissiveness of DC to infection.
DENDRITIC CELL IMMUNOMODULATORY SURFACE MOLECULE
EXPRESSION CHANGES AFTER INFECTION WITH DENGUE 2 VIRUS
Cytokines produced in response to viral infection, including IFN-a and TNF-a, are
implicated in the process of DC activation and maturation (Luft et ai. , 1998; Honda et aI.
2003; Sallusto and Lanzavecchia, 1994). One aspect of DC matuation is the induction
of surface molecules involved in the regulation of adaptive immune responses. To
determine if D2V activates DCs and induces expression of these immunoregulatory
proteins , we used flow cytometry to compare DC surface phenotypes following infection
with live dengue virus, treatment with TNF-a/IFN-a or LPS , or mock infection.
When compared to isotype control staining, mock-infected cells expressed low
levels ofCD40 and PD-L2 and intermediate levels ofMHC class I and PD-Ll. CD86
CD80 , and HLA DR were expressed by approximately 50%, 90%, and 95%, respectively,
of DC following mock infection (Figure 6). CD83 expression was similar to isotype
control staining, although in most experiments a small population (less than 15%) ofDCs
were CD83 (refer to Figure 6). In order to quantify changes related to treating these
DCs with additional stimuli , we calculated fold-expression by normalizing the MFI for
each condition relative to mock infection for the same donor s DCs. Both D2V infection
and TNF-a/IFN-a treatment induced similar patterns of surface molecule expression
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Figure 4: Live dengue virus activates DC surface molecule expression.
DCs were adsorbed for 90 minutes with control medium (mock) or D2V New
Guinea C, MOI=2 , then washed and returned to culture for 24 hours. For positive
control comparisons , immediately following mock adsorption , some cells received
treatment with TNF-a/IFN-a (50ng/mL and 1000 U/mL=5 ng/mL , respectively) or
LPS (from E. coli , 50 ng/mL). At 24 hours cells were harvested and surface
stained for the specified protein markers. Values are represented as a fold-
expression versus mock treatment alone, calculated as a ratio of geometric mean
fluorescence intensities: MFI(treatment)/MFI(mock). Each line/color represents 
single DC donor. White diamonds represent mean values for each condition from
the four experiments. The black line at 1 represents no change in expression from
mock treatment (fold expression=1).
(Figure 4). Relative expression to mock infection of CD83 (mean:1SEM, 4. 73:10.
versus 3.18:10. 15) and CD80 (2.48:10.29 versus 1.77:10.21) was clearly higher in
cytokine-matured cells as compared to infected cells , while differences in CD40
(1.58:10.04 versus 1.32:10. 02) and HLA DR (1.96:10.41 versus 1.47:10. I 1 ) induction were
less pronounced. Expression levels ofCD86 , PD- , PD- , and HLA A C showed
similarly small differences between D2V- infected and cytokine-treated DCs, although
cytokine-matured cells had higher mean expression in all cases.
As expected, LPS (50 ng/mL) was a potent stimulus for DC activation, inducing
the greatest increases in expression for all markers tested. CD83 , CD80, CD86 , and PD-
Llshowed the greatest induction of expression in response to LPS, with mean geometric
MFI values 4- to 6-fold those seen with mock infection (5.44:10. 80:10. 37:10.
and 5.9l:0. respectively)o CD40 , PD- , HLA A, B , C , and HLA DR showed less
induction than the aforementioned products when compared with mock infection, ranging
from 1.77:10.11 for CD40 t02. 17:10.24 for PD-L2. These data indicate that live D2V
exposure stimulates expression of immunomodulatory surface molecules on DC. The
degree of stimulation following infection with D2V was slightly lower than that of TNF-
a/IFN-a treatment and clearly less pronounced than seen with high-dose LPS.
EFFECTS OF UV LIGHT INACTIVATION OF DENGUE VIRUS ON DENDRITIC
CELL SURFACE MOLECULE EXPRESSION
In order to determine if D2V replicative capability was necessary for the induction of
surface immunomodulatory molecules , we compared mock-infected DCs to DCs exposed
to either UV-inactivated or live D2V (Figure 5). We found that exposure to UV-
inactivated virus significantly enhanced expression of the B7- family molecules CD80
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Figure 5: Replication enhances surface molecule expression changes
induced following D2V exposure: DC were mock infected, infected with live
D2V New Guinea C strain at an MOI=2 , or infected with the same virus,
inactivated with UV light as previously described (UV-D2V). DCs were harvested
and surface stained as previously described , then analyzed by flow cytometry to
determine mean fluorescence intensity for each surface marker. Values are
represented as a fold-expression versus mock treatment alone , calculated as MFI
(treatment)/MFI(mock). Each line/color represents a single DC donor. White
diamonds represent mean values for each condition from the six experiments.
The black line at 1 represents no change in expression versus mock treatment
(fold expression=1).
(mean::SEM, geometric MFI ratio to mock infection, 1.42::0. , p=0. 03), CD86
(2.23::0. , p=0. 03), PD-LI (1.76::0. , p=0. 03), and CD83 (1.84:: 20). PD-
expression following exposure to UV-inactivated virus was also consistently higher than
expression following mock infection, although the changes were modest (1.26::0.
p=0. 03). Treatment ofDCs with UV-inactivated virus also enhanced MHCII expression
although this effect did not reach statistical significance (1.24::0. , p=0.06). DC
expression ofHLA A, B , C (1.09::0. , p=0.29) and CD40 (1.04::0. , p=0. 3l)
demonstrated minimal changes in response to UV -inactivated virus , which were not
statistically significant. Infection with live virus resulted in statistically significant
increases in expression for all molecules tested when compared to mock infection
(p=0.03), with the greatest increases in PD-Ll (3.27::0.41) and CD83 (3.02::0. 28),
smaller increases in expression level for CD86 (2.48::0.24) and CD80 (1.91:0.25). Viral
induction of CD40 (1.32::0.08), PD-L2 (1.57::0. I I ), HLA A, B , C (1.33::0. 12) and HLA
DR (1.51:0.09) was less pronounced. Despite more clear activation in response to live
virus than UV- inactivated virus when comparing each treatment to mock infection, only
PD-L2 expression was statistically significantly greater in a comparison of live virus to
inactivated virus treatment (p=0. 03); CD40 , CD83 , and MHC-I showed a trend toward
greater expression following live virus infection that did not reach statistical significance
(p=0. 06). Weaker trends were seen for PD-Ll and MHC II (p=0.09) and CD80 (p=0. 14),
while CD86 expression was essentially identical (p=1.0). These experiments demonstrate
that both live and inactivated D2V stimulate increases in the expression of DC surface
molecules , and demonstrate that viral replication further enhances DC activation.
DIFFERENTIAL EXPRESSION OF DENDRITIC CELL SURFACE MARKERS
ON INFECTED VERSUS BYSTANDER CELLS
Previous reports have identified several dengue proteins involved in modulating
intracellular signaling (Munoz-Jordan et aI. , 2003; Munoz-Jordan et aI. , 2005; Jones et
aI. , 2005; Chua et aI. , 2005). Additionally, there are conflicting reports regarding the
expression of co-stimulatory molecules on dengue infected DCs versus uninfected
bystander cells within the same culture (Libraty et aI. , 2001; Sanchez et ai. , 2006; Palmer
et aI. , 2005). Therefore , we expanded our studies of cell-surface immunomodulatory
proteins by infecting DC cultures and combining surface antibody staining for phenotyic
markers with intracellular staining for dengue E protein, to discriminate between infected
and bystander DCs (Figure 6). Again, we quantitated differences in the expression of
surface markers by normalizing geometric MFI values for each molecule to mock
infection. Both infected and bystander cells increased surface expression of all molecules
tested when compared to mock infection (p":0.02), with the exception of HLA A, B , C on
infected DCs (p= 1.0). However, we noted reduced expression of the B-7 family
molecules CD86 (geometric MFI ratio to mock- infected cells::SEM for eight donors
1.86::0. 14 versus 2.61:0. 17), PD-Ll (2.62::0.26 versus 3. 33::0. 32), and CD80 (1.63::0.
versus 1.82::0.20), as well as MHC class I molecules HLA A, B , C (1.05::0. 08 versus
1.36::0. 10) (p..0. 02 for all comparisons) on infected DCs , in comparison to bystander
cells. CD83 was also lower on infected DCs (2. 72::0.21 versus 3. 1 0::0.2 I ) when
compared to bystanders , although this difference was not statistically significant
(p=0.055). Conversely, infected DCs had significantly greater expression than did
bystander cells ofPD-L2 (geometric MFI relative to mock- infected cells::SEM
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Figure 6. Actively infected cells have altered surface molecule expression when compared
to bystanders: DC infected with dengue virus 2 New Guinea C strain MOI=2 were harvested at 24
hours and surface stained for t e specified proteins prior to fixation and intracellular staining for
dengue E protein. Cells were gated by flow cytometry based on dengue E protein expression
detected with a monocionallgG2a anti-dengue E antibody bound to a Pacific Blue TM-conjugated anti-
IgG2a Fab fragment. A) Representative histograms for each surface molecule on DCs from one donor.
Top: Mock infection versus isotype control staining. Bottom: Surface molecule expression in infected
versus bystander DC. B) Expression of each surface molecule on infected and bystander DC
populations was quantitated by geometric mean fluorescence intensity and normalized to mock
infection for each donor, as previously described. Each line/color represents a single DC donor. White
diamonds represent mean values for the eight individual donors. Asterisks above graph (*): Pc:O.
for infectedc:bystander; ** : Pc:O. 05 for infected bystander, both by two-tailed Wilcoxon ranked signs
test.
1.95:10. 14 versus 1.49:10. 10) and HLA DR (1. 78:10. I I versus 1.39:10.09) (p':0. 02 for
both comparisons). CD40 (1.35:10. 07 vs. 1.30:10.07) was unaffected by the presence of
viral antigen (p=0.31). These data demonstrate that D2V exposure activates DCs through
both direct and indirect mechanisms. The differences in protein expression could not be
explained solely by viral suppression of IFN-a/~ signaling, since relative differences
were bi-directional. Active DV replication both positively and negatively modifies DC
phenotye, depending on the surface molecule in question.
CHAPTER SUMMARY
In this chapter, we demonstrated that DCs could be efficiently generated from PBMC
following CDl4-positive selection ofmonocytes and culture with GM-CSF and IL-
Monocyte-derived DCs were permissive for infection with multiple serotyes and strains
of DV, including both prototype viruses and low-passage clinical isolates. Dengue E
protein staining was highest at 24 hours post-infection with D2V NGC strain and
declined at 48 hours post-infection. While infection with D2V NGC was dose-
dependent, there was substantial variability in the susceptibility of DC preparations from
different donors.
D2V infection activated DC to express increased levels of surface molecules
involved in immunoregulation. The changes seen in response to D2V were similar to , but
slightly lower than, those seen with TNF-a/IFN-a, and were clearly lower than those
seen following LPS treatment. The enhancement of surface molecule expression did not
require replication-competent virus , although the magnitude of the changes seen with live
virus were greater than those seen with UV-inactivated virus. While both infected and
bystander DCs had enhanced surface molecule expression, these two populations
demonstrated statistically significant differences in phenotype. Specifically, actively
infected DCs had reduced expression ofCD80 , CD86 , PD- , CD83 , and MHC Class I
molecules but increased expression ofPD-L2 and MHC Class II molecules when
compared to bystander DCs in the same culture,
CHAPTER IV
INDUCTION AND REGULATION OF DENDRITIC CELL CYTOKINE AND
CHEMOKINE RESPONSES BY DENGUE VIRUS
DENDRITIC CELL INFLAMMATORY MEDIATOR SECRETION PATTERNS
Previous in vitro studies with other viruses indicated that monocyte-derived DCs were
capable of production ofa wide range of secreted products (Ziliox et ai. , 2006; Piqueras
et aI. , 2006). D2V infection ofDCs has been reported to cause the production of
inflammatory cytokines such as IFN-a and TNF-a (Libraty et aI. , 2001; Ho et aI. , 2001),
and chemokines including IL-8 and RANTES (Medin et aI. , 2005). We hypothesized that
dengue infection ofDCs would induce a largely donor-independent, characteristic
. secretory response. Using:a multiplex cytokine bead assay, we compared the secretory
responses in 24-hour supernatants of mock-infected and D2V-infected DCs. Virus
infection was a potent stimulus for the secretion of chemokines (Figure 7). IP 1 0
RANTES , MIP , and MCP-l were all found at substantially higher levels in
supernatants from infected cultues when compared to those from mock-infected DCs.
Of these , IP I 0 reached the highest concentrations , uniformly greater than the maximum
threshold for quantitation in this assay, at 18750 pg/mL. Concentrations ofIL-8 and
Eotaxin also increased with virus infection, although the effect of dengue exposure was
less pronounced, as basal levels with mock infection were generally higher than those
seen for IPlO , RANTES , MIPl-a , and MCP-
Inflammatory cytokines including TNF-a , IL- , and IL- la were increased 
culture supernatants when compared with mock-treated cells. Of these , IL- Ia reached
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Figure 7 D2V infection of DC cultures induces a broad inflammatory cytokine
and chemokine secretory response.
DCs were mock-infected (M) or infected with D2V NGC strain (D2V) as previously
described, at an MOI=2. Cells were washed and re-suspended at 10 DCs per mL.
Supernatants were collected at 24 hours and analyzed using Luminex technology for a
panel of immune mediators. Shown are the results from four independent experiments.
Samples for which the values fell below the limit of detection are plotted at the detection
limit. Samples for which the values exceeded the maximum threshold are plotted at the
upper limit of quantitation, as determined by the highest value utilized in preparation of
the standard curve (See Materials and Methods).
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Figure 8 DC responses to LPg and D2V differ both qualitatively and
quantitatively. Immature DC from three donors were mock-infected or
infected with live D2V NGC at an MOI=2 as previously described. Following
the virus adsorption period and return to culture at 1.0x1 0 celis/mL , some
mock-treated cells were activated with LPS at 50 ng/mL. Supernatants were
collected after 24 hours and stored at - C for analysis. Samples were
analyzed using a multiplex cytokine assay. Symbols represent three individual
donors; black bars and lines represent geometric mean values.
the highest levels (mean, 2316 pg/mL; range , 1764-2734 pg/mL). TNF-a appeared to be
the most inducible, being undetectable in all mock-treated cultures and reaching a mean
concentration of 1216 pg/mL (range, 24-3673 pg/mL) in supernatants from infected DCs.
We also detected elevated levels of the T cell growth factor IL- 7 and the PDC growth
factor IL-3 following dengue viral infection of DCs. IFN-a secretion was undetectable in
mock-infected cells, but became elevated in three of four donors in response to D2V
infection (mean, 200 pg/mL; range 75-420 pg/mL). IFN-a was undetectable in
supernatants following either treatment in one donor (experiment 2 see Figure 7). This
donor notably appeared to have a blunted overall response. This was evident in IL-
p40 production as well, where three of four experiments showed 3- to 20- fold increases
following infection, while this donor showed essentially no change, despite an infection
rate of 3 5% of DCs in the culture (not shown). In all experiments the levels of IFN-
inducing IL- 12 p70 heterodimer were 1-2 orders of magnitude lower than those of the
subunit IL- 12 p40 , and there was no clear virus-specific response for this cytokine. IL-
production was detected slightly above the assay threshold in one of four mock-infected
samples (10 pg/mL) and one of four D2V-infected samples (23 pg/mL). Separate
experiments demonstrated no differences in transforming growth factor beta (TGF-~)-
, -
, or -3 isoform secretion between mock- and D2V- infected cultures (data not shown).
To confirm that DCs were capable ofIL- lO and high- level IL- 12 production, we
compared secretory responses in mock infected DC cultures to those treated with live
D2V or the known DC activator LPS. This set of experiments compared 24-hour culture
supernatants from three donors ' DCs after mock- infection, infection with live virus , or
stimulation with LPS at 50 ng/mL (Figure 8). LPS treatment induced the secretion of
IL- lO (mean, 327 pg/mL; range, 259-433 pg/mL, N=3), while IL- lO was undetectable in
mock- infected cultures and was detectable (12 pg/mL) in only one D2V-infected culture
supernatant. Secreted levels of IP I 0 with LPS stimulation were similar to those seen
with dengue infection, while IFN-a secretion was slightly lower. Levels ofTNF-a
MCP- , IL- 12 p40, MIP- , RANTES , and IL-6 were much greater with LPS treatment
than with dengue virus infection. These data demonstrate that iDCs produce and secrete a
broad array of immune mediators in response to D2V infection that is clearly distinct
from LPS stimulation, with low relative IL- I 0 production.
EFFECTS OF UV LIGHT INACTIVATION OF DENGUE VIRUS ON
SECRETORY RESPONSES TO INFECTION
The putative DC receptor for dengue, DC-SIGN, is a C-type lectin capable of
intracellular signaling (Caparros et aI. , 2006; Hodges et aI. , 2007). Viral replication is
associated with the activation of intracellular signaling pathways as well, most notably
through dsRNA-sensing pathways such as RIG- I and mitochondrially-associated MA VS
(Y oneyama et aI. , 2004; Hiscott et aI. , 2006) or endosomal TLR3 (Lee et aI. , 2006)
(Alexopoulou et aI. , 2001). In order to distinguish cytokine responses to virion binding
from those requiring viral replication, we compared cytokine and chemokine levels in
supernatants from mock- infected, UV- inactivated virus-treated, or live-virus infected DC
(Figure 9). In experiments with four separate donors , both UV- inactivated virus and live
virus induced the secretion of several cytokines and chemokines, most convincingly
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Figure Viral replication enhances DC secretory responses to
DV exposure.
DCs were mock- infected, or infected with UV-killed or live dengue 2 virus
New Guinea C strain at an MOI=2 as previously described Following
adsorption , cells were washed and re-suspended at 10 DC per mL.
Supernatants were harvested at 24 hours and analyzed using Luminex
technology. Each symbol represents a separate DC donor. Lines with
bars represent the geometric means of the four independent values for
each analyte under each condition.
MCP- I and IP- IO. Levels ofMIP- , RANTES , IFN-a, and TNF-a were lower in UV-
treated DC supernatants than in those from virus- infected DCs. Neither treatment with
inactivated virus nor live. virus induced secretion ofIL- 12 p40 or IL- la in these
experiments. These results demonstrate that binding of D2V is sufficient for the
induction of some secretory responses, but that viral replication augments DC cytokine
secretion.
DOSE-REsPONSIVENESS OF DENDRITIC CELL SECRETORY RESPONSES
TO INFECTION WITH DENGUE VIRUS
In order to determine if the secretion of cytokines and chemokines by DCs following
D2V exposure was related to the virus dose and the percentage of infected cells , we
measured TNF;.a, RANTES , MIP- , IFN-a, IP- , and IL- lO in culture supernatants
from seven donors ' DCs following infection with D2V over a range ofMOIs (Figure 10).
In this series of experiments , we noted distinct profiles between these products. Levels 
TNF-a, RANTES , and MIP- la in the culture supernatants increased with increasing
MOI , although DCs from donor 2 were the exception for each cytokine. For example
DCs from donor 2 showed potent TNF-a secretion at lower MOIs (peaking at ?700
pg/mL at an MOI=0.2), despite absent detectable dengue E protein, but unlike the
remaining six donors , detection ofTNF-a decreased at the highest MOIs , when infection
became evident.
A similar pattern was detected with both RANTES and MIP- Ia production, as
these chemokines were produced at progressively higher levels with increasing MOI for
all donors ' DCs save donor 2. Both of these chemokines were potently induced at low
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Figure 10 DC cytokine and chemokine
production is not strictly dose-dependent
following D2V infection.
DCs were infected with dengue 2 strain NGC
at varying MOls and plated at 1x10 cells/mL
for 24 hours. A) DCs were harvested and
intra-cellularly stained for dengue E protein
(previously shown in figure 3). G) Super-
natants were collected and frozen at -
then simultaneously analyzed using Luminex
technology for a panel of secreted cytokines
and chemokines. Symbols/colors represent
the same individual donors in each graph.
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MOIs by DCs from both donor 2 and, to a lesser extent, donor I , despite neither donors
DCs demonstrating substantial infection except at an MOI of 5. Dose-responsiveness 
IFN-a production was highly variable between DCs from different donors. For example
DCs from donor 3 showed minimal IFN-a production at all MOIs studied. On the other
hand, supernatants from donors ' 4 , 6 , and 7 DCs showed high IFN-a levels at an
MOI=0. , with detected levels showing a plateau in DC supernatants from donor 6, a
rapid drop in donor 4, and a milder drop in donor 7 at higher MOIs. IPlO, on the other
hand, was secreted at high levels in all donors, even with minimal infection (at an
MOI=0.04). IPlO levels reached a plateau in the midrange ofMOIs , and in four of seven
donors, dropped as infection rates increased.
IL- IO was detected in culture supernatants from DCs derived from all donors in
th.is series of experiments. IL- IO levels showed progressive dose-dependent increases and
were highest at an MOI=5 for supernatants from four of the seven donors (I , 3 , 4 , and 5);
supernatants from the remaining donors ' DCs demonstrated peak levels at an MOI=0.
High-level (:;800 pg/ml) IL- lO secretion was detected in supernatants from the DCs of
donor 4 , although infection rate response curves for this donor s DCs were similar to
those in DCs from donors 3 and 5 , which had much lower (63 pg/mL and 85 pg/mL
respectively) IL- I 0 production.
These results demonstrate that TNF-a, MIP- , and RANTES production by DCs
in response to D2V infection increase progressively as the D2V dose increases , while
IFN-a and IL- IO production show similar effects in only some donors, and decrease at
higher MOIs in others. High- level IPlO secretion was not dose-dependent.
DIFFERENTIAL PRODUCTION OF TNF-ALPHA AND IPIO BY INFECTED
VERSUS BYSTANDER CELLS FOLLOWING DENGUE EXPOSURE
Because dengue proteins are implicated in interferon inhibition (Munoz-Jordan et ai.
2005; Munoz-Jordan et aI. , 2003), we hypothesized that a consequence of differential
interferon signaling would be distinct cytokine production profiles in actively infected
versus bystander DCs. To answer this question, we first mock- infected DCs , or infected
them with either UV-inactivated or live D2V, and used brefeldin A treatment coupled
with intracellular cytokine staining to measure TNF-a and IPIO production in the 16-
hour time period, while using anti-dengue staining to distinguish infected from uninfected
cells. We chose these analytes based on high levels of secretion suggesting adequate
detectability, and to reflect two different types of response , specifically, inflammation
versus chemoattractiono In addition, these products showed differing patterns of dose-
dependence. Mock-infected cells produced neither TNF-a nor IPlO , and UV-inactivated
virus induced low levels of IP I 0 , without causing TNF -a production during this
timeframe (Figure 11). However, in DCs infected with live D2V , we noted marked
production of both proteins (Figures , 12). In addition, we found a clear disparity in
production of these proteins on the single-cell level , depending on the presence of
detectable viral E protein (Figure 12A). IP I 0 induction occurred primarily in bystander
cells, while TNF-a was predominantly associated with infected cells (Figure 12C).
Analysis of multiple experiments demonstrated that the frequency of cells staining
positive for IP I 0 was consistently lower in infected cells than in bystanders (mean::SD
252::0. 160 vs. 0.455::0.216), p=O. OOI) (Figure 12B). Bystander DCs demonstrated a
range ofIPIO staining, including IPlO-high populations, whereas infected DCs had
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Figure 11: Replication-competent virus is required for detection of
intracellular production of TNF-a and IP10. DCs were mock-infected or
infected with UV-inactivated D2V NGC at an MOI=2 (UV-D2V), or live D2V
NGC at an MOI=2 (D2V) as previously described. Brefeldin A was added at
18 hr. , and the cells harvested and fixed at 24 hr. Cells were stained using an
anti-dengue E protein monoclonal antibody and monoclonal antibodies for
IP10 (top), orTNF-a. (bottom). Results are representative of at least 3
independent experiments for each cytokine/chemokine under each specified
condition
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uniformly low to negative IPlO staining. On the other hand, TNF-a positive cells were
6 times more abundant in the infected DC population than in uninfected bystander cells
(mean:iSD frequency, 0.248:i0.on vs. 0.096:i0. 084 , p=O. OOOI) (Figure 12 D). These
findings demonstrate that on a single-cell level, D2V infection of DCs differentially
regulates IP I 0 and TNF -a , inhibiting IP I 0 production while enhancing that of TNF -a.
, '
ENDOGENOUS DENDRITIC CELL-DERIVED IFN-ALPHA/BET A
INHIBITION OF DENGUE VIRUS INFECTION
Dengue susceptibility to the antiviral effects of interferons has been described in
immortalized cells , but required pretreatment to be effective (Diamond et ai. , 2000;
Diamond and Harris, 200 I). Although monocyte-derived DCs produce substantially less
IFN-a than plasmacytoid DCs in response to viruses (Izaguirre et aI. , 2003; Colonna et
aI. , 2002), we hypothesized that the endogenous IFN-a/~ induced following D2V
exposure might inhibit active infection. We utilized the anti-CD I 18 (IFN-a receptor
subunit 2; IFNAR2) monoclonal antibody to block IFN-a/~ signaling in DCs during
virus adsorption and cultue. DCs infected in the presence of blocking antibody
exhibited a higher percentage of dengue antigen-positive cells than DCs infected in the
absence of antibody or the presence of a control antibody (Figure 13A). In five
experiments , the percentage of cells infected at 24 hours was similar for D2V alone
(mean:iSD , 28.0:i8. 2%) and D2V plus control IgG antibody (26.2:i5. %), but increased
with blocking antibody (38. 8:i7. 5%, p=0. 06) treatment (Figure 13B). These results
demonstrate that IFN-a/~ produced by monocyte-derived DCs inhibits ongoing D2V
infection.
P=O.0625
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Figure 13 Endogenous type I interferon inhibits dengue infection
of DCs: DCs were preincubated for 30 min. with medium , controllgG2a
monoclonal antibody, or anti- interferon alpha receptor subunit 2 (lFNAR2,
CD118) at 50 f!g/mL. DEN was then adsorbed to DC for 90 minutes
(resulting in antibody dilution to 10 f!g/mL) and the cells cultured for 24 hr
without Ab, or with IgG2a or anti- I FNAR2 antibody at 10 f!g/mL. Cells were
harvested and stained for intracellular DVantigen using a monoclonal anti-
dengue envelope antibody. A) Representative flow cytometric analysis of
dengue antigen staining. Black fill: Mock- infected cells treated with IFNAR2
blocking antibody; Red: Infected cells treated with IgG2a; Green: Infected
cells treated with IFNAR2 blocking antibody. B) Percent of DC staining
positive for dengue E protein in experiments with five separate donors.
EFFECTS OF IFN.ALPHAIBETA SIGNALING ON DENDRITIC CELL IPIO
AND TNF-ALPHA PRODUCTION AFTER INFECTION WITH DENGUE VIRUS
Viral antigen expression was posItIvely assocIated with TNF-a production and negatively
associated with IP I 0 production. Potent IP 10 productIOn II bystander cells suggested
that a soluble factor was responsible, and IFN-a is capable of inducing IPIO in
monocyte-derived DCs (Padovan et aI. , 2002). We therefore hypothesized that blocking
IFN-a/~ would suppress DC IPlO production in response to infection with D2V, but
would not affect the expressIOn ofTNF-a. For these experiments , we pre-treated DCs
with anti-CDll8 (a blocking antibody for the IFN-a receptor subunit 2), isotype control
antibody, or medium alone , followed by adsorption ofNGC at an MOI of 2, washing, and
re-cultue in the presence of the original antibody treatment. In control experiments , we
used a similar approach to pre-block CD118 , followed by mock infection, washing, re-
culture, and addition ofIFN-a at 1000 U (:;5. 5 ng) per milliliter, or roughly 5- to lO-fold
greater concentrations than the peak levels we observed in supernatants from infected
cultures (refer to Figures , 8, 9 and 10).
In this series of experiments, we had three cultures where we measured greater
than 20% of all cells staining positive for IPIO after infectIOn with dengue 2 virus NGC
(Figure 14A). IP I 0 production in DCs infected wIth hve virus and treated with anti-
CDl18 blocking antibody was reduced (mean::SD frequency of all IPlO+ DC
156::0.041) compared with isotype control antibody (0.414::0. 124) or no antibody
(0. 38H0.100) (Figure 14B). IPIO inhibitIOn by IFN-a/~ block occurred in both the
infected and bystander cell populations. In control experiments , we noted total inhibition
ofIPIO productIOn II response to exogenous IFN-a using this concentration of blocking
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Figure 14 Blocking endogenous type I interferon signaling inhibits DC IP10
production in response to dengue infection.
A) Addition of IFNAR2 blocking antibody, but not isotype control antibody, reduces IP10
production in both infected (upper right quadrant) and bystander (lower right quadrant)
DCs. Representative flow cytometry from one of 3 experiments. B) The frequency of
IP10 expressing cells by flow cytometry was calculated for each cell population specified.
Shown are the means:tSD for three experiments , demonstrating that IP10 production is
inhibited in both infected and bystander cells by blocking type I interferon signaling.
C) Mock-treated cells (black fill) produce IP10 in response to IFN-a treatment at 
ng/mL (grey fill). Addition of blocking antibody (red line) but not isotype control antibody
(blue line) completely abrogates IP10 production in response to IFN-a. Representative
of 3 experiments.
antibody (Figure 14 C). IFN-a/~ block had minimal effects on the overall frequency of
TNF -a + cells (Figure 15A and B). In five experiments , the mean::SD frequency of all
TNF-a+ DC with virus treatment alone (0. 14::0.0 I 8) was similar to cultures treated with
the addition of isotype control IgG (0. 131:0.026), and anti-CD 118 antibody
(0. 117::0. 025) treatment had no effect on the overall expression ofTNF-a (Figure 15 B).
These results demonstrate that endogenous IFN-a/~ produced by DCs in response to DV
infection acts in an autocrine/paracrine manner to induce IPlO production. The lack 
complete blocking, in light of the fact that high-dose exogenous IFN-a treatment could
be fully inhibited in our system, suggests that IP I 0 induction was not solely IFN-a/~
dependent.
STRAIN-DEPENDENT DIFFERENCES IN DENDRITIC CELL IPIO INDUCTION
FOLLOWING INFECTION WITH DENGUE VIRUS
Previous studies using intracellular cytokine staining have indicated that there are
differences between attenuated and wild type dengue strains in the viral antigen-
dependence of dendritic cell cytokine responses , including TNF-a (Sanchez et ai. , 2006).
We therefore postulated that dengue viral strains might also differ in the patterns of
induction of IP 1 O. In four experiments , we infected DCs from the same donor using
control C6/36 supernatant (mock infection), live D2V strain NGC , or live D2V strain
C0166/96 , a low-passage clinical isolate from a DF patient in Thailand (Vaughn et aI.
1997). Both viruses were tested at an MOI of 2. Using intracellular staining for dengue E
protein and IPIO as previously described, we quantitated IPlO-producing DCs and
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Figure 15 Blocking endogenous type I interferon does not inhibit
TNF-a. production by DCs.
DCs were left untreated or were treated with IgG2a or anti-IFNAR2 antibody
as previously described , followed by addition of D2V NGC at an MOI=2.
A) Representative flow cytometry plots from the same donor as in Figure 14
(IP10), showing intraqellular dengue E protein and TNF staining. One of five
similar experiments. B) Mean frequencies:!SD of TNF-positive cells in the
specified populations from five DC cultures.
compared infection rates , in addition to assessing the respective abilities of the two
viruses to induce IP lOin both infected and bystander DCs.
We noted a clear distinction between IPIO responses to NGC and those to the low
. passage clinical isolate. Representative flow cytometry shown in Figure 16A
demonstrates that NGC induced IPIO potently in bystander DCs, and weakly in infected
cells. By way of comparison, the Thai CO 166/96 isolate largely failed to induce IP lOin
either infected or bystander cell populations (Figure 16B). The percentage of DCs
infected varied among donors for both viruses (Figure 16C), however overall infection
rates were similar across the four experiments between NGC (mean::SD , 29.2::10.0%)
and C0166/96 (26. 5::8. 6%) strains.
To determine if the relative lack ofIPlO with low-passage strain infection at the
24-hour time point was explained by altered kinetics ofIPlO production, we performed a
24-hour time course experiment. We treated DCs with brefeldin A for three different 
hour intervals over the 24-hour infection period. DCs from each 8-hour timeframe (0-
hours , 8- 16 hours , and 16-24 hours) were harvested and fixed immediately following
their respective incubation period (8 , 16, or 24 hours). DCs from all samples were
simultaneously stained following completion of the experiment. Although dengue E
protein was detected earlier with CO I 66/96 than with NGC infection, IPlO was not
(Figure 16D).
Together, these data indicate that our low-passage D2V strain was deficient in
IPIO induction when compared with the laboratory-adapted strain NGC. This effect was
neither related to differences in susceptibility to infection, nor was it due to kinetic
differences in antigen or IP I 0 expression between viruses for this time period.
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CHAPTER SUMMARY
In this series of experiments , we found that D2V stimulated DC secretion of a wide range
of inflammatory cytokines and chemokines. Initial experiments comparing mock-
infected DCs to D2V -infected DCs revealed that in terms of absolute amounts the
chemokines IPIO , MCP- , MIP- , and RANTES were the most potently induced
molecules assayed. D2V infection of DCs also consistently induced the secretion of
inflammatory cytokines such. as TNF -a, IL- , and IL- l ; three of four donors also
responded with IFN -a secretion. D2V was not a potent stimulus for the release of IL-
p40 , as this cytokine was only weakly induced in two independent series of experiments
and IL- 12p70 was not a factor in the DC response to D2V.
Results regarding IL- I 0 were inconsistent, as D2V did not induce this cytokine in
two sets of analyses , while in virus dose-response experiments we detected IL- l 0
secretion, albeit low in most donors. A substantial IL- I 0 response was observed in only
one of seven donors ' DCs in the dose-response experiments. UV- inactivated D2V
induced similar levels ofMCP- , IPlO , as did live D2V, and IL- 12 p40 and IL-6 levels
were also similar with both treatments. DC secretion of the chemokines MIP- la and
RANTES , as well as the cytokines TNF-a and IFN-a , was lower in UV-inactivated DV-
infected DCs than DCs infected with live virus.
Using increasing amounts of input virus, we found that MIP- , TNF-a, and
RANTES secretion were dose-dependent, although one of seven donors ' DCs responded
most potently at low MOIs for all three molecules. In contrast, IFN-a secretion peaked
before the highest MOI (of 5) in five of seven donors, with substantial variation in dose-
responsiveness and absolute amounts detected between donors. IP 10 was the only
analyte measured in this experiment that was consistently secreted at high levels
following treatment with the lowest virus dose; in all donors, IP I 0 secretion reached a
plateau early; and in some donors production decreased as MOI increased.
Intracellular cytokine staining from 16- or 18- to 24 hours demonstrated that
TNF-a and IPlO production during this time period depended on replicating virus , and
that the production profiles of these molecules in DCs were also replication-dependent.
Specifically, D2V infection induced potent IPlO production in uninfected bystander cells
while infected DCs had low, and often absent, staining for IPIO, suggesting that
autocrine/paracrine activation through a soluble mediator was responsible for triggering
IP I 0 and that signaling by this molecule was inhibited by active D2V infection. TNF-a
production, on the other hand, was significantly more common in infected cells
implicating replication as the stimulus for expression. Blocking experiments
demonstrated a role for endogenous IFN-a/~ in both the inhibition of viral replication
and in the stimulation of IP 1 0 production, although not in the regulation of TNF-
a production. In addition, experiments comparing NGC and a low-passage Thai patient
isolate , CO I 66/96 , demonstrated an absence of IP I 0 production with CO 166/96 infection
of DCs. This effect was not related to the efficiency of infection, or viral replication
kinetics , and in light of the results demonstrating IFN-a/~ dependence for IPIO secretion
by NGC- infected DCs , suggests that C0166/96 does not induce IFN-a/~ secretion
following infection of DCs.
CHAPTER V
, .
EFFECTS OF DENGUE INFECTION ON THE ABILITY OF DENDRITIC CELLS TO
PRIME ALLOGENEIC RESTING CD4 T CELLS
OUTCOME OF DENGUE INFECTION ON DENDRITIC CELL PRIMING OF
RESTING CD45RO- CD4 T CELLS
Our studies on expression of cell surface molecules indicated that DVwas an activating
stimulus for DCs following infection, although infected and bystander cells had different
levels of expression of a number of the surface molecules we tested. Similarly, we found
that although DCs were induced to produce and secrete a number of cytokines and
chemokines in response to infection, infected and bystander cells were again distinct in
their activities. Therefore, we were interested in examining the effect of DV infection of
DCs onthe T cell priming capabilities of these cells. Priming of CD4 T cells is a major
function ofDCs in the stimulation of adaptive immune responses , through both cell-
surface-bound and soluble mediators.
To investigate whether iDCs gain T cell priming function upon exposure to
dengue virus , we compared DCs for their ability to stimulate proliferative responses
following mock infection, D2V- infection or cytokine-mediated maturation, using co-
cultures with allogeneic, negatively selected, resting CD45RA + CD45RO- CD4 T cells
from CDI4- PBMC. Isolated cells were typically ::90-99% CD3 , of which 95% were
CD4. Of the CD3 CD4 cells , 98% or greater were CD45RA+ CD45RO- . We cultured
these T cells with allogeneic DCs 24 hours after mock infection, treatment with TNF-a
plus IFN-a or infection with D2V strain NGC. We measured T cell proliferation on day
4 or 5 by tritiated thymidine incorporation.
. As expected, we noted a dose-dependent increase in CD4 T cell proliferation with
increasing numbers, of DCs; regardless of DC treatment (Figure 17 A). In comparison with
mock infection, D2V increased the T cell priming capacity of DC cultures. This effect
was statistically significant (PsO.03) at T: DC ratios of20: I and 40: I , and was
associated with the highest values for stimulation index (SI, calculated as (cpm DV-
infectedJ/( cpm mock- infectedJ; (Figure 17B) between 2500 and 313 DC/well
corresponding to T: DC ratios between 20: 1 and 160: 1.
DCs matured with the addition of exogenous TNF-a/IFN-a were likewise
superior to mock- infected DCs as stimulator cells , at all T: DC ratios (PsO.03), with SI
values highestwhen the number of added DCs was lowest (T: DC ratio , 80: I;
mean=34. , range, 4. 58.6 and T: DC ratio, 160:1; mean=36.4 , range , 5. 144.4). T cell
proliferation induced by cytokine-matured DCs was also statistically significantly higher
than that observed with D2V.. infected DC with addition of2500 or fewer DC
(corresponding to 20: 1 and higher T: DC ratios; psO.03). These results demonstrate that
dengue infection of DC cultures enhances their ability to stimulate CD4 T cell
alloresponses , in concert with the observed changes in cell phenotype. Again reflecting
previously observed differences in cell surface phenotype , DCs infected with D2V were
somewhat less effective than DCs treated with exogenous cytokines at inducing CD4 T
cell proliferation.
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Figure 17: Dengue infection of DC cultures faciltates priming of
allogeneic resting CD4T+ cells: DCs were mock infected (Mock) or infected with
D2V NGC strain at an MOI=2 (D2V) as previously described. Cells were washed
and returned to culture for 24 hours. Some mock infected cells were stimulated
by the addition of exogenous recombinant human (rh)TNF-a (50 ng/mL) plus
rhlFN-a (1000 U/mL=5 ng/mL) (TNFIIFN). After 24 hours in culture , DCs were
harvested, washed , counted , and two-fold serial dilutions performed. DCs were
added to 50 000 allogeneic CD45RA+CD45RO- CD4 T cells and proliferation
quantitated by tritiated thymidine incorporation on day 4 of co-culture using a 
counter. Data points represent means from quintuplicate wells. A) Proliferation
responses from six independent experiments at a range of T: DC ratios from 5:1 to
160:1. Data are presented as log10 (mean cpm (counts per minute) from
quintuplicate wells) for clarity. Black lines represent the geometric mean values
for all six experiments. B) Stimulation indices (SI values) were calculated from the
data in (A) by normalizing to mock treatment for all experiments. The calculation
is as follows: SI= cpm (treatment)/cpm (Mock).
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EFFECTS OF INCREASING MULTIPLICITY OF INFECTION ON DC CAPACITY
FOR INDUCING T CELL PROLIFERATION AND TIl OR TIl2 DEVELOPMENT
In previous experiments , we noted differences between infected and bystander DCs in
cytokine/chemokine production profiles and surface molecule expression. Therefore , we
postulated that the efficiency of T cell priming would also be related to the level of
infection within DC cultures exposed to D2V. To test this hypothesis , we infected DCs
with D2V using a range ofMOIs from 0.04 to 5 and co-cultured them with T cells using
a T: DC ratio of 20: 1. In seven experiments, DC infection was dose-dependent, albeit
with considerable variability between DC donors at any given MOI 
(Figure 18A; data
also shown in Figures and 10).
In this series of experiments, we found the lowest proliferative responses to DCs
infected at an MOI=5 , whereas DCs infected at an MOI=0.04 induced the greatest
proliferative responses (Figure 18B). CD4 T cell proliferation responses to DCs infected
at MOI=0. 04 or 0.2 (mean::SD cpm 20261:4207 and 175 I 5::2895 , respectively) were
higher than that to mock-infected DCs (MOI=O; cpm 10919::6739), although these
differences were not statistically significant. However, DCs infected at an MOI=l
(11545::5073) induced lower T cell proliferation than did DCs infected at an MOI=0.
or MOI=0. , a statistically significant effect (p-c0.02). Proliferative responses to DCs
infected at an MOI=5 were lowest of all conditions tested (7982::48l5), and was
statistically significantly lower when compared to virus infection at lower MOls
(p-C0. 008). These results indicate that actively infected DCs are PQor stimulators ofT cell
proliferation when compared to bystander DCs.
Two previous reports from the same group suggested that IL- I 0 production was
responsible for reduced T cell proliferative responses to DV- infected DCs, but that
CD40-CD40L interactions enhanced IFN-y. secretion in co-cultures of resting CD4 T cells
with DV- infected DCs (Palmer et aI. , 2005; Sun et aI. , 2006). Therefore, we assayed
supernatants from this series of experiments in order to determine if increasing DC
infection with D2V resulted in a characteristic Th response , by measuring IL- , IL-
and IFN- (Figure panels C-E) using multiplex cytokine analysis. We found minimal
IL- IO in the majority of co-culture supernatants, regardless of the MOI used to infect
DCso Both IL- 13 and IFN-y were produced at similar levels, and neither cytokine
showed a consistent response to increasing the MOL These results indicate that co-
culture of resting CD4 T cells with D2V -infected DCs is not associated with substantial
. IL- l o production, and suggests that increasing numbers of infected DCs do not skew
alloresponsive CD4 T cells towards a Th l or Th2 phenotype during priming.
In order to determine if viral replication was responsible for the reduced
proliferation noted at high MOIs , we compared T cell proliferation in co-cultures with
DCs infected using either live dengue virus at an MOI=5 , or the same virus inactivated
with UV-irradiation. In four of five co-culture experiments where T cell proliferative
responses to live virus infected DCs were reduced relative to mock infection, we did not
note a similar effect for DCs infected with UV- inactivated virus; in one co-culture, the
results were similar for both treatments (Figure 18F). These data demonstrate that viral
replication is the determining factor in reduced allostimulatory functions of directly DV-
infected DCs.
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,figure' 18: Higher rates of DV infection in DC are associated with
decreased resting allogeneic CD4T cell proliferation without Th skewing. DCs
were mock- infected or infected at varying MOls by using 5-fold serial dilutions.
Following 24 hours of culture , DC were harvested, washed, counted, and added to
50, 000 negatively-selected allogeneic CD4 T cells at a T: DC ratio of 20: 1. A) 
from each experiment were intracellularly stained to determine infection rates
(results previously shown in figure 3). E) After 4 days of co-culture
supernatants were collected and frozen at - C, 1 Ci of tritiated thymidine was
added per well , and the cells incubated for a further 18-20 hours. Co-cultures were
harvested and quantified using a -counter. B) Proliferative responses in seven T-
DC co-cultures. Data points represent the mean cpm from quintuplicate wells. DC
from donors 4 and 5 were each tested against T cells from two donors. For these
experiments, mean values were calculated as described above for each T cell
donor, and the mean of the values obtained from both T cell preparations plotted.
Symbols in the legend to the right in (8) represent the same donors ' DCs in each
panel A-E. *pc:0. 05 vs. MOI=0. 04 and 0.2. **pc:0. 05 vs. MOI=0. , 0. , and 1. Co-
culture supernatants were analyzed using a multiplex cytokine analysis for
production of C) IL 10 0) IL- 13 and E) IFN-y to determine Th skew. Solid lines
represent geometric mean concentrations. LOD=limit of detection. F) Comparison
of proliferative responses in T-DC co-cultures where DCs were mock infected (0),
infected withUV- inactivated D2V at an MOl of 5 (UV-5) , or infected with live D2V
at an MOl of 5 (5). Shown are five T:DC combinations where live virus treatment
induced lower proliferation than mock treatment alone. DC4 represents donor 4
from panels A-E; DC8 and DC9 are additional donors.
Because response patterns were variable, particularly with regards to baseline
proliferation induced by mock-infected DCs, we sought to determine the relative
contributions ofDCs and T cells to inter-experimental variability. When DCs from two
donors were each tested against two different allogeneic T cell preparations
, both T cell
response curves to a given DC donor were highly concordant (Figure 19). These results
demonstrate that the proliferative responses observed in this series of assays are largely a
product of the qualities of the DCs utilized in the assay, and less so the characteristics of
the T cells.
FAILURE OF HETEROSPECIFIC DENGUE IMMUNE PLASMA TO ALTER
DV EFFECTS ON DC PRIMING FUNCTION
The presence of antibodies from a prior dengue infection has been proposed to contribute
to severe disease in secondary dengue infections by increasing infection of FcyR-positive
cells, particularly monocytes and monocyte-derived cells (Morens and Halstead, 1990).
In addition, antibody-complexed Ross River virus (an alphavirus) has been demonstrated
to inhibit antiviral responses and induce IL- l 0 production in the mouse macrophage line
RAW 264. 7 (Mahalingam and Lidbury, 2002). Although previous studies reported that
heterologous dengue antibody failed to enhance dengue infection of DC (Wu et ai.
2000), we hypothesized that DC functions might be modified by infection with DV-
antibody complexes.
We infected DC with D2V (MOl = 1) alone, D2V combined with control (dengue-
naIve donor) plasma, or D2V combined with dengue 3 immune plasma. Final plasma
dilutions were I :20 , a concentration previously shown to enhance D2V infection of K562
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Figure 19: DCs largely determine the qualitative aspects of alloresponsive
resting CD4 T cell proliferation. In each experiment , DCs from two separate
donors were simultaneously generated , infected , and co-cultured with CD45RO.
CD4T cells freshly prepared from two allogeneic donors in a 2x2 matrix. Shown are
the results from two independent experiments. Data are presented as proliferation
response curves to both T cell preparations (open or closed squares) in a given
experiment with each donor DC. Values are mean:tSEM cpm of quintuplicate wells.
I 0 I
cells (Laoprasopwattana et ai. , 2005) and monocytes (unpublished data). Plasma and
virus were pre-incubated for 30 minutes prior to addition to DC.
In experiments using four separate donors ' DCs , we noted minimal differences in
infection rates between DCs infected with virus alone or virus pre-incubated with either
control plasma or D3V-immune plasma (Figure 20A). When these DCs were co-cultured
with CD45RO- CD4 T cells and assayed for proliferation, we again noted no differences.
DCs infected with D2V alone, D2V plus control plasma, and D2V plus D3V-immune
plasma all demonstrated enhanced allostimulatory function compared to mock infection
in the presence or absence of control plasma or immune plasma (Figure 20B). These
results indicate that this dengue heterospecific imune plasma neither enhanced infection
of DCs nor altered DC priming functions following infection with D2V.
CHAPTER SUMMARY
In this series of experiments , we demonstrated that infection of DC cultures enhanced the
ability of these cells to stimulate alloproliferation in resting CD4 T cells over mock
infection alone. This effect became increasingly pronounced as the levels of alloantigen
(i. , the number of DCs) became limiting, and was similar to the effects seen when DCs
were pretreated with a combination ofTNF-a and IFN-a prior to co-culture, although the
proliferation induced by infected DC cultures was clearly less pronounced than with
cytokine treatment. Despite the increase in proliferation of allogeneic CD4 T cells noted
in co-cultures with DCs that had been exposed to live virus , further experiments revealed
that increasing the MOl of D2V used to infect DCs resulted in a reduction in the ability
of the DCs to stimulate T cells at a T: DC ratio (20: I) that demonstrated a significant
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Figure 20 DC exposure to D2V in the
presence of heterotype- immune plasma does
not alter DC infection or T cell priming.
DC were mock infected or infected with live D2V
NGC strain at an MOI=1 as previously described.
For some samples, virus or mock treatment were
combined with either control (CtI. ) plasma or
plasma from a D3V vaccine recipient (D3V) at a
final dilution of 20: 1 , and incubated on ice for 30
min , prior to adsorption. A) Percentages of
dengue E protein-expressing DCs as determined
by flow cytometry in experiments with four DC
donors (A-D), following infection under the
specified conditions for 24 hr. B) DCs from (A)
were co-cultured with CD45RO- CD4 T cells at T:
DC ratios of 20: 1 , 40: 1 , and 80: 1 and proliferation
measured by tritiated thymidine incorporation as
previously described. Symbols correspond to the
respective DC donors shown in (A). Lines and
bars indicate mean values from the four
experiments.
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increase in stimulatory functions of infected DCs in our first series of experiments. Thus
increasing MOl (and increasing infection rate) was associated with a reduction in the T
cell allostimulatory activity of DV -infected DCs. This effect depended on replication-
competent virus , since UV - inactivated virus at an MOI of 5 did not suppress DC
stimulatory functions in comparisons to live virus. Experiments in which two T cell
donors were tested against two DC donors revealed that DCs were largely responsible for
determining the qualitative aspects of the responses we observed (i.
, virus-dose
dependent stimulation or suppression). In addition, cases of reduced proliferation in T-
DC co-cultures could not be explained by IL- l 0 production, since we detected only low
levels of this cytokine in nearly all T-DC co-cultures. Finally, increasing MOI
(increasing infection rate) did not have an effect on the Th-typeskewing of responding T
cells, since the levels of secreted IFN-y and IL- 13 measured in co-culture supernatants
were stable across the range of MOIs used to infect DCs.
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CHAPTER 
DISCUSSION
In this thesis work, I sought to identify the properties that DCs adopt following
exposure to D2V and to elucidate the direct and indirect roles that D2V plays in
determining the responses ofD2V-exposed DCs. Exposure of whole DC cultures to
D2V infection resulted in cellular activation, as measured by enhanced expression of cell
surface molecules, secretion of inflammatory mediators , and increased capacity for
eliciting allospecific CD4 T cell proliferation. However, measuring these effects was
complicated by the fact that direct cellular infection has its own unique consequences for
the functional properties of targeted DCs. Th challenge , therefore , was to discriminate
between multiple responses: 1) the response of all DCs to the virus particle , 2) the
response of infected cells to internal viral replication, 3) the response of all DCs in
culture to products secreted following infection, and 4) the virally-modified secondary
responses of infected cells. The experimental plan was to observe whole culture
responses to infection and then to determine which responses required viral replication
and, where possible, to discriminate between the functions of infected and bystander
cells. I applied this methodology to three levels of DC function:
phenotypic maturation
cytokine and chemokine production and secretion
CD4 T cell priming
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DCs in DV -exposed cultures demonstrated phenotypic maturation by increasing
the expression of immunoregulatory molecules in comparison to mock-infected cells.
Since UV- inactivated virus increased expression of several phenotypic markers
, part of
that effect was attributed to binding and/or internalization of virs particles. Replication-
competent DV was required for the full effect. In cultures exposed to live virs
, both
infected (dengue antigen positive) and uninfected (dengue antigen negative) DCs
demonstrated an activated surface phenotype when compared to mock-treated cells.
However, the densities of surface molecules induced on infected versus bystander cells in
the same culture were different. Of eight molecules tested, DV- infected cells had
significantly lower surface expression than bystander cells for CD80
, CD86 , PD- , and
MHC I, and trended towards lower CD83 expression. On the other hand, infected DCs
had greater expression of PD-L2 and MHC II , and in the case of CD40 , expression levels
were equivalent. Therefore, although DV activated surface molecule expression on all
cells , replicating virus altered the phenotype of actively infected cells.
To determine if DV stimulated a characteristic DC cytokine and chemokine
secretion pattern in response to infection, we measured a range of inflammatory
mediators in culture supernatants following DV exposure, I observed that live DV was a
potent stimulus for secretion of multiple cytokines and chemokines. By contrast
, UV-
inactivated virus induced only a partial secretory response. Furthermore
, the secretory
response that D2V infection elicited differed both qualitatively and quantitatively from
the defined TLR4-mediated signaling of LPS. Examination ofthe dose-responsiveness of
DCs to DV infection revealed that TNF-a, RANTES , and MIP- la production increased
with increasing virus dose. IFN-a and IL- IO responses were more variable , and IPIO
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secretion was high even at the lowest Mal. When responses were analyzed on the
single-cell level , infected DCs had dramatically reduced intracellular staining for IP 1 0
when compared with uninfected bystander cells; conversely, infected cells had enhanced
TNF-a expression. DV infection resulted in DC release of biologically active IFN-a/
with consequences for both infected and bystander DCs. Endogenous IFN-a/ produced
during infection process inhibited further infection of DCs and was the major factor
driving DC IPlO production. IPlO production differed between D2V strains , suggesting
strain-dependent differences in IFN-a/~ induction. This series of experiments indicated
that DV causes DCs to secrete a broad range of inflammatory cytokines and chemokines
but the specific responses of infected and bystander DCs to DV were distinct. Both direct
and indirect effects of virus mediated secretory responses , effects that were distinct in a
comparison of culture-adapted and wild tye dengue viruses.
One main function of DCs is to initiate and direct primary immune responses; a
series of experiments was designed to quantify DC priming function using multiple
resting CD4 T cell activities as the readouts. Introducing D2V into DC cultures generally
increased the ability ofDCs to stimulate T cells; however, increasing the virus dose
weakened or even abrogated this effect. When compared to mock- infected DCs , in most
cases DV - infected DC cultures induced greater proliferation of resting allogeneic CD4 T
cells. These effects were observed consistently across a range ofT:DC ratios and were
most pronounced when DC numbers were limited. The effect was less pronounced
however, when compared with the differences between cytokine-matured DCs and mock-
infected DCs. In another set of experiments, DCs infected at lower MOIs were
consistently better stimulators than cells infected at higher MOIs. In cases where DCs
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suppressed T cell proliferation at high Mal , replicating virus was required since UV-
inactivated virus did not have an equivalent effect. IL- IO induction during co-culture did
not explain the reduced alloproliferation observed at high MOI , since I detected minimal
IL- lO secretion in T-DC co-cultues. Nor was increasing MOI associated with Th-type
skewing, since similar levels of1L- 13 and IFN-y were detected in co-culture supernatants
and did not show Mal-dependent effects. Infection ofDCs with DV in the presence of
serotype-heterospecific antibodies neither enhanced infection of these cells , nor altered
their ability to induce proliferation in co-culture with quiescent CD4 T cells. My results
indicate that exposure to DV stimulates proliferative priming function in bystander cells
an effect that is not infuenced by infection with immune-complexed DV. By comparison
DV -infected DCs appear to be relatively poor CD4 T cell stimulators and do not
potentiate the development of a specific T h I or T h2 response.
GENERATION OF DENDRITIC CELLS AND INFECTION WITH DENGUE VIRUS
Positive selection ofCD14-expressing monocytes and subsequent culture with GM-CSF
and IL-4 allowed us to generate DC cultues with high conversion rates to CD la-
expressing cells. This result was in accordance with previous literature reports , including
those addressing dengue infection (Wu et aI. , 2000; Palmer et ai. , 2005). Monocyte-
derived DCs have the advantages of being primary cells , are readily generated , use
established laboratory cutture methods , and result in generally high purity of the desired
cell population. However, being primary cells they must be isolated from multiple
donors , thus introducing a substantial element of experimental variability into the system.
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Following exposure of DCs to dengue virs , we noted peak antigen staining prior
to 48 hours, in agreement with previous work using D2V NGC (Wu et ai.
, 2000).
Therefore, we used a 24-hour time point post- infection for our subsequent analyses. In
several other studies the investigators utilized a 48-hour time point post-infection
(Libraty et ai. , 2001; Palmer et ai. , 2005; Sanchez et ai. , 2006). The 24-hour time point in
our studies was also selected based on a report that suggested increasing apoptosis in
mode-infected cells with prolonged culture (Ho et ai. , 2001). Since this could potentially
artificially skew our observations in favor of greater differences between mock infection
and DV infection at later time points, we chose an earlier time than in previous studies.
Additional studies indicate that DV infection has either no effect on
, or actually reduces
apoptosis in DC cultures infected at an MOl of 1 (Palmer et ai. , 2005; Sun et ai. , 2006).
The finding that dengue antigen staining was greater at 24 hrs than at 48 hours post-
infection suggests either selective attrition of infected cells or reduced virus production
for example, as a consequence of the paracrine effect ofIFNs. We were interested in
examining DCs during the period of peak viral replication, when these cells would be
expected to be migrating in vivo and arriving in secondary lymphoid organs. Temporal
effects are reported to have significant influence on the fuctions of DCs following their
stimulation (Langenkamp et ai. , 2000).
New Guinea C strain was selected based on original experiments with DV
infection ofDCs (Wu ettii. , 2000), and the ready availability of virus stocks. We found
that, as expected, infection with NGC was dose-dependent, as infection rates increased
with increasing Mal. For most experiments , I utilized an MOI of2 , similar to previous
reports (Wu et ai. , 2000; Ho et ai. , 200 I; Libraty et ai. , 2001; Palmer et al. 2005). In my
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analyses , there was substantial variation in the susceptibility to infection of DC derived
from different donors , which was evident even in cultures infected on the same day.
High variability in infection rate between DC preparations was previously reported
suggesting that this is a common effect in the DV-DC system (Cologna and Rico-Hesse
2003; Sanchez et aI. , 2006).
The question of donor-to-donor variability in susceptibility to infection is an
interesting one. Regarding our findings, the variability we noted could not be explained
solely by the virus stock used or the day of infection
, since donors ' DCs infected on the
same day (see Figure , donors 1-3) or donors infected using a single virus stock (see
Figure , donors 1-5) stil demonstrated variability in infection. In contrast, infection
rates were similar for separate cultures of DCs from the same donor infected on the same
day with and without addition of control IgG (refer to Figure 13), or control human
plasma (refer to Figure 20 A). Therefore it is unlikely that the variation we observed in
the infectivity of DCs derived from separate donors was due solely to intra-experimental
effects inherent to the infection procedure itself. These results suggest that donor-
specific traits of DCs have substantial influence on the variability in this experimental
system. This conclusion is supported by a report that promoter activity for DC-SIGN
appears to be protective against DF (Sakuntabhai et ai. , 2005). This observation suggests
that relative DC-SIGN expression levels between individuals may determine the
development of symptomatic disease through influence on DC infectivity. Additional
downstream responses , such as donor-dependent efficiency of IFN-a/ production by
DCs in response to DV infection, the activity of PDCs in a given individual, or the
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sensitivity of an individual's conventional DCs to IFN-a/~ signaling likely also playa
significant role in determining DC susceptibility to infection, either in vitro orin vivo.
Donor-dependent variability in DC responses to infection (and in other responses
including cytokine production, which is addressed later in this discussion) is an important
observation for future research in the role of DCs in dengue disease etiology. The
occurrence of outliers among donors might highlight rare aspects of DC responses to DV
that either enhance or reduce the risk for disease pathology. This may be argued to be
critical in the study of dengue, since individuals developing the most severe disease
represent only a small fraction of those who contract the virus. Thus
, "
common
responses observed in studies such as ours , and others using similar systems which
identify trends consistent between donors, may be more likely to reveal global responses
associated with protective, rather than pathological, immunological behavior.
Because NGC is a laboratory-adapted strain, we addressed the issue of infection
with other dengue viruses. Similar to previous reports , we report the susceptibility of
DCs to multiple serotypes ofDV (Cologna and Rico-Hesse, 2003; Wu et ai. , 2000; Ho et
ai. , 2001), which in our study included low-passage clinical isolates of American and
Asian strains ofD2V. Our results , combined with the observations of others , indicate
that DC infection with NGC performed in this body of work can be readily reproduced
with other dengue viruses. Work with multiple viruses is important, since differences in
cellular responses (such as cytokine/chemokine induction, which we noted) may reflect
mechanisms of viral adaptation that contribute to virulence , and pathology.
Although analyses of functional differences between viruses were limited in the
scope of this thesis , one literature report began to address this question by comparing DC
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infection with both parent and attenuated vaccine strains of D2V
, reporting differences
between the two strains in DC responses as determined by surface molecule expression
and cytokine production (Sanchez et ai. , 2006). Another study examining the replicative
capacity of different D2V genotypes in DCs found that genome structures of American
D2V strains were associated with reduced infection and virus production
, as compared
with those of Asian strains (Cologna and Rico-Hesse, 2003). Future investigation into
the role that virus strain plays in DC susceptibility to infection
, and the comparison of
responses that different viruses elicit from DCs wil prove an exciting avenue to pursue.
In particular, comparisons of DV strains from individuals with severe disease against
strains which are known to be attenuated, or are isolated from individuals with very mild
disease, will facilitate the understanding of the mechanisms by which DV infection of
DCs contributes to disease pathogenesis. Important molecules to address are IFN-a and
IL- , among others. Differences between strains in their effects on DC functions in
alloreactions may also reveal important strain-dependent differences in quantitative
and/or qualitative priming ofT cells.
EFFECTS OF DENGUE VIRUS EXPOSURE ON DENDRITIC CELL
SURFACE PHENOTYPE
DV exposure enhanced the expression of a panel of immunoregulatory surface proteins in
both infected and bystan er DCs. In a comparison of D2V to lmown DC activators
(TNF-a/IFN-a and LPS), although D2V was the weakest stimulus , surface molecule
expression changes seen with live virus were generally similar to those seen with high-
dose cytokine treatment. This was apparent despite the fact that the concentrations of
exogenous cytokines added were more than 5- 10 fold those detected in culture following
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infection (specifically, TNF-a at 50 ng/mL and IFN-a at approximately 5 ng/mL). D2V
infection was most consistent with TNF-a/IFN-a treatment in the induction of CD40
PD- , PD- , CD86, and HLA A, B , C, and relative changes in CD80 were also
somewhat similar between D2V infection and TNF-a/IFN-a treatment. The comparison
to defined activators such as TNF -a/IFN -a and LPS were not addressed in previous
related studies (Ho et ai. , 2001; Libraty et ai. , 2001; Palmer et ai. , 2005; Sanchez et ai.
2006). Thus , D2V infection of DCs was not only able to activate phenotypic matuation
of DCs , but the magnitude of the effect observed was substantial when viewed in light of
the degree of change inducible in this system.
In experiments comparing UV-inactivated D2V to live virus, replication was not
required for the induction of surface molecule expression, since significant increases in
CD80 , CD86 , PD- , and PD-L2 expression occurred following treatment with UV-
inactivated D2V as compared with mock infection. However, we observed greater
expression levels in DCs infected with live virus when compared to UV -inactivated virus
indicating a role for viral replication in enhancement of phenotypic maturation. Although
most differences between live and inactivated virus were not statistically significant
increases in expression levels following live virus treatment were statistically significant
in comparison to mock infection for all molecules assayed, while UV -inactivated virus
induced statistically significant changes in B-7 family molecules only. Therefore
increased surface marker lexpression on infected DCs as compared with UV -inactivated
virus infected DCs likely represent real differences related to activation occurring
secondary to viral replication.
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Since I confirmed that there was no detectable residual infectious virus in the UV-
inactivated samples , these data suggest that the binding and/or uptake of virus particles
alone, possibly via E protein recognition by DC-SIGN, causes signaling within the DC
resulting in the observed changes in DC phenotype. Two studies found that DC-SIGN
ligation by DC-SIGN specific antibodies did not result in phenotypic changes in DCs
(Geijtenbeek et aI. , 2000b; Caparros et ai. , 2006), although the second study found
phosphorylation of the signaling kinases extracellular regulated kinase (ERK) 1/2 and
Akt, without p38 mitogen-activated protein kinase (MAPK) activation, and noted PLC-
phosphorylation and transient calcium influx. However, the structual epitope recognized
by DC-SIGN specific antibodies influences their effects on signaling, as antibodies with
both activating and ligand-blocking functions have been identified (Hodges et ai. , 2007).
Therefore , DV binding to DC-SIGN could be responsible for the changes in cell surface
phenotype that we observed.
Alternatively, virion internalization may be necessary to elicit cellular responses.
DC-SIGN has internalization motifs , which are responsible for the uptake of HIV (Kwon
et ai. , 2002). Antibody blocking of DC-SIGN binding prevents infection-induced
phenotypic changes to DlV, however, abrogation of DC-SIGN internalization motif
function does not prevent DV uptake, suggesting a role for additional molecules in DV
internalization (Lozach et aI. , 2005; Tassaneetrithep et aI. , 2003). Therefore , virion
binding alone to DC-SIGN may fail to induce, or induce weak and/or transient, activation
that could be amplified when the DV particle is internalized. In one report, DC-SIGN-
mediated human papilloma virs (HPV) pseudovirion (virus- like particle, VLP) binding
to DCs , and antibody blocking of DC-SIGN specifically inhibited HPV VLP-induced
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MHC I induction (Garcia-Pifieres et aI., 2006). The lack of nucleic acid in VLPs
demonstrates that the effects seen were dependent on protein structual components
alone, although these findings cannot rule out a role for additional signaling mechanisms
secondary to VLP binding by DC-SIGN. DC-SIGN binding by multiple pathogens
including mycobacteria, measles , and HIV- , has also been demonstrated to activate
signal transduction through Raf- l mediated acetylation ofNF-KB p65 , although this
required prior TLR-mediated NFKB activation (Gringhuis et aI. , 2007). Therefore
additional receptor-ligand interactions (or activation of intracellular pathways) may be
essential for signaling following DV binding as well. These findings also suggest that
DC-SIGN binding by DV may regulate later activation and intracellular signaling events
that are dependent on replication. It should be noted, as discussed in the introduction
that multiple cellular receptors for DV have been postulated; the studies discussed above
highlight the importance of determining additional cell-surface targets for both DV
internalization and signaling beyond DC-SIGN.
It is possible that C6/36 cellular contaminants in the virus inoculum, such as heat-
shock proteins , are partially responsible for DC activation in these experiments.
Nevertheless , the observed differences in responses of DC to live virs and UV-
inactivated virus show that DCs respond specifically to dengue viral replication and
additional intracellular signaling events. We observed viral protein production in
response to NGC infectiop. between 8 and 16 hours (refer to Figure 16 D), consistent with
previous reports (Wu et aI. , 2000). Therefore, phenotypic responses to replicative virus
and resulting autocrine/paracrine cytokine signaling would likely become evident at 24
hours post- infection and later time points.
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One study utilizing UV-inactivated DV suggested that viral particles themselves
did not induce phenotypic maturation of DC, although the data were not shown (Libraty
et al. , 2001). Other studies using formalin inactivation or heat inactivation reported
similar results to those of Libraty et al. (2001), although again, the data were not shown
(Palmer et aI. , 2005; Sanchez et al. , 2006). Our data are in contrast to these findings , but
demonstrated a reproducible and statistically significant effect. One possible explanation
for the disparity between our studies and those described above is the magnitude of the
response to UV-inactivated virus observed in our system, which was low for PD-
CD40 , and MHC molecules (although statistically significant in the case ofPD-L2). We
observed larger expression level changes in CD80 , CD86 , PD- , and CD83 (all of
which were statistically significant), indicating that the choice of surface markers
analyzed would affect conclusions regarding the effects of UV - inactivated virus.
Specifically, none of the aforementioned studies addressed PD-Ll or PD-L2 expression
both of which we found to be significantly enhanced following UV- inactivated virus
treatment of DCs. Low numbers of replicates , differences in viral strains , and temporal
effects (with our studies performed at 24 hours, and previous work performed at 48 hours
(Libraty et al. , 2001; Palmer et al. , 2005; Sanchez et al. , 2006) may all be contributing
factors in the discordance of our data and the work of other groups , although we can only
speculate on the former, as none of those studies presented data on the effects of
inactivated virus on DC urface molecule regulation.
Ideally, to answer the question of dengue particle-mediated effects on DCs , a
highly purified preparation of virus could be utilized for infection, allowing comparison
in the absence of potential medium contaminants including cellular debris. Studies 
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dengue VLPs in comparison to UV-inactivated whole virus would allow for
differentiation between structural protein and nucleic acid-mediated effects. Heat
inactivation could also be used to denature virion components (or cellular protein
contaminants) that may be responsible for signaling. Our findings indicate that DCs are
partially activated following exposure to non-replicative virus
, and therefore warrant
further investigation into the mechanisms by which the DV particle itself induces
signaling. One group of candidate DC-expressed molecules , which are involved in
pathogen recognition and may be involved in DV-induced signaling, are the Toll- like
receptors (TLRs). TLR recognition has been shown to be involved in the responses of
murine DCs to YFV, a close relative of dengue (Querec et ai. , 2006).
When we examined the phenotypes of infected and bystander DCs based on
dengue E protein expression, our data included the novel finding that DV induces
expression of both PD-LI and PD- , the known ligands for programmed-death- l (PD-
1). PD- I is expressed on activated T cells , and binding to either of its ligands results in
co-suppressive signals which inhibit T cell proliferation and cytokine production in vitro
using primary human cells (Brown et ai. , 2003; Cai et ai. , 2004). We also found enhanced
expression of CD40 , CD83 , CD80 , CD86 , and MHC class II molecules on both infected
and bystander cells, while only bystander cells up-regulated MHC class 1. These data
demonstrate that both actively infected cells and uninfected bystanders increase
expression of surface moll:cules involved in immune regulation following live DV
infection of DC cultures.
In a contrast of infected to bystander DCs following DV exposure
, PD- , CD80
CD86 , and MHC Class I expression were lower in infected DCs; conversely PD-L2 and
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HLA DR surface levels were enhanced. Using murine cells, PD-Ll has been shown to
effectively inhibit both Th l and Th2 responses in antigen-specific T cells , while PD-
preferentially inhibited Th l responses alone (Latchman et ai. , 2001). In experiments with
human DCs in co-culture with CD4 T cells , blocking PD-Ll and PD-L2 had additive
effects, although in this case, PD-L2 was the more potent cytokine and proliferation
suppressor (Brown et aI. , 2003). The fact that both of these molecules were differentially
regulated on infected versus bystander DCs in our experiments suggested that priming
functions between these two populations may differ, particularly with regard to T 
skewing, although we did not confirm such an effect (refer to Figure panels C-E).
IFN-a induces PD-Ll in cultured DC and renal tubular cells (Schreiner et ai. , 2004;
Waeckerle-Men et ai. , 2007), and we observed up-regulation of both PD-Ll and PD-
in response to IFN-a treatment of DC (data not shown). Type I interferons (IFN-
have been implicated in the regulation of other B7-family molecules in DCs , and
enhance the expression ofMHC Class I (Luft et ai. , 2002; Mohty et ai. , 2003). We also
found that MHC Class II expression on DC could be induced by IFN-a (not shown);
although DV infection has been shown to inhibit IFN-a/~ signaling within infected cells
(Munoz-Jordan et ai. , 2003; Munoz-Jordan et ai. , 2005; Ho et ai. , 2005), HLA DR and
PD-L2 expression were selectively enhanced on infected DCs when compared to
bystander cells in our system. These findings indicate that the observed differences
between infected and bystander DC surface molecule expression could not be explained
on the basis of DV -mediated IFN-a/~ inhibition alone. Therefore, additional regulatory
pathways affecting surface molecule expression, attributable to replicating virus , are
active in DCs following infection, This is not surprising in that both dengue NS 1 and
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NS5 are implicated as mediators of intracellular signaling (Chua et aI. , 2005; Medin et
aI. , 2005).
There is general agreement in the literatue that bystander DCs have enhanced
expression of co-stimulatory and MHC molecules following dengue exposure (Libraty et
aI. , 2001; Palmer et aI. , 2005; Sanchez et aI. , 2006). In one study, CD80 and CD83
expression appeared to be slightly enhanced in infected DCs when compared to bystander
cells , although this effect was not statistically significant (Sanchez et aI. , 2006). In that
study, infection and culture were carried out at 32 C and used both a D2V attenuated
vaccine strain, PDK53 , and the parent prototype strain 16681. In a second study using
D2V strain 16681 , the authors reported that CD83 , CD40 , CD80 , CD86 , and MHC I and
II molecule expression were all enhanced versus mock infection in both infected and
bystander DCs , although infected cells had lower expression of CD83 , CD80 , CD86 , and
MHC I relative to bystanders (Libraty et aI. , 2001). Another study reporting on the same
panel of markers found that DCs infected with the D2V prototype strain 16803 showed
no induction of surface molecule expression when compared to mock infection, despite
increases in surface expression of all of the molecules assayed in bystander DCs, and
concluded that there was potent virus-specific suppression of responses (Palmer et aI.
2005). Our findings were in contrast to the report by Palmer et al. (2005), being most
consistent with those of Libraty et al. (2001), although we found enhanced expression of
MHC Class II on actively infected DCs. In summary, including our work, three of four
studies indicate differences in phenotypic maturation between infected and bystander
DCs , and three of four studies report statistically significant phenotypic responses
specifically in infected cells compared with mock infection. The differences in findings
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regarding surface molecule expression between studies likely reflect differences between
virus strains , genetic polymorphisms between DC donors , and the kinetics of surface
molecule expression.
. WHOLE CULTURE DENDRITIC CELL CYTOKINE AND CHEMOKINE
RESPONSES TO DENGUE 2 VIRUS INFECTION
When we infected DCs with dengue virs , we noted a broad inflammatory cytokine and
chemokine response , with the most striking changes being in chemokine production.
Previous work in our laboratory indicated that DV induced DC expression of the
chemokines MIP- , MIP- , IL- , RANTES , and MCP- l (Medin et aI. , 2005). Here
we report similar findings, along with the observation that dengue also induces high- level
secretion ofIPlO from monocyte-derived DCs. This additional finding is potentially
significant, since IPlO and not the other CXCR3 ligands MIG (monokine induced by
gamma interferon, CXCL9) and IT AC (interferon-inducible T cell alpha chemoattractant
CXCLll) was reported to be critical for survival in a murine model of primary dengue
ilness (Hsieh et al. , 2006).
Similar to previous reports (Ho et al. , 2001; Libraty et al. , 2001; Palmer et al.
2005), we found that dengue was also a potent inducer of inflammatory cytokines IFN-a
and TNF-a, and that IL- 12 p70 was not induced in response to DV infection. We did
find increased IL- 12 p40 induction by some donors ' DCs in response to dengue infection
in several experiments (Figures 7 , 8 , and 9), suggesting that failure to produce IL- 12 p70
is also related to a failure to produce the IL- 12p3 5 subunit. One potential alternative
pathway for IL- 12 p40 is IL- , which utilizes the p40 subunit along with IL-23-specific
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P 19 (Oppmann et aI. , 2000). While IL-23 is reported to induce IL- 17 secretion in CD4 T
cells (Aggarwal et aI. , 2003), in preliminary experiments, we did not note any differences
in IL- 17 levels in co-cultures of T cells combined with mock-infected versus dengue-
infected DC, suggesting that dengue did not specifically enhance IL-23 secretion by DCs
however (data not shown). DV infection was also a stimulus for the release of several
additional inflammatory mediators , including IL-6 and IL- Ia. Infection also stimulated
the release of IL- , which is a growth factor for plasmacytoid dendritic cells (PDCs)
(Strobl et ai. , 1998). PDCs are potent IFN-a producing cells , which are activated through
TLR7 following exposure to DV (Wang et aI. , 2006). In a study of hospitalized children
with febrile illness , those who developed DHF did not demonstrate elevated PDC
frequencies in their PBMC , while those with DF had increased PDC numbers early
during ilness (Pichyangkul et ai. , 2003b). That same study reported that total PBMC
IFN-a secretion in response to PDC-specific stimulation is dramatically reduced during
acute dengue ilness as compared with healthy controls (Pichyangkul et ai. , 2003b).
Thus, PDCs appear to play an important role in dengue ilness , and IL-3 production might
be involved in the early proliferation of these cells following infection.
Similar to our findings on surface molecule regulation, UV -inactivated virus was
capable of inducing the secretion of several cytokines and chemokines , including IL-
MCP- , RATES, and IP 1 O. These results are not surprising, in that DC cytokine
responses to non-replicative VLPs and inactivated virus have been reported. HPV VLP
binding to DCs induced secretion ofTNF-a, IL- , and RANTES (Garcia-Pineres et ai.
2006), while UV-inactivated YFV l7D was able to elicit TNF-a and MCP- l secretion
from DCs (Querec et ai. , 2006). We found that secretion of most molecules , notably
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IFN -a and TNF -a, as well as RANTES , were greater following stimulation with live
virus than with UV -inactivated virus , indicating (similarly to surface molecule
regulation), that D2V exposure stimulates DC functional activity, while replication
enhances this activation. The finding that IFN-a and TNF-a production were increased
specifically by live virs treatment likely reflects dependence on viral protein production
or intermediates such as dsRNA formed during viral replication. As previously
mentioned, DCs produce TNF-a in response to NSI-mediated signals (Chua et ai. , 2005),
and dsRNA activates IFN-a/~ production through multiple pathways (Cella et ai. , 1999;
Y oneyama et aI. , 2004). Autocrine/paracrine signaling by these molecules could then
further influence the secretion of other products.
Our findings with New Guinea C strain reflect previous literature reports
indicating that DV either does not induce, or induces low levels of, IL- lO production in
DCs from most donors (Libraty et ai. , 2001; Palmer et al. , 2005). Specifically, we found
low or absent IL- l 0 production in response to dengue infection in independent
experiments (refer to Figures and 8), results that were consistent with those of Libraty
et al (2001). DCs did consistently produce IL- lO in response to LPS stimulation (refer to
Figure 8), demonstrating their functional capacity to produce this cytokine. In other
experiments where we did detect IL- l 0 (refer to Figure 10 D), responses were low for all
but one donor across a range of virus inocula tested, and reflected levels reported by
Palmer et al. (2005) at 2L1 hours. This assay had the best low-end sensitivity of our three
multiplex analyses , as samples were diluted 2-fold for dose-response experiments , as
opposed to 7. fold in experiments comparing D2V to LPS (See Materials and Methods).
Only one of seven donors ' DCs (donor 4) showed potent IL- I 0 secretion, which was
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dose-dependent. IL- lO induction has been reported to occur late following DC
stimulation, when compared with other cytokines (Langenkamp et al. , 2000), suggesting
that any differences between our results and those of Palmer et al. (2005) may be
temporally related. However, the kinetics ofDV infection did not appear to be
responsible, since in our original analysis (refer to Figure 7), we measured high levels of
intracellular dengue E protein staining at 24 hours post-infection, ranging from 33-90%
(not shown). Therefore, in our system, low or absent IL- lO induction was not simply due
to poor viral replication. Sanchez et al. (2006) reported some secretion of IL- l 0 by DCs
following DV infection, but were unable to detect IL- IO during intracellular cytokine
staining assays , further demonstrating the inconsistency ofIL- 10 induction in the DV-
system. Donor-dependent cytokine responses should be considered, and would represent
an interesting area for further research.
Further studies regarding the role of DC in IL- l 0 secretory responses to dengue
viruses are needed, particularly given our finding that potent IL- lO induction by DV
infection of DCs is an exception, and not the rule. IL- lO levels in plasma from patients
with acute dengue infection are elevated with more severe disease (Perez et al. , 2004;
Green et aI. , 1999b), similar to findings in fatal Ebola virus infection of humans (Baize et
al. 2002). APCs derived from the PBMC of acute dengue patients are unable to
stimulate T cell alloproliferation and recall responses and show poor IFN-a secretory
function (Mathew et al. !1998; Pichyangkul et al. , 2003a). Together, these findings
suggest a role for IL- l 0 in acute APC dysfunction during dengue ilness. Individuals
whose DCs are predisposed to produce IL- I 0 in response to dengue infection might
therefore be at high risk of developing severe disease. In particular, early IL- I 0
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production might suppress antiviral IFN activity and co-stimulatory molecule expression
in APCs (!to et ai. , 1999; Ding et ai. , 1993), as well suppressing cytokine synthesis in Thl
cells (Fiorentino et ai. , 1989). This would inhbit effective memory activation, and
failure to eliminate infected DCs would allow for continued viral replication, triggering
ADE and leading to even higher viremia. The resulting antigen load could cause a
rebound" over-stimulation of adaptive responses , activation of pathological T cell
subsets , and T cell death. Such effects may be reflected by the increased levels of soluble
T cell-associated receptors (CD8 and IL-2R) and CD8 T cell apoptosis seen during acute
dengue infection (Green et ai. , 1999a; Mongkolsapaya et aI. , 2003).
In additional analyses examining the secretory responses of DCs to increasing
input levels ofD2V, we found that production ofTNF-a, MIP- , and RANTES showed
similar patterns, essentially responding in a dose-dependent manner. Experiments
utilizing UV -inactivated virs revealed that replication had a substantial enhancing effect
on the secretion of each of these products. Also germane to the virus-dose responsive
nature of the secreted products noted above was the observation that TNF-a production
occurred far more frequently in infected cells than in bystanders during our ICS assays
(see Figures 11 & 12). Together, these data support the conclusion that the dose-
dependent increases in TNF-a, MIP- , and RANTES secretion were driven by
increasing DV infection ofDCs, particularly in light of the fact that UV-inactivated virus
only marginally induced these products when compared to mock infection. These data
also suggest that MIP- la and RANTES may have similar profiles in intracellular staining
assays as compared with TNF -a.
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On the other hand, variability ofIFN-a levels in relation to virs dose and the
induction ofIP 1 0 at low concentrations of virs are very likely related. This is
particularly evident when viewed in the context of our finding that IFN-a/~ receptor
blockade inhibited IP 1 0 production in intracellular staining assays (refer to Figure 14).
The fact that IFN-a/ receptor blockade mediated biological effects indicates that, during
culture , DCs are binding IFN-a produced in an autocrine/paracrine fashion. Therefore
quantitative measurement ofIFN-a in supernatants is confounded by constant uptake , in
addition to the potential effects ofIFN inhbition by DV (Munoz-Jordan et ai. , 2003;
Munoz-Jordan et ai. , 2005; Ho et ai. , 2005). Viral inhibition ofIFN signaling might
reduce IFN-a secretion through blocking effects on IFN- signaling, particularly as
infection rates and viral protein production increase. IP 1 0 secretion appears to suffer
some degree of inhibition as well at the highest MOIs , when we noted the highest cellular
infection rates. This is not surprising, again, when viewed in light of the intracellular
staining data, which indicate that infected DCs are particularly poor producers of IP I 
(refer to Figure 12).
DIFFERENTIAL INDUCTION OF IPIO AND TNF-ALPHA FOLLOWING DENGUE
2 VIRUS INFECTION AND THE ROLE OF IFN-ALPHA
While we found a wide range of secreted products in response to dengue infection
intracellular staining revealed distinct cytokine production phenotypes for infected and
bystander DCs. IPlO production was potently induced in bystander cells , whereas DCs
with detectable dengue E protein levels demonstrated uniformly low levels of staining for
IPIO (see Figure 12 A). In multiple experiments , the frequencies ofIPlO+ cells in the
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infected cell population were significantly lower than those in bystander cells , an effect
that was statistically significant (Figure 12 B). On the other hand , TNF-a production
was more prominently induced in infected DCs (see Figure 12 C), and frequencies of
TNF -a + cells were higher in the infected cell population than in the uninfected bystander
cell population, also a statistically significant effect (see Figure 12 D). Our findings with
IPI0 are novel, while Sanchez et al. (2006) reported similar results with TNF-a using an
attenuated dengue 2 strain. There are multiple potential effects for these observations
based on the biological activity of these two molecules.
The receptor for IPlO is CXCR3 (Loetscher et al. , 1996). Interestingly, it was
reported that CXCR3 is expressed on "central memory" helper T cells that selectively
become Th type cells producing IFN-y on activation (Rivino et aI. , 2004). IPI0
production by DCs has been shown to be important for clustering and retention of
responding Th l cells in the hepatic lymph nodes in a murine model of granulomatous
liver disease. In that study, blockade ofIP I 0 resulted in hepatic infiltration of T h I cells
and liver injury (Y oneyama et ai. , 2002). Failure of infected DC to produce substantial
IP 1 0 suggests that in vivo these cells are relatively weak recruiters for T cells expressing
CXCR3. Therefore, it is possible that DV-infected DCs fail to recruit and to retain IFN-
producing Th cells from the memory compartment. Such an effect has clear implications
for DC function, since IFN-y-mediated signaling appears to be intact in DV-infected DCs
(Ho et al. , 2005; Libraty d aI. , 2001). Failure to recruit and activate Thl cells would
prevent further DC activation and allow for unchecked viral replication in DCs.
Secondarily, a lack of IFN-y in the local environment would potentially interfere with the
instructive" IFN-y stimulated IFN-y production in responding T cells , negatively
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affecting downstream antiviral mechanisms , including the "conditioning" of DCs to
induce cytotoxic CD8 T cell activity in the absence of immediate (i. , in contact with the
DC) T cell help (Ridge et aI. , 1998). Pathology might be further enhanced by ineffective
retention of dengue-specific T h cells in the draining lymph nodes of affected tissues such
as liver, skin, or bone marrow, resulting in organ infiltration and immune-mediated
damage.
The selective induction ofTNF-a by inected DCs , on the other hand, may be
directly involved in apoptotic signaling in responding T cells. In particular, CD8 T cells
have been shown to be sensitive to TNF -mediated killing, while CD4 T cells are
susceptible to Fas ligand (FasL) (Zheng et ai. , 1995). TNF-mediated cell death would
reduce the number of DV -specific T cells generated during primary infection, and cause
attrition of responding memory cells during secondary infection. In fact, CD8 T cell
apoptosis has been demonstrated for DV epitope-specific MHC-tetramer+ cells during
secondary infection, indicating that these cells are receiving death signals
(Mongkolsapaya et aI. , 2003). During primary infection, CD8 T cell death may be of
relatively little consequence, since cross-priming and presentation of apoptotic cells
could eventually provide a suffcient response to clear the virus. The absence of ADE
and generation of a serotype-specific antibody response would effectively neutralize
circulating virus. However, during secondary infection, kiling of dengue-specific T
cells, particularly CD8 T1cells , would have adverse consequences , since early effective
responses may be crucial to control dissemination of the virus by infected DCs. Failure
to eliminate these cells (as we also noted a lack ofMHC Class I upregulation in infected
DCs) would allow for viral replication and dissemination. At that point, contributing
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factors to the development of severe disease such as ADE effects and pathological T cell
expansion would be facilitated. It would therefore be of interest to examine the responses
of dengue-specific CD8 T cell clones to autologous DV -infected DCs in the absence or
presence of antibodies directed against TNF-a, to determine if antigen-specific activation
followed by TNF-mediated apoptosis occurs in these cells.
IFN-a/ was reported to inhibit DV infection of human cells in vitro but required
pre-treatment to be effective (Diamond et ai. , 2000). Monocyte-derived DCs have been
described as weak IFN-a producers when compared with plasmacytoid DCs (Izaguirre et
ai. , 2003; Colonna et ai. , 2002), and IFN-a levels detected in supernatants from our
experiments were low compared with a number of other DV- induced cytokines and
chemokines. Nevertheless , autocrine and/or paracrine signaling by endogenous IFN-a/
was active in controllng ongoing DV infection in DC cultures. Blocking experiments
revealed that IP 1 0 production in response to virus was largely IFN -a/ dependent. D V
has been shown to suppress IFN actions in multiple in vitro systems (Munoz-Jordan et
ai. , 2003; Munoz-Jordan et aI. , 2005; Jones et ai. , 2005; Ho et aI. , 2005). In light of
those findings , viral inhibition of IFN-a/~ signaling is likely the cause of weak IP 1 0
induction in infected DCs.
In control experiments , anti-IFNAR2 antibody completely blocked IPIO induction
in response to approximately 10- fold higher levels of IFN-a than we measured in culture
supernatants from DV - infected DCs (refer to Figure 14 C), suggesting the production of
additional regulators ofIPIO in this system. These regulators may include IFN-y, which
we detected at very low levels in DC supernatants following infection, or the recently
described IFN-As (Pekarek et ai. , 2007).
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Unlike IPlO , TNF-a production was not affected by IFN-a/~ blockade, and
appeared to represent a direct response to ongoing viral replication in infected DC.
Results with Sendai virus infection of murine DCs were similar to ours , in that IFN-a
was not involved in TNF-a production (Lopez et aI. , 2003). In addition to the report by
Chua et al. (2005) implicating dengue NSI in TNF-a production, intracellular signaling
mechanisms responding to viral products are likely also active in infected DCs , including
the RIG- MA VS pathway (reviewed by Hiscott et ai. , 2006). Alternatively, TNF-a may
be regulated similarly to IL-8 induction, through the dengue NS5 protein (Medin et aI.
2005).
We also found that DCs infected with the low-passage Thai DF patient isolate
CO 166/96 essentially failed to induce IP 1 0 production at all following infection (Figure
16) when compared with NGC, despite the fact that these two viruses resulted in similar
infection levels. That the C0166/96 strain and not NGC was associated with early
dengue antigen expression indicates that this observation was not due to a consequence of
delayed viral replication and therefore delayed secondary activation of IFN-a/(3
production in DCs infected with the CO 166/96 strain. These findings suggest that the
C0166/96 strain does not induce IFN-a production upon infection, or may act to
selectively ablate IFN-a production. Interestingly, both RSV and measles strains which
are able to prevent IFN-a production from plasmacytoid DCs in response to agonistic
stimuli have been identified (Schlender et ai. , 2005). Variant strains of Sendai virus 52
(low production) and Cantell (high production) have also been shown to have vastly
different capacities to induce IFN-a/~ in murine DCs (Lopez et aI. , 2003). Given the
important role of IFN-a/~ in control of viral infection in general , and in dengue infection
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specifically, investigation of the cause of this phenomenon is an extremely important
avenue of future research.
STIMULATION OF T CELLS IN CO-CULTURE WITH DENGUE 2 VIRUS-
INFECTED DENDRITIC CELLS
The experiments we performed on DCs in the absence of secondary stimulation indicated
that D2V activates whole-culture responses. Therefore , we sought to determine if the
activation of phenotypic and secretory function in these cells was reflective of enhanced
function during interaction with CD4 T cells , as a measure of adaptive immune
stimulatory capacity. Specifically, I was interested in determining if DV infection of
DCs facilitated their T cell priming function. In my initial experiments, in accordance
with the activation of DC surface molecule expression, most D2V -infected DC cultures
stimulated allogeneic resting CD4 T cell proliferation. This effect was particularly
striking as DC numbers , and background proliferation stimulated by mock-infected DCs
decreased (see Figures 17 A and B). At lower T: DC ratios , e.g. 5:1 and 10:1 , some DV-
infected DC cultures (but not cytokine-matured DC cultures) showed slightly reduced
allostimulatory function. Specifically, although at both aforementioned ratios, three of
six experiments showed enhanced T cell proliferative responses to DV -infected DC
cultures when compared with mock- infected cultues , two cultures at 5: 1 had reduced
responses and one showe essentially no effect; one co-culture at 10: I had a reduced
response, and two more essentially no change. Even at 20: 1 , responses in three of six
cultures were unchanged or only marginally enhanced (see Figure , experiments l , 4
and 5). Therefore, under some conditions , particularly with high antigen load (high DC
numbers), DV infection of DC cultures has minimal, even negative , effects on T cell
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allostimulation. Interestingly, the variability in SI values (Figure 17B) for DV -infected
DCs co-cultured with T cells appears to be a function of the substantial variability in
absolute responses (i. , cpm values) to mock-infected DCs between experiments (see
Figure 17A Mock), as absolute responses to DV-DCs tended to be consistent between
experiments (Figure 17 D2V). Therefore, the intrinsic capacity of mock-infected DCs
to stimulate the T cell preparation used in a specific experiment has clear weight in
interpreting the results following alternative treatments.
In consistent agreement with our surface phenotyping results, DCs that were
matured with the addition of exogenous cytokines (TNF-a/IFN-a) gained in their ability
to stimulate CD4 T cell proliferation. We saw moderately greater levels of surface
markers on cytokine-matued DCs as compared to DCs infected with D2V, most clearly
for CD83 , but also for HLA DR, CD40 , and CD80 (refer to Figure 4). Although absolute
differences between mean expression levels of HLA DR and CD40 in this comparison
were small , in both cases , they represented a substantial fraction of the " inducibility
within the system, as determined by the maximal stimulus for all molecules tested, LPS.
In addition, PD-Ll and PD-L2 expression levels between DCs from D2V-infected
cultures and cytokine-matured cultures were similar. Together, this indicates that the
balance of co-stimulation versus co-suppression was more favorable in cytokine-matued
DCs as compared to D2V - infected DCs. Not surprisingly, TNF-a/IFN-a treatment was a
more effective and consiSient stimulus for enhancing the ability of DCs to induce resting
CD4 T cell proliferation than was infection with D2V (see Figures 17 A and B). 
comparison of SI values shows that in essentially all cases , cytokine maturation resulted
in enhanced allostimulatory function, while in some instances , particularly at lower T:
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DC ratios (greater alloantigen levels), D2V did not. However, in this experiment, failure
of DCs to increase their allostimulatory activity following DV exposure was an
infrequent finding when considering the sum of responses across the range of T: DC
ratios. This argues against the conclusion that DV infection of DC cultures suppresses
DC allostimulatory activity as reported by Palmer et al. (2005) and Sun et ai. (2006).
Although not as potent a stimulus as cytokine maturation, D2V infection generally
resulted in improved allostimulatory function in DC cultures.
These results indicate that D2V infection of DC cultures does not induce an
inherently allosuppressive culture-wide effect, as has been reported for MV (Fugier-
Vivier et ai. , 1997; Grosjean et ai. , 1997; Schnorr et aI. , 1997; Dubois et ai. , 2001) and
RSV (de Graaff et ai. , 2005; Bartz et ai. , 2003). Rather, results from Figure 18B suggest
that direct infection of a given DC in cultue appears to inhibit the allostimulatory
capability of that specific cell , relative to bystander DCs within the same culture. This
conclusion is drawn from the observation that higher multiplicities of infection, reflected
in increasing infection rates (see Figure 18 A), were associated with reduced proliferation
(see Figure 18 B) when compared to lower MOIs. Surprisingly, the results in this series
of experiments comparing DV-DCs to mock-infected DCs appeared to be discordant on
some levels with the data presented in Figure 17. Infection at lower MOIs in this series
of experiments tended to enhance allostimulatory responses, similar to the results seen in
the experiments comprising Figure 17. However, at higher MOIs that were more in
keeping with the Figure 17 data, mean allostimulation (i. , the values for all seven
experiments combined) tended to be similar to , or lower than, that seen with mock
infection. This effect was not statistically significant, however, and the range of values
132
obtained in response to mock infection was highly variable, as previously described for
Figure 17.
In the series of experiments presented in Figure , proliferative responses to
DV- infected DCs in four of seven co-cultures were greater than responses to mock-
infected DCs , while in three co-cultues responses were suppressed. Notably, in two of
the co-cultures with reduced responses (donors 6 and 7), proliferative responses to mock-
infected DCs were unusually high. DCs from these donors, and from donor 4 (which also
demonstrated reduced allostimulatory function when compared with mock infection) had
the greatest infection rates at an MOI=l , and all demonstrated infection of greater than
50% at an MOI=5. Also , in six of seven co-cultures , proliferation induced by DV-DCs at
the lowest MOI (=0. 04) was greater than that induced by mock-infected DCs , suggesting
that activation of DCs in the absence of high percentages of infected cells (i. , activation
in the presence of a vast majority of bystander cells) is a consistent stimulus for enhanced
alloproliferative activity.
As alluded to above, the failure of DCs infected at high MOIs to induce
alloproliferation in some of the experiments presented in Figure 18 could also be
reflective of the high infection rates noted for this series of DC infections; the
experiments in Figure 17 could not be correlated to DC infection rates. In fact, four
further experiments performed comparing mock-infected DCs to D2V-infected DCs
(MOI=l; shown in Figure 20) found enhanced allostimulatory activity in DV- infected
DC cultures as compared with mock infected DCs , reminiscent of the results in Figure
, albeit with generally lower infection rates than in Figure 18. When taken as a whole
reduced T cell proliferation to DV -infected DC cultures was rare (for example, only 3 of
133
17 co-cultures at a T:DC ratio of20:l and MOI=1 or 2; see Figures , 18 and 20).
Again, I interpret these data to mean that bystander DCs in D2V- infected cultures gain in
allostimulatory activity, while the data in Figure 18 argue that directly infected DCs have
generally poor relative allostimulatory function.
Although the T: DC ratio in the Figure 18 experiments was 20: 1 , in most cases
the cpm values were more reflective of the cpm values obtained for T:DC ratios of 5: 1 or
10: 1 than those at 20: 1 shown in Figure 17 (compare responses to mock-infected DCs
and DCs infected at an MOI=l or 5 in Figure 18B to mock-infection or D2V infection in
Figure 17 with addition of 10000 , 5000 , and 2500 DC). Furthermore, these data argue
that increased baseline proliferation (e. , with high DC numbers or in donors whose
mock-infected DCs have unusually high allostimulatory function) reduces the ability of
the system to detect increases in proliferation, while likely increasing the system s ability
to detect suppression. While most pronounced at low T: DC ratios , such an effect
appears to extend to the 20: 1 T:DC ratio chosen for the experiments in Figure 18
indicating that fuher similar experiments at a higher T:DC ratio may have substantial
value in clarifying the results in this experimental series in light of the additional
experiments I have presented here. Thus, a general increase in the proliferative responses
to mock- infected DCs and the presence of outliers with aberrantly high responses to
mock-infected DCs appears to be contributing to the discordant nature of the results
comprising Figure , as! viewed in light of all co-culture data. However, a global
assessment of all T:DC co-cultures performed in the experiments comprising Figures 17
, and 20 indicates that D2V-infection of DC cultures enhances the culture
allostimulatory potential, while Figure 18 specifically suggests that increasing infection
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rates , and thus a higher infected: bystander DC ratio independently reduces
allostimulation. Variability in the susceptibility of donors ' DCs to direct suppression by
internally replicating virus likely contributes to the range of effects (e. , stimulation in
the face of infection versus frankly reduced proliferation) seen in these experiments.
The system I utilized for my co-cultures was unable to directly compare T cell
proliferative responses to infected versus bystander DCs, since surface expression of
dengue proteins was inadequate to effectively sort viable cells. However, in the series of
experiments shown in Figure , in a minority of donors (4 , 6 , and 7), I did observe
decreased T cell proliferation to DV-infected DCs in co-cultures as compared to mock-
infected DC at the highest MOIs (Figure 17 B), and even at low MOIs (donors 6 and 7),
similar to previous reports (Palmer et al. , 2005; Sun et aI. , 2006). Reduced
allostimulation in these experiments was dependent on replicating virus, since equivalent
reductions did not occur with UV-inactivated D2V infection ofDCs (Figure 18 E).
In donor 4, I found high- level IL- IO production during the initial 24-hour
infection period (Figure 10 D), reflecting the mechanism proposed by Palmer et al.
(2005). However, in T-DC co-culture, DCs from this donor had enhanced
allostimulatory function at MOIs of 0. 04 and 0.2 (Figure 17 B). This was despite the
greatest IL- l 0 production of seven donors ' DCs at all MOIs , as measured in supernatants
from the 24-hour period post-infection, prior to use in T cell stimulation assays (Figure
10 D), indicating that IL-I 0 induction alone in this donors ' DCs was not sufficient to
prevent them from developing enhanced allostimulatory capability. Both donors 6 and 7
also showed increases in IL- l 0 production during the infection period, prior to co-culture
particularly at an MOI=0.2. Although IL- lO levels detected in supernatants from these
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donors ' DCs decreased at higher MOIs , the DCs became progressively less functional as
infection rates increased (Figures 17 A and B), with reduced proliferation at an MOI=0.
and higher. Also , donor 1 showed a dose-dependent increase in secreted IL- lO levels to
levels similar to those of donors 6 and 7, yet DCs ffom donor I remained stimulatory,
relative to mock infection, even at an MOI=5 (although T cell stimulation peaked at
MOI=0.04). Together, these results suggest that, in some cases , D2V infection results in
IL- lO production and associated reduction in DC allostimulatory function, although the
magnitude of the effect appears to be highly variable, possibly reflecting the variability in
IL- lO induction. Notably, this did not appear to be a dominant effect, since in four of
seven co-cultures performed across the range ofMOIs , we found greater proliferation at
each MOI as compared with mock infection.
Both previous studies reporting reduced alloproliferative responses to dengue-
exposed DCs showed data in which proliferation decreased as MOI increased (Sun et al.
2006; Palmer et al. , 2005). This contrasts with the data we present here , which shows
that at lower MOIs , DC stimulatory function is enhanced , while as MOl increases , DC
stimulatory function tends to decrease, a statistically significant effect at an MOI=l or 5
as compared with all other conditions using infected DC. The authors of the
aforementioned previous studies interpreted their findings as indicative of D2V -mediated
suppression of DC function, although even at the highest MOIs, proliferative responses
were between 50% and 76% of the responses seen with mock infection (Palmer et aI.
2005; Sun et al. , 2006). Both reports by this group included only representative data
failing to address the consistency of their results (Palmer et al. , 2005; Sun et al. , 2006).
Clearly, the effect noted in those studies , and in similar observations in our studies , is
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mild when compared to results reported for either MV or RSV (Grosjean et al. , 1997;
Fugier-Vivier et al. , 1997; Dubois et al. , 2001; de Graaff et al. , 2005). In addition
Palmer et al. (2005) reported enhanced apoptosis of DCs infected with high MOls of
D2V. Therefore, in that study, reduced T cell proliferation may have been secondary to
increased attrition of infected DCs in culture.
Also in contrast to findings by Palmer et al. (2005), we noted little or no
detectable IL- lO in supernatants from T - DC co-cultures , suggesting that this cytokine
was not produced in response to the alloreaction, and thus does not playa role in
suppressing T cell responses during the course of T - DC co-culture. Sun et al. (2006)
reported lFN-y production during T -DC co-culture, an observation I also made. Here, I
report that T-DC co-culture results in the secretion ofIL- 13 as well. Mean IFN-y and lL-
13 levels were equivalent across the range of DC MOls (see Figures 18D and E). 
addition, neither IFN-y nor IL- 13 showed a dose-responsiveness to DC MOI, indicating
that activation of resting CD4 T cells in co-culture with DV-infected DCs primes a mixed
l/T 2 response, similar to mock infection. Increasing MOl was associated with
increasing infection rates , and in most co-cultures, DV -infected DCs represented the
major fraction of DCs added.
These results indicate that co-culture of DV-infected DCs with CD4 T cells does
not skew responses towards either a Td or Th2 phenotype. This , in turn, suggests that
following DV exposure, ihfected DCs do not develop intrinsic properties for skewing
CD4 T cell responses. These findings contrast with those using RSV, in which case CD4
T cells co-cultured with infected DCs exhibited minimal production ofIFN-y or IL-
although both of these cytokines were produced at substantial levels in T - DC co-cultues
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where DCs were matured using exogenous cytokines , poly I:C, or InN (de Graaffet ai.
2005). Notably, in that study, InN was a particularly potent stimulator ofTh l-skewing,
as IFN-y levels were substantially higher than those ofIL- 13. On the other hand, results
in our experiments were reminiscent of that noted for YFV 17D infection in mice, which
facilitated the induction of both Th l and Th type responses (Querec et aI. , 2006).
Although these experiments did not allow me to discriminate the source of IL- 13 and
IFN -'I, additional experiments are possible to determine this. Restimulation of T cells
with a non-specific stimulus such as phorbol esters (PMA) and ionomycin after 1 week in
culture coupled with intracellular staining would reveal specific functional activities in
CD4 T cell subsets. Analysis of CD4 T cell surface expression of molecules such as the
IL-7 receptor would provide information regarding the ability of cells developed during
co-culture with infected DCs to respond to homeostatic cytokine signaling. Also
functional studies using blocking antibodies to Fas or TNF -a would provide information
as to whether or not these molecules were inducing death signals during co-culture of
CD4 T cells with infected DCs. Performing a similar series of experiments with CD8 T
cells as those presented in this thesis using CD4 T cells would yield information
regarding the stimulatory activity of infected DCs for cytotoxic T lymphocyte function.
Finally, testing autologous PBMC and T cell clones specific for DV against DV-infected
DC targets wil yield specific information regarding how DV infection affects T cell
memory responses to infetted DCs. Such activities might include DC lysis , T cell
cytokine production, and DC-mediated T cell apoptosis (potentially through Fas or TNF-
a as previously mentioned).
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Our findings regarding T cell responses in co-culture with DCs infected with a
range of MOIs clearly demonstrated variable results, despite the consistent trend for
decreased proliferative responses at the highest MOIs. This suggests that donor-
dependent effects may have a strong influence on DC allostimulatory activity, in keeping
with the variability we noted in infection rates and the secretion of soluble factors.
Testing of DCs and T cells in a 2x2 factorial design suggested that the DC source had the
greater influence on the pattern of proliferation responses (refer to Figure 19). However
the characteristics of the T cells are likely also important. We used negatively selected
CD45RO' " resting" CD4 T cells. In contrast , Palmer et al. performed proliferation
assays using positively selected CD3+ T cells, which included both naIve and memory
CD4 and CD8+ T cells. These cells showed higher proliferation responses to mock-
infected DC and may be more readily activated to express PD- , thus becoming
susceptible to inhibition by PD-Ll/PD-L2 expression on the DC (Vibhakar et ai. , 1997;
Latchman et ai. , 2001). In the report by Sun et al. (2006), which used naIve CD4 T cells
selected in a similar manner as in our studies, the effect ofDV infection on DC
stimulation was more modest than that reported by Palmer et al (2005).
The presence of antibody during primary infection is thought to influence disease
severity in infants , putatively through ADE of monocytes or macrophages. We tested the
effects of dengue-immune plasma on the infection of DCs and their allostimulatory
function. This experiment was in response to the question of whether immune-
complexed DV demonstrated distinct effects on DC priming capacity as compared to DV
in the absence of cross-reactive antibodies. In this experiment, we found no effect of
D3V- immune plasma on either DC infection rates , or on the ability of these cells to
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stimulate allogeneic CD4 T cell proliferation. This result indicates that DV in the context
of immune complexes does not have intrinsic properties that differentiate it from naked
virus as related to the induction of DC allostimulatory function. This finding argues
against a role for immune-complex-mediated effects on DC function in disease pathology
during primary infection of infants, or secondary infection in older children and adults.
FINAL WORDS ON DENDRITIC CELL INFECTION AND TRANSLA TING IN VITRO
RESPONSES TO IN VIVO/CLINICAL FINDINGS
An important point to recall when examining the effects of both measles and RSV
infections in vivo versus in vitro in DCs is that the consequences in vivo are rarely as
profound as might be predicted by those in vitro. This might be appreciated most simply
by recalling that living organisms employ myriad semi- (and fully-) redundant
mechanisms to cope with invading pathogens. Rather, the in vitro imunosuppression
noted in T cell-DC co-cultues with these virses may be reflective of a common survival
and dissemination mechanism of acute cytopathic viruses , which replicate rapidly to high
titers, induce potent immune responses, and thus must transmit themselves in as
expeditious a manner as possible (reviewed by Hangartner et ai. , 2006). In such cases
immunosuppression may actually help to keep the host alive long enough to permit the
virus access to a new host, rather than rapidly killing host (and thus virus). Examples of
poorly human-adapted , emergent virses such as Sin Nombre and Ebola, which "burn
fiercely within a host or community thus have either failed to adapt yet to facilitate
transmission via the new host (humans), or induce such profound immunosuppression
that the host is incapable ofrecovery (as appears to be the case with Ebola).
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. A PATHOGENESIS DISCUSSION: FUTURE WORK IN THE DV-DC (AND DV-
APC) SYSTEM
In this thesis work, I found that DV infection of DC cultures activated a range of
functions in these cells. Virion binding alone resulted in phenotypic and secretory
functional responses , but these were quantitatively and qualitatively different in the
presence of replicating virus. Viral replication stimulated IFN-a//3 production, which
drove bystander IPlO production, while production of this chemokine was inhibited in
infected cells. On the other hand, infected DCs potently produced TNF-a. These data
combined with dose-response data, suggest that a number of cytokines and chemokines
have a similar dependence on active replication. Experiments using DV- infected DCs to
stimulate T cell responses demonstrated stimulation by infected cultures, although
substantial evidence indicated that bystander DCs , and not infected DCs , were the more
potent stimulators. I did not note IL- l 0 production in T - DC co-cultures , nor did I note
T h-skewing effects of infected DCs.
Since DCs have been demonstrated to be targets ofDV infection in vivo these
data are extremely relevant to understanding dengue disease pathogenesis. A model
proposed by Palmer et al. (2005) argued for a major role ofIL- lO in DV infection of
DCs , suggesting that DV-induced immunosuppressive effects facilitate the development
of severe disease. However , any model that includes DCs must account for the fact that
there is no difference in DC populations present between disease states (DF vs. DHF) or
exposure histories (primary vs. secondary), suggesting that any potential pathogenesis
arising from DC infection is related to downstream responses. Therefore, I argue that the
Palmer model is inherently flawed, since , if all DCs produced IL- l 0 and caused
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immunosuppression leading to severe dengue ilness , DHF would be equally common in
both primary and secondary infections. Instead, I propose that DCs playa role in the
etiology of severe dengue disease through both typical, and atypical, responses to DV
infection. A discussion of the infection process in light of the data presented in this thesis
follows, with particular attention to the events following inoculation, and the roles that
DCs may play in primary versus secondary infection.
Despite purported susceptibility of a number of cell types to dengue infection
including those previously mentioned in vivo dendritic cells have substantially greater
susceptibility to infection when compared to other cells. However, DCs might be
expected to be relatively rare cells in the tissue microenvironment immediately following
a mosquito bite and subsequent inoculation. Furthermore, the tissue architecture of the
skin likely determines the local susceptibility to infection for resident cell types.
Specifically, the superficial keratinizing stratified squamous epithelium of the skin is
separated from both vascularized papilary dermis and deeper reticular dermis/cutaneous
vascular plexi by a thick basement membrane. Insertion of the mosquito feeding
apparatus transects the avascular epithelial layers , which contain Langerhans cells
basally, and the physical barrier of the basement membrane. Because LCs are physically
separated from the site of vinlS inoculation (which likely occurs most substantially at the
deeper vascular layers) by the basement membrane, these cells might be expected to be
much less common targets for natural infection than cells of the dermis, including
conventional DCs (such as interstitial DCs or monocyte-derived DCs).
Following virus exposure, multiple cell types would be infected at various (but
generally low) rates , based on previously discussed in vivo and in vitro studies. One
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target that is of potential importance early after viral entry is the dermal fibroblast.
Human foreskin fibroblasts are infected by dengue virus, and produce cytokines such as
GM-CSF (Kurane et ai. , 1992). While the infection rate in these cells may be relatively
low, their abundance in the dermis suggests that fibroblast infection may contribute
substantially to downstream events early following exposure. Dermal fibroblasts may
represent the earliest infected cell type, along with interstitial DCs , thus serving as an
important source of virion production if, as might be expected, infected DCs migrated out
of the local microenvironment following maturation. In addition, dermal fibroblasts
would also serve in the recruitment of immune effectors in response to chemotactic
factors and cytokines generated from cellular exposure to and/or infection by DV
particles. In particular, recruitment of monocytes into the inflammatory
microenvironment in the presence of factors such as GM-CSF may provide large
numbers of highly susceptible target cells as viral replication begins to accelerate.
Infection of these cells would become more effcient as they differentiated into a DC
morphology.
Work in the murine system suggests that two major subsets of blood monocytes
distinct based on expression levels of the chemokine receptor CX CRl , represent
precursor cells with divergent functions. Furthermore, analogous subsets are also present
in humans , in which phenotypic distinction can be made based on the human homologue
also CX3CRI (Geissmanr et ai. , 2003). The CX CRl population serves as a short- lived
acute response" to local inflammation, while the CX CRI hi population is longer lived
and migrates to tissue in the absence of inflammation. Both subsets are capable of
differentiation into DCs in vitro and in vivo and have T cell priming capability, with the
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former ostensibly recruited to local sites of infection in order to augment immunity in the
face of an invading pathogen, and the latter likely serving as tissue resident interstitial
DCs (Geissmann et ai. , 2003).
DCs are considered to be critical during viral infections because of their abilities
to cross-prime , or present exogenous antigens in the context of MHC I molecules
(reviewed by(Bevan, 2006)). Although there is considerable disagreement in the
literature regarding the role that monocyte precursors from blood have in this process , it
is possible that during viral infection, monocyte-derived DCs may serve as antigen
transporting cells , carrying endogenously expressed viral epitopes in the context of MHC
I following peripheral exposure to secondary lymphoid tissues , where antigen transfer
may occur either through plasma membrane transfer to T-cell priming DCs , or through
uptake of apoptotic monocyte-derived DCs (Randolph et ai. , 2007). An additional
mechanism may be that viral transport to secondary lymphoid tissues results in local
infection, with locally resident DCs either infected by the virus , or presenting
exogenously acquired viral particles through a cross-presentation pathway. CD4 T cell
stimulation would likewise be stimulated following exogenous particle uptake
particularly in the presence of specific antibodies. CD4 T cell-mediated local IL-
induction and would potentiate outgrowth of the antiviral CD8 T cell population , an
effect that would be enhanced by and environment favoring IFN-y secretion and further
stimulation of DC priming function.
In the case ofDV infection, monocyte-derived DCs are likely to playa critical
role at multiple stages during infection, since this cell population represents a mobile
susceptible reservoir of target cells that would facilitate viral dissemination beyond the
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site of inoculation, and may also be infected secondarily after viremia occurs and target
organ systems become sites for viral synthesis. The high infection rates associated with
monocyte-derived DCs suggests that a substantial portion of emigrating cells from the
initial nidus of infection would carr replicating virus, effectively translocating infection
from the inoculation site to secondary lymphoid tissue as the DCs received maturation
signals from virus-triggered inflammatory mediators , or from the direct effects of viral
replication within a given cell. Once present in secondary lymphoid tissue, the virus
would have access to a highly cellular environment, with a relatively dense target cell
population, and potential for egress into the bloodstream, facilitating generalized viremia.
A modifying factor that likely plays a role early during viral replication and
dissemination is the presence of potent IFN-a/~ producing cells. In this thesis work, I
found that monocyte-derived DCs were able to produce functional type I IFNs that were
then able to inhbit ongoing dengue virion production in infected cultures. However, as
previously mentioned, the role of monocyte-derived DCs in production of type I IFNs is
generally considered to be marginal , depending on the system used, when compared with
PDCs (Izaguirre et ai. , 2003; Colonna et aI. , 2002). An important adjunct cell type for
IFN-a production in response to DV infection is likely the PDC; activity of these cells in
producing IFN-a would spare monocyte-derived DCs (and interstitial DCs) by inducing
maturation and inhibiting viral replication. Interestingly, although PDCs express the
IP10 receptor CXCR3 , re'cruitment appears to depend not on the concentration gradient
of IPlO (or the additional CXCR3 ligands ITAC and Mig), but rather constitutively
expressed chemokines that signal at much greater effectiveness following CXCR3
binding on the PDC (Vanbervliet et ai. , 2003). Therefore , in a pathological cycle , weak
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IPlO induction by infected MDDCs would hamper PDC migration into the inflamed
stroma of DV- infected skin, resulting in greater susceptibility of conventional DCs to DV
infection. Indeed, the clinical use of PDC stimulators such as the TLR7 agonist
imiquimod likely facilitate clearance of viral infections of the skin, such as HPV, through
PDC activation and IFN production.
PDCs would appear to have additional roles in the secondary lymphoid tissue
during DV infection as well. Such activities may include lymph node homing, with IFN-
a dependent protection of cellular constituents following the arrival of peripherally
infected conventional DCs , and IFN-a mediated Th l skewing. In fact, in humans PDCs
are recruited to lymph nodes following natural infection with influenza virus (Cella et ai.
1999), severe dengue disease is associated with reduced PDC numbers in blood early
during disease (Pichyangkul et ai. , 2003), and in vitro PDCs support Th l priming (Cella
et aI. , 2000). Reduced PDC numbers in the blood of severely il patients , as opposed to
the initial spike seen in patients with mild disease, may represent either ineffective
stimulation ofPDC growth and emigration from bone marrow, or possibly enhanced
extravasation to sites of infection (skin, lymphoid tissue, liver, etc. ). PDCs might also be
infected directly with DV, although this has not be demonstrated, and seems unlikely
given the potency with which DV stimulates IFN-a production in these cells (Wang et
ai. , 2006), and the fact that IFN-a production appears to protect PDCs from vir ally-
induced cell death (Cella et ai. , 2000).
The absence of an appropriate PDC response in individuals suffering from more
severe infections suggests a functional defect in type I IFN-mediated immunity secondary
to weak PDC activity. Failed type I IFN activity would predispose these individuals not
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only to increased viral load, but would shift the monocyte-derived DC infected: bystander
ratio towards higher proportions of infected DCs. In some cases , monocyte-derived DCs
may produce IL- l 0 in response to DV infection, which would functionally blunt both
PDC and conventional DC innate immune activity by reducing the effectiveness of
secreted type I IFNs, as well as suppressing antigen-presenting activity. The
consequences of either case would be weaker adaptive immune stimulation and delayed
DV-specific responses. That PDCs can stimulate Thl priming (Cella et ai. , 2000) also
suggests that PDC recruitment to secondary lymphoid tissue, in concert with monocyte-
derived DCs , may be important in providing help to skew T h responsiveness towards an
IFN-y producing paradigm, a capacity that was conspicuously absent in our experiments
when MDDCs alone were co-cultued with CD4 T cells.
Following local infection, monocyte-derived DCs would likely represent the
earliest and most substantial population of cells migrating to secondary lymphoid organs
to stimulate adaptive responses. The previously mentioned role of monocyte-derived
DCs during acute inflammation suggests that there is an increasing influx of monocyte-
derived and interstitial DCs to immune tissues during the course of infection until the
point where viral replication is controlled through adaptive immune mechanisms
including the generation of neutralizing levels of DV -specific antibodies. During primary
infection, the lack of dengue-specific antibodies early during viral replication would
allow for infection of a fJroader range of cell types than might be expected during
secondary infection. In the case of secondary infection, FcyR-expressing cells , including
macrophages and blood monocytes , would be infected at enhanced rates , while non-
FcyR-bearing cells might demonstrate reduced susceptibility with partial viral
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neutralization. During the phase of generalized viremia, either in primary or secondary
infection, the importance of DCs in determining the outcome of infection would likely be
reduced, since in the case of primary infection, adaptive immune responses would be
expanding and combating infection of target organs, while in secondary infection, ADE
would likely shift the APC target population to macrophages and undifferentiated blood
monocytes.
Early, rather than late , events surrounding DC infection are likely the critical
factor (with regards to DCs) in determining the course of ongoing dengue infection.
Since initiation of adaptive immunity is presumably necessary for viral clearance, the
ratio of infected to bystander cells providing virus-specific stimulation is potentially
important in determining the magnitude, if not the quality, of the T cell response. Host
and/or viral factors contributing to a state that predisposes the host to a high ratio of
infected to bystander DCs in secondary lymphoid tissues would therefore reduce the
effectiveness of T cell priming. Some examples include defects in PDC numbers
recruitment, or IFN-a production in response to DV. High DC-SIGN expression on
conventional (particularly monocyte-derived) DCs , high-level IL- lO induction by
monocyte-derived DCs resulting in suppression ofIFN-a signaling, and high-affinity
binding, low-IFN-a inducing, or particularly aggressively replicating strains of DV are
additional examples. The delay in T cell expansion might be further exacerbated by
reduced recruitment of ctll types responsive to IPlO (memory T cells or PDCs) and
capable of potentiating IFN-y production. Lastly, TNF-a production by infected DCs
could result in T cell killng, and the infected DC surface phenotype may favor T cell
inhibition or, in the case of secondary infection, expansion of pathologic memory T cell
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subsets. Pathological responses , however, are likely multifactorial, as in most cases
dengue ilness is effectively cleared. This suggests that in the vast majority of cases , DC
infection (in opposition to the model proposed by Palmer et al.) appropriately directs
downstream immunity.
Based on the findings in this thesis, in the case of common DC responses to DV
infection, I propose that during primary exposure, DV infection of DCs in most
individuals results in immunostimulation. Stimulatory DC function depends on a relative
abundance of bystander DCs , low infection rates , and low DC numbers. Such a situation
would facilitate mixed T h priming, and the generation of appropriate mixed immune
responses that include dengue-specific cellular and humoral immunity, which effectively
clear the infection. The minority of individuals prone to high infection rates , IL-
production, or suppressed T cell responsiveness to infected DCs would exhibit mildly
enhanced pathology.
During secondary infection, suppressed IP 1 0 production and MHC I expression
combined with TNF -a production in infected DCs would result in poor DC recruitment
of Thl-type memory cells (thus affecting IFN-y secretion and further DC activation) and
reduced CD8 T cell-mediated lysis (through inhibition ofMHC I induction and TNF-a
mediated killing of activated high-avidity dengue-specific CD8 T cells). The infected
DCs are thus ineffciently eliminated from circulation, and migrate to secondary
lymphoid tissues , where they serve as reservoirs for DV dissemination. At that point
virus produced by DCs would more efficiently infect monocytes and macrophages
through ADE, targeting organs such as the liver (Kupffer cells), skin macrophages , and
possibly peritoneal/serosal macrophages. ADE-mediated infection of this normally
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infection-resistant group of cells would induce IL- lO secretion and inhibit the antiviral
functions of IFNs , and shift the major epitope-presenting population away from DCs.
This is turn would cause activation of non-protective or pathological T cell subsets
(which are not present during primary infection) that are inefficient in their clearance of
infected APCs , including DCs. This effect would be further exacerbated through the
inhibition of APC function by circulating IL- lO. Factors such as early DC IFN-a
production, low DC susceptibility to infection, and resistance to infection-dependent
blunting of DC function would protect against this pathological cascade. DC IL- l 0
production, higher susceptibility ofDCs to infection, and high levels ofTNF-a secretion
by infected DCs would exacerbate early immune suppression, and predispose the
individual to development ofDHF.
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